id	sid	tid	token	lemma	pos
iajs-3390	1	1	263	263	NUM
iajs-3390	1	2	©	©	ADP
iajs-3390	1	3	2024	2024	NUM
iajs-3390	1	4	the	the	DET
iajs-3390	1	5	author(s	author(s	NOUN
iajs-3390	1	6	)	)	PUNCT
iajs-3390	1	7	.	.	PUNCT
iajs-3390	2	1	published	publish	VERB
iajs-3390	2	2	by	by	ADP
iajs-3390	2	3	college	college	NOUN
iajs-3390	2	4	of	of	ADP
iajs-3390	2	5	education	education	NOUN
iajs-3390	2	6	for	for	ADP
iajs-3390	2	7	pure	pure	ADJ
iajs-3390	2	8	science	science	NOUN
iajs-3390	2	9	(	(	PUNCT
iajs-3390	2	10	ibn	ibn	PROPN
iajs-3390	2	11	al	al	PROPN
iajs-3390	2	12	-	-	PUNCT
iajs-3390	2	13	haitham	haitham	PROPN
iajs-3390	2	14	)	)	PUNCT
iajs-3390	2	15	,	,	PUNCT
iajs-3390	2	16	university	university	NOUN
iajs-3390	2	17	of	of	ADP
iajs-3390	2	18	baghdad	baghdad	PROPN
iajs-3390	2	19	.	.	PUNCT
iajs-3390	3	1	this	this	PRON
iajs-3390	3	2	is	be	AUX
iajs-3390	3	3	an	an	DET
iajs-3390	3	4	open	open	ADJ
iajs-3390	3	5	-	-	PUNCT
iajs-3390	3	6	access	access	NOUN
iajs-3390	3	7	article	article	NOUN
iajs-3390	3	8	distributed	distribute	VERB
iajs-3390	3	9	under	under	ADP
iajs-3390	3	10	the	the	DET
iajs-3390	3	11	terms	term	NOUN
iajs-3390	3	12	of	of	ADP
iajs-3390	3	13	the	the	DET
iajs-3390	3	14	creative	creative	ADJ
iajs-3390	3	15	commons	common	NOUN
iajs-3390	3	16	attribution	attribution	NOUN
iajs-3390	3	17	4.0	4.0	NUM
iajs-3390	3	18	international	international	ADJ
iajs-3390	3	19	license	license	NOUN
iajs-3390	3	20	ibn	ibn	PROPN
iajs-3390	3	21	al	al	PROPN
iajs-3390	3	22	-	-	PUNCT
iajs-3390	3	23	haitham	haitham	PROPN
iajs-3390	3	24	journal	journal	PROPN
iajs-3390	3	25	for	for	ADP
iajs-3390	3	26	pure	pure	ADJ
iajs-3390	3	27	and	and	CCONJ
iajs-3390	3	28	applied	applied	ADJ
iajs-3390	3	29	sciences	sciences	PROPN
iajs-3390	3	30	journal	journal	PROPN
iajs-3390	3	31	homepage	homepage	NOUN
iajs-3390	3	32	:	:	PUNCT
iajs-3390	3	33	jih.uobaghdad.edu.iq	jih.uobaghdad.edu.iq	NOUN
iajs-3390	3	34	pissn	pissn	ADJ
iajs-3390	3	35	:	:	PUNCT
iajs-3390	3	36	1609	1609	NUM
iajs-3390	3	37	-	-	SYM
iajs-3390	3	38	4042	4042	NUM
iajs-3390	3	39	,	,	PUNCT
iajs-3390	3	40	eissn	eissn	NOUN
iajs-3390	3	41	:	:	PUNCT
iajs-3390	3	42	2521	2521	NUM
iajs-3390	3	43	-	-	SYM
iajs-3390	3	44	3407	3407	NUM
iajs-3390	3	45	ihjpas	ihjpa	NOUN
iajs-3390	3	46	.	.	PUNCT
iajs-3390	4	1	2024	2024	NUM
iajs-3390	4	2	,	,	PUNCT
iajs-3390	4	3	37(4	37(4	X
iajs-3390	4	4	)	)	PUNCT
iajs-3390	4	5	assessment	assessment	NOUN
iajs-3390	4	6	of	of	ADP
iajs-3390	4	7	cartilage	cartilage	NOUN
iajs-3390	4	8	acidic	acidic	ADJ
iajs-3390	4	9	protein	protein	NOUN
iajs-3390	4	10	1	1	NUM
iajs-3390	4	11	and	and	CCONJ
iajs-3390	4	12	other	other	ADJ
iajs-3390	4	13	biomarkers	biomarker	NOUN
iajs-3390	4	14	in	in	ADP
iajs-3390	4	15	pre	pre	NOUN
iajs-3390	4	16	and	and	CCONJ
iajs-3390	4	17	post	post	ADJ
iajs-3390	4	18	-	-	ADJ
iajs-3390	4	19	menopausal	menopausal	ADJ
iajs-3390	4	20	iraqi	iraqi	ADJ
iajs-3390	4	21	women	woman	NOUN
iajs-3390	4	22	with	with	ADP
iajs-3390	4	23	osteoarthritis	osteoarthritis	NOUN
iajs-3390	4	24	disease	disease	NOUN
iajs-3390	4	25	noor	noor	PROPN
iajs-3390	4	26	basil	basil	PROPN
iajs-3390	4	27	ghanim1	ghanim1	PROPN
iajs-3390	4	28	,	,	PUNCT
iajs-3390	4	29	*	*	PUNCT
iajs-3390	4	30	and	and	CCONJ
iajs-3390	4	31	bushra	bushra	PROPN
iajs-3390	4	32	faris	faris	PROPN
iajs-3390	4	33	hasan2	hasan2	PROPN
iajs-3390	5	1	1,2department	1,2department	NUM
iajs-3390	5	2	of	of	ADP
iajs-3390	5	3	chemistry	chemistry	NOUN
iajs-3390	5	4	,	,	PUNCT
iajs-3390	5	5	college	college	NOUN
iajs-3390	5	6	of	of	ADP
iajs-3390	5	7	science	science	NOUN
iajs-3390	5	8	for	for	ADP
iajs-3390	5	9	women	woman	NOUN
iajs-3390	5	10	,	,	PUNCT
iajs-3390	5	11	university	university	NOUN
iajs-3390	5	12	of	of	ADP
iajs-3390	5	13	baghdad	baghdad	PROPN
iajs-3390	5	14	,	,	PUNCT
iajs-3390	5	15	baghdad	baghdad	PROPN
iajs-3390	5	16	,	,	PUNCT
iajs-3390	5	17	iraq	iraq	PROPN
iajs-3390	5	18	.	.	PUNCT
iajs-3390	6	1	*	*	PUNCT
iajs-3390	6	2	corresponding	correspond	VERB
iajs-3390	6	3	author	author	NOUN
iajs-3390	6	4	.	.	PUNCT
iajs-3390	7	1	received	receive	VERB
iajs-3390	7	2	:	:	PUNCT
iajs-3390	7	3	8	8	NUM
iajs-3390	7	4	april	april	PROPN
iajs-3390	7	5	2023	2023	NUM
iajs-3390	7	6	accepted	accept	VERB
iajs-3390	7	7	:	:	PUNCT
iajs-3390	7	8	25	25	NUM
iajs-3390	7	9	june	june	PROPN
iajs-3390	7	10	2023	2023	NUM
iajs-3390	7	11	published	publish	VERB
iajs-3390	7	12	:	:	PUNCT
iajs-3390	7	13	20	20	NUM
iajs-3390	7	14	october	october	NOUN
iajs-3390	7	15	2024	2024	NUM
iajs-3390	7	16	doi.org/10.30526/37.4.3390	doi.org/10.30526/37.4.3390	X
iajs-3390	7	17	abstract	abstract	ADJ
iajs-3390	7	18	osteoarthritis	osteoarthritis	NOUN
iajs-3390	7	19	(	(	PUNCT
iajs-3390	7	20	oa	oa	X
iajs-3390	7	21	)	)	PUNCT
iajs-3390	7	22	is	be	AUX
iajs-3390	7	23	a	a	DET
iajs-3390	7	24	degenerative	degenerative	ADJ
iajs-3390	7	25	disease	disease	NOUN
iajs-3390	7	26	that	that	PRON
iajs-3390	7	27	causes	cause	VERB
iajs-3390	7	28	pain	pain	NOUN
iajs-3390	7	29	in	in	ADP
iajs-3390	7	30	humans	human	NOUN
iajs-3390	7	31	'	'	PART
iajs-3390	7	32	joints	joint	NOUN
iajs-3390	7	33	during	during	ADP
iajs-3390	7	34	movement	movement	NOUN
iajs-3390	7	35	,	,	PUNCT
iajs-3390	7	36	especially	especially	ADV
iajs-3390	7	37	in	in	ADP
iajs-3390	7	38	the	the	DET
iajs-3390	7	39	elderly	elderly	ADJ
iajs-3390	7	40	and	and	CCONJ
iajs-3390	7	41	many	many	ADJ
iajs-3390	7	42	women	woman	NOUN
iajs-3390	7	43	.	.	PUNCT
iajs-3390	8	1	since	since	SCONJ
iajs-3390	8	2	cartilage	cartilage	NOUN
iajs-3390	8	3	plays	play	VERB
iajs-3390	8	4	a	a	DET
iajs-3390	8	5	major	major	ADJ
iajs-3390	8	6	destructive	destructive	ADJ
iajs-3390	8	7	role	role	NOUN
iajs-3390	8	8	during	during	ADP
iajs-3390	8	9	oa	oa	NOUN
iajs-3390	8	10	incidence	incidence	NOUN
iajs-3390	8	11	,	,	PUNCT
iajs-3390	8	12	its	its	PRON
iajs-3390	8	13	chemical	chemical	ADJ
iajs-3390	8	14	components	component	NOUN
iajs-3390	8	15	can	can	AUX
iajs-3390	8	16	serve	serve	VERB
iajs-3390	8	17	as	as	ADP
iajs-3390	8	18	a	a	DET
iajs-3390	8	19	sensitive	sensitive	ADJ
iajs-3390	8	20	biomarker	biomarker	NOUN
iajs-3390	8	21	for	for	ADP
iajs-3390	8	22	diagnosing	diagnose	VERB
iajs-3390	8	23	the	the	DET
iajs-3390	8	24	onset	onset	NOUN
iajs-3390	8	25	and	and	CCONJ
iajs-3390	8	26	severity	severity	NOUN
iajs-3390	8	27	of	of	ADP
iajs-3390	8	28	oa	oa	PROPN
iajs-3390	8	29	disease	disease	NOUN
iajs-3390	8	30	.	.	PUNCT
iajs-3390	9	1	cartilage	cartilage	NOUN
iajs-3390	9	2	acidic	acidic	ADJ
iajs-3390	9	3	protein	protein	NOUN
iajs-3390	9	4	1	1	NUM
iajs-3390	9	5	(	(	PUNCT
iajs-3390	9	6	crtac1	crtac1	NOUN
iajs-3390	9	7	)	)	PUNCT
iajs-3390	9	8	is	be	AUX
iajs-3390	9	9	a	a	DET
iajs-3390	9	10	critical	critical	ADJ
iajs-3390	9	11	component	component	NOUN
iajs-3390	9	12	of	of	ADP
iajs-3390	9	13	the	the	DET
iajs-3390	9	14	cartilage	cartilage	NOUN
iajs-3390	9	15	's	's	PART
iajs-3390	9	16	extracellular	extracellular	ADJ
iajs-3390	9	17	matrix	matrix	NOUN
iajs-3390	9	18	.	.	PUNCT
iajs-3390	10	1	we	we	PRON
iajs-3390	10	2	have	have	AUX
iajs-3390	10	3	aimed	aim	VERB
iajs-3390	10	4	to	to	PART
iajs-3390	10	5	test	test	VERB
iajs-3390	10	6	the	the	DET
iajs-3390	10	7	sensitivity	sensitivity	NOUN
iajs-3390	10	8	of	of	ADP
iajs-3390	10	9	crtac1	crtac1	NOUN
iajs-3390	10	10	to	to	ADP
iajs-3390	10	11	the	the	DET
iajs-3390	10	12	prognosis	prognosis	NOUN
iajs-3390	10	13	of	of	ADP
iajs-3390	10	14	oa	oa	PROPN
iajs-3390	10	15	disease	disease	NOUN
iajs-3390	10	16	in	in	ADP
iajs-3390	10	17	pre	pre	ADJ
iajs-3390	10	18	-	-	ADJ
iajs-3390	10	19	and	and	CCONJ
iajs-3390	10	20	post	post	ADJ
iajs-3390	10	21	-	-	ADJ
iajs-3390	10	22	menopausal	menopausal	ADJ
iajs-3390	10	23	women	woman	NOUN
iajs-3390	10	24	with	with	ADP
iajs-3390	10	25	oa	oa	PROPN
iajs-3390	10	26	disease	disease	NOUN
iajs-3390	10	27	.	.	PUNCT
iajs-3390	11	1	the	the	DET
iajs-3390	11	2	results	result	NOUN
iajs-3390	11	3	showed	show	VERB
iajs-3390	11	4	that	that	SCONJ
iajs-3390	11	5	the	the	DET
iajs-3390	11	6	levels	level	NOUN
iajs-3390	11	7	of	of	ADP
iajs-3390	11	8	crtac1	crtac1	NOUN
iajs-3390	11	9	in	in	ADP
iajs-3390	11	10	the	the	DET
iajs-3390	11	11	serum	serum	NOUN
iajs-3390	11	12	of	of	ADP
iajs-3390	11	13	pre	pre	ADJ
iajs-3390	11	14	-	-	ADJ
iajs-3390	11	15	and	and	CCONJ
iajs-3390	11	16	postmenopausal	postmenopausal	ADJ
iajs-3390	11	17	women	woman	NOUN
iajs-3390	11	18	with	with	ADP
iajs-3390	11	19	oa	oa	NOUN
iajs-3390	11	20	disease	disease	NOUN
iajs-3390	11	21	were	be	AUX
iajs-3390	11	22	significantly	significantly	ADV
iajs-3390	11	23	higher	high	ADJ
iajs-3390	11	24	than	than	ADP
iajs-3390	11	25	those	those	PRON
iajs-3390	11	26	in	in	ADP
iajs-3390	11	27	control	control	NOUN
iajs-3390	11	28	groups	group	NOUN
iajs-3390	11	29	of	of	ADP
iajs-3390	11	30	the	the	DET
iajs-3390	11	31	same	same	ADJ
iajs-3390	11	32	age	age	NOUN
iajs-3390	11	33	.	.	PUNCT
iajs-3390	12	1	c	c	X
iajs-3390	12	2	-	-	PUNCT
iajs-3390	12	3	reactive	reactive	ADJ
iajs-3390	12	4	protein	protein	NOUN
iajs-3390	12	5	(	(	PUNCT
iajs-3390	12	6	crp	crp	NOUN
iajs-3390	12	7	)	)	PUNCT
iajs-3390	12	8	and	and	CCONJ
iajs-3390	12	9	erythrocyte	erythrocyte	PROPN
iajs-3390	12	10	sedimentation	sedimentation	NOUN
iajs-3390	12	11	rate	rate	NOUN
iajs-3390	12	12	(	(	PUNCT
iajs-3390	12	13	esr	esr	PROPN
iajs-3390	12	14	)	)	PUNCT
iajs-3390	12	15	were	be	AUX
iajs-3390	12	16	also	also	ADV
iajs-3390	12	17	higher	high	ADJ
iajs-3390	12	18	in	in	ADP
iajs-3390	12	19	these	these	DET
iajs-3390	12	20	patients	patient	NOUN
iajs-3390	12	21	.	.	PUNCT
iajs-3390	13	1	nonetheless	nonetheless	ADV
iajs-3390	13	2	,	,	PUNCT
iajs-3390	13	3	follicle	follicle	NOUN
iajs-3390	13	4	-	-	PUNCT
iajs-3390	13	5	stimulating	stimulate	VERB
iajs-3390	13	6	hormone	hormone	NOUN
iajs-3390	13	7	(	(	PUNCT
iajs-3390	13	8	fsh	fsh	NOUN
iajs-3390	13	9	)	)	PUNCT
iajs-3390	13	10	,	,	PUNCT
iajs-3390	13	11	luteinizing	luteinizing	NOUN
iajs-3390	13	12	hormones	hormone	NOUN
iajs-3390	13	13	(	(	PUNCT
iajs-3390	13	14	lh	lh	PROPN
iajs-3390	13	15	)	)	PUNCT
iajs-3390	13	16	,	,	PUNCT
iajs-3390	13	17	and	and	CCONJ
iajs-3390	13	18	testosterone	testosterone	NOUN
iajs-3390	13	19	were	be	AUX
iajs-3390	13	20	non	non	ADJ
iajs-3390	13	21	-	-	ADJ
iajs-3390	13	22	significantly	significantly	ADV
iajs-3390	13	23	changed	change	VERB
iajs-3390	13	24	in	in	ADP
iajs-3390	13	25	oa	oa	ADP
iajs-3390	13	26	patients	patient	NOUN
iajs-3390	13	27	and	and	CCONJ
iajs-3390	13	28	the	the	DET
iajs-3390	13	29	corresponding	corresponding	PROPN
iajs-3390	13	30	control	control	NOUN
iajs-3390	13	31	group	group	NOUN
iajs-3390	13	32	at	at	ADP
iajs-3390	13	33	both	both	PRON
iajs-3390	13	34	preand	preand	VERB
iajs-3390	13	35	post	post	ADJ
iajs-3390	13	36	-	-	ADJ
iajs-3390	13	37	menopausal	menopausal	ADJ
iajs-3390	13	38	age	age	NOUN
iajs-3390	13	39	.	.	PUNCT
iajs-3390	14	1	pearson	pearson	PROPN
iajs-3390	14	2	’s	’s	PART
iajs-3390	14	3	correlation	correlation	NOUN
iajs-3390	14	4	was	be	AUX
iajs-3390	14	5	non	non	ADJ
iajs-3390	14	6	-	-	ADJ
iajs-3390	14	7	significant	significant	ADJ
iajs-3390	14	8	between	between	ADP
iajs-3390	14	9	crtac1	crtac1	NOUN
iajs-3390	14	10	and	and	CCONJ
iajs-3390	14	11	the	the	DET
iajs-3390	14	12	rest	rest	NOUN
iajs-3390	14	13	of	of	ADP
iajs-3390	14	14	the	the	DET
iajs-3390	14	15	biomarkers	biomarker	NOUN
iajs-3390	14	16	.	.	PUNCT
iajs-3390	15	1	finally	finally	ADV
iajs-3390	15	2	,	,	PUNCT
iajs-3390	15	3	using	use	VERB
iajs-3390	15	4	crtac1	crtac1	NOUN
iajs-3390	15	5	as	as	ADP
iajs-3390	15	6	a	a	DET
iajs-3390	15	7	biomarker	biomarker	NOUN
iajs-3390	15	8	to	to	PART
iajs-3390	15	9	predict	predict	VERB
iajs-3390	15	10	when	when	SCONJ
iajs-3390	15	11	oa	oa	PROPN
iajs-3390	15	12	will	will	AUX
iajs-3390	15	13	start	start	VERB
iajs-3390	15	14	and	and	CCONJ
iajs-3390	15	15	how	how	SCONJ
iajs-3390	15	16	bad	bad	ADJ
iajs-3390	15	17	it	it	PRON
iajs-3390	15	18	will	will	AUX
iajs-3390	15	19	get	get	VERB
iajs-3390	15	20	has	have	AUX
iajs-3390	15	21	shown	show	VERB
iajs-3390	15	22	that	that	SCONJ
iajs-3390	15	23	it	it	PRON
iajs-3390	15	24	works	work	VERB
iajs-3390	15	25	well	well	ADV
iajs-3390	15	26	as	as	ADP
iajs-3390	15	27	a	a	DET
iajs-3390	15	28	very	very	ADV
iajs-3390	15	29	sensitive	sensitive	ADJ
iajs-3390	15	30	and	and	CCONJ
iajs-3390	15	31	specific	specific	ADJ
iajs-3390	15	32	biomarker	biomarker	NOUN
iajs-3390	15	33	for	for	ADP
iajs-3390	15	34	the	the	DET
iajs-3390	15	35	disease	disease	NOUN
iajs-3390	15	36	in	in	ADP
iajs-3390	15	37	women	woman	NOUN
iajs-3390	15	38	before	before	ADP
iajs-3390	15	39	and	and	CCONJ
iajs-3390	15	40	after	after	ADP
iajs-3390	15	41	menopause	menopause	NOUN
iajs-3390	15	42	.	.	PUNCT
iajs-3390	16	1	keywords	keyword	NOUN
iajs-3390	16	2	:	:	PUNCT
iajs-3390	16	3	cartilage	cartilage	NOUN
iajs-3390	16	4	acidic	acidic	ADJ
iajs-3390	16	5	protein	protein	NOUN
iajs-3390	16	6	1	1	NUM
iajs-3390	16	7	,	,	PUNCT
iajs-3390	16	8	follicle	follicle	NOUN
iajs-3390	16	9	-	-	PUNCT
iajs-3390	16	10	stimulating	stimulate	VERB
iajs-3390	16	11	hormone	hormone	NOUN
iajs-3390	16	12	,	,	PUNCT
iajs-3390	16	13	luteinizing	luteinizing	NOUN
iajs-3390	16	14	hormones	hormone	NOUN
iajs-3390	16	15	,	,	PUNCT
iajs-3390	16	16	menopause	menopause	NOUN
iajs-3390	16	17	,	,	PUNCT
iajs-3390	16	18	osteoarthritis	osteoarthritis	NOUN
iajs-3390	16	19	.	.	PUNCT
iajs-3390	17	1	1	1	X
iajs-3390	17	2	.	.	X
iajs-3390	17	3	introduction	introduction	NOUN
iajs-3390	17	4	osteoarthritis	osteoarthritis	NOUN
iajs-3390	17	5	(	(	PUNCT
iajs-3390	17	6	oa	oa	X
iajs-3390	17	7	)	)	PUNCT
iajs-3390	17	8	is	be	AUX
iajs-3390	17	9	a	a	DET
iajs-3390	17	10	disease	disease	NOUN
iajs-3390	17	11	that	that	PRON
iajs-3390	17	12	causes	cause	VERB
iajs-3390	17	13	joint	joint	ADJ
iajs-3390	17	14	pain	pain	NOUN
iajs-3390	17	15	as	as	ADP
iajs-3390	17	16	a	a	DET
iajs-3390	17	17	result	result	NOUN
iajs-3390	17	18	of	of	ADP
iajs-3390	17	19	mechanical	mechanical	ADJ
iajs-3390	17	20	damage	damage	NOUN
iajs-3390	17	21	to	to	ADP
iajs-3390	17	22	the	the	DET
iajs-3390	17	23	cartilage	cartilage	NOUN
iajs-3390	17	24	lying	lie	VERB
iajs-3390	17	25	in	in	ADP
iajs-3390	17	26	that	that	DET
iajs-3390	17	27	joint	joint	NOUN
iajs-3390	17	28	[	[	X
iajs-3390	17	29	1	1	NUM
iajs-3390	17	30	]	]	PUNCT
iajs-3390	17	31	,	,	PUNCT
iajs-3390	17	32	most	most	ADV
iajs-3390	17	33	commonly	commonly	ADV
iajs-3390	17	34	in	in	ADP
iajs-3390	17	35	the	the	DET
iajs-3390	17	36	knee	knee	NOUN
iajs-3390	17	37	and	and	CCONJ
iajs-3390	17	38	hip	hip	NOUN
iajs-3390	17	39	joints	joint	NOUN
iajs-3390	17	40	[	[	X
iajs-3390	17	41	2	2	NUM
iajs-3390	17	42	]	]	PUNCT
iajs-3390	17	43	.	.	PUNCT
iajs-3390	18	1	oa	oa	PROPN
iajs-3390	18	2	is	be	AUX
iajs-3390	18	3	a	a	DET
iajs-3390	18	4	chronic	chronic	ADJ
iajs-3390	18	5	disease	disease	NOUN
iajs-3390	18	6	associated	associate	VERB
iajs-3390	18	7	with	with	ADP
iajs-3390	18	8	inflammatory	inflammatory	ADJ
iajs-3390	18	9	events	event	NOUN
iajs-3390	18	10	,	,	PUNCT
iajs-3390	18	11	yet	yet	CCONJ
iajs-3390	18	12	unlike	unlike	ADP
iajs-3390	18	13	rheumatoid	rheumatoid	NOUN
iajs-3390	18	14	arthritis	arthritis	NOUN
iajs-3390	18	15	,	,	PUNCT
iajs-3390	18	16	it	it	PRON
iajs-3390	18	17	is	be	AUX
iajs-3390	18	18	not	not	PART
iajs-3390	18	19	an	an	DET
iajs-3390	18	20	autoimmune	autoimmune	ADJ
iajs-3390	18	21	disease	disease	NOUN
iajs-3390	19	1	[	[	X
iajs-3390	19	2	3	3	NUM
iajs-3390	19	3	]	]	PUNCT
iajs-3390	19	4	.	.	PUNCT
iajs-3390	20	1	epidemiological	epidemiological	ADJ
iajs-3390	20	2	studies	study	NOUN
iajs-3390	20	3	have	have	AUX
iajs-3390	20	4	shown	show	VERB
iajs-3390	20	5	that	that	SCONJ
iajs-3390	20	6	oa	oa	PROPN
iajs-3390	20	7	has	have	VERB
iajs-3390	20	8	advanced	advanced	ADJ
iajs-3390	20	9	incidence	incidence	NOUN
iajs-3390	20	10	rates	rate	NOUN
iajs-3390	20	11	[	[	X
iajs-3390	20	12	4–6	4–6	X
iajs-3390	20	13	]	]	PUNCT
iajs-3390	20	14	.	.	PUNCT
iajs-3390	21	1	reports	report	NOUN
iajs-3390	21	2	also	also	ADV
iajs-3390	21	3	indicate	indicate	VERB
iajs-3390	21	4	that	that	SCONJ
iajs-3390	21	5	the	the	DET
iajs-3390	21	6	incidence	incidence	NOUN
iajs-3390	21	7	of	of	ADP
iajs-3390	21	8	oa	oa	PROPN
iajs-3390	21	9	is	be	AUX
iajs-3390	21	10	significantly	significantly	ADV
iajs-3390	21	11	higher	high	ADJ
iajs-3390	21	12	in	in	ADP
iajs-3390	21	13	women	woman	NOUN
iajs-3390	21	14	than	than	ADP
iajs-3390	21	15	in	in	ADP
iajs-3390	21	16	men	man	NOUN
iajs-3390	22	1	[	[	X
iajs-3390	22	2	7	7	NUM
iajs-3390	22	3	]	]	PUNCT
iajs-3390	22	4	.	.	PUNCT
iajs-3390	23	1	furthermore	furthermore	ADV
iajs-3390	23	2	,	,	PUNCT
iajs-3390	23	3	oa	oa	PROPN
iajs-3390	23	4	is	be	AUX
iajs-3390	23	5	considered	consider	VERB
iajs-3390	23	6	a	a	DET
iajs-3390	23	7	major	major	ADJ
iajs-3390	23	8	health	health	NOUN
iajs-3390	23	9	risk	risk	NOUN
iajs-3390	23	10	for	for	ADP
iajs-3390	23	11	the	the	DET
iajs-3390	23	12	elderly	elderly	ADJ
iajs-3390	23	13	[	[	X
iajs-3390	23	14	8	8	NUM
iajs-3390	23	15	]	]	PUNCT
iajs-3390	23	16	.	.	PUNCT
iajs-3390	24	1	over	over	ADP
iajs-3390	24	2	500	500	NUM
iajs-3390	24	3	million	million	NUM
iajs-3390	24	4	individuals	individual	NOUN
iajs-3390	24	5	globally	globally	ADV
iajs-3390	24	6	,	,	PUNCT
iajs-3390	24	7	or	or	CCONJ
iajs-3390	24	8	7	7	NUM
iajs-3390	24	9	%	%	NOUN
iajs-3390	24	10	of	of	ADP
iajs-3390	24	11	the	the	DET
iajs-3390	24	12	world	world	NOUN
iajs-3390	24	13	's	's	PART
iajs-3390	24	14	population	population	NOUN
iajs-3390	24	15	,	,	PUNCT
iajs-3390	24	16	have	have	VERB
iajs-3390	24	17	oa	oa	INTJ
iajs-3390	24	18	,	,	PUNCT
iajs-3390	24	19	which	which	PRON
iajs-3390	24	20	primarily	primarily	ADV
iajs-3390	24	21	impacts	impact	VERB
iajs-3390	24	22	women	woman	NOUN
iajs-3390	24	23	.	.	PUNCT
iajs-3390	25	1	it	it	PRON
iajs-3390	25	2	has	have	AUX
iajs-3390	25	3	been	be	AUX
iajs-3390	25	4	expected	expect	VERB
iajs-3390	25	5	an	an	DET
iajs-3390	25	6	aging	age	VERB
iajs-3390	25	7	population	population	NOUN
iajs-3390	25	8	and	and	CCONJ
iajs-3390	25	9	rising	rise	VERB
iajs-3390	25	10	obesity	obesity	NOUN
iajs-3390	25	11	rates	rate	NOUN
iajs-3390	25	12	to	to	PART
iajs-3390	25	13	exacerbate	exacerbate	VERB
iajs-3390	25	14	oa	oa	NOUN
iajs-3390	25	15	,	,	PUNCT
iajs-3390	25	16	a	a	DET
iajs-3390	25	17	primary	primary	ADJ
iajs-3390	25	18	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3390	25	19	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3390	25	20	https://orcid.org/my-orcid?orcid=0009-0009-4158-6128	https://orcid.org/my-orcid?orcid=0009-0009-4158-6128	PROPN
iajs-3390	25	21	mailto:basilnoor60@gmail.com	mailto:basilnoor60@gmail.com	PROPN
iajs-3390	25	22	https://orcid.org/0000-0002-4766-6120	https://orcid.org/0000-0002-4766-6120	PROPN
iajs-3390	25	23	mailto:bushrafh_chem@csw.uobaghdad.edu.iq	mailto:bushrafh_chem@csw.uobaghdad.edu.iq	PROPN
iajs-3390	25	24	ihjpas	ihjpa	NOUN
iajs-3390	25	25	.	.	PUNCT
iajs-3390	26	1	2024	2024	NUM
iajs-3390	26	2	,	,	PUNCT
iajs-3390	26	3	37(4	37(4	NOUN
iajs-3390	26	4	)	)	PUNCT
iajs-3390	26	5	264	264	NUM
iajs-3390	26	6	factor	factor	NOUN
iajs-3390	26	7	of	of	ADP
iajs-3390	26	8	disability	disability	NOUN
iajs-3390	26	9	in	in	ADP
iajs-3390	26	10	elderly	elderly	ADJ
iajs-3390	26	11	adults	adult	NOUN
iajs-3390	26	12	[	[	X
iajs-3390	26	13	9	9	NUM
iajs-3390	26	14	]	]	PUNCT
iajs-3390	26	15	.	.	PUNCT
iajs-3390	27	1	women	woman	NOUN
iajs-3390	27	2	in	in	ADP
iajs-3390	27	3	the	the	DET
iajs-3390	27	4	postmenopausal	postmenopausal	ADJ
iajs-3390	27	5	stage	stage	NOUN
iajs-3390	27	6	have	have	VERB
iajs-3390	27	7	a	a	DET
iajs-3390	27	8	wide	wide	ADJ
iajs-3390	27	9	range	range	NOUN
iajs-3390	27	10	of	of	ADP
iajs-3390	27	11	hormonal	hormonal	ADJ
iajs-3390	27	12	and	and	CCONJ
iajs-3390	27	13	signal	signal	ADJ
iajs-3390	27	14	transduction	transduction	NOUN
iajs-3390	27	15	system	system	NOUN
iajs-3390	27	16	variations	variation	NOUN
iajs-3390	27	17	[	[	X
iajs-3390	27	18	10	10	NUM
iajs-3390	27	19	]	]	PUNCT
iajs-3390	27	20	that	that	PRON
iajs-3390	27	21	can	can	AUX
iajs-3390	27	22	make	make	VERB
iajs-3390	27	23	mechanical	mechanical	ADJ
iajs-3390	27	24	stress	stress	NOUN
iajs-3390	27	25	worse	worse	ADV
iajs-3390	28	1	[	[	X
iajs-3390	28	2	11	11	NUM
iajs-3390	28	3	]	]	PUNCT
iajs-3390	28	4	and	and	CCONJ
iajs-3390	28	5	inflammatory	inflammatory	ADJ
iajs-3390	28	6	conditions	condition	NOUN
iajs-3390	28	7	more	more	ADV
iajs-3390	28	8	aggressive	aggressive	ADJ
iajs-3390	29	1	[	[	X
iajs-3390	29	2	12	12	NUM
iajs-3390	29	3	]	]	PUNCT
iajs-3390	29	4	.	.	PUNCT
iajs-3390	30	1	as	as	ADP
iajs-3390	30	2	a	a	DET
iajs-3390	30	3	result	result	NOUN
iajs-3390	30	4	,	,	PUNCT
iajs-3390	30	5	it	it	PRON
iajs-3390	30	6	's	be	AUX
iajs-3390	30	7	critical	critical	ADJ
iajs-3390	30	8	to	to	PART
iajs-3390	30	9	identify	identify	VERB
iajs-3390	30	10	how	how	SCONJ
iajs-3390	30	11	the	the	DET
iajs-3390	30	12	pathophysiology	pathophysiology	NOUN
iajs-3390	30	13	of	of	ADP
iajs-3390	30	14	oa	oa	PROPN
iajs-3390	30	15	differs	differ	VERB
iajs-3390	30	16	in	in	ADP
iajs-3390	30	17	pre	pre	ADJ
iajs-3390	30	18	-	-	ADJ
iajs-3390	30	19	and	and	CCONJ
iajs-3390	30	20	post	post	ADJ
iajs-3390	30	21	-	-	ADJ
iajs-3390	30	22	menopausal	menopausal	ADJ
iajs-3390	30	23	women	woman	NOUN
iajs-3390	30	24	.	.	PUNCT
iajs-3390	31	1	there	there	PRON
iajs-3390	31	2	is	be	VERB
iajs-3390	31	3	a	a	DET
iajs-3390	31	4	lack	lack	NOUN
iajs-3390	31	5	of	of	ADP
iajs-3390	31	6	biomarkers	biomarker	NOUN
iajs-3390	31	7	that	that	PRON
iajs-3390	31	8	diagnose	diagnose	VERB
iajs-3390	31	9	the	the	DET
iajs-3390	31	10	onset	onset	NOUN
iajs-3390	31	11	and	and	CCONJ
iajs-3390	31	12	severity	severity	NOUN
iajs-3390	31	13	of	of	ADP
iajs-3390	31	14	oa	oa	PROPN
iajs-3390	31	15	disease	disease	NOUN
iajs-3390	31	16	.	.	PUNCT
iajs-3390	32	1	researchers	researcher	NOUN
iajs-3390	32	2	have	have	AUX
iajs-3390	32	3	dedicated	dedicate	VERB
iajs-3390	32	4	a	a	DET
iajs-3390	32	5	wide	wide	ADJ
iajs-3390	32	6	range	range	NOUN
iajs-3390	32	7	of	of	ADP
iajs-3390	32	8	resources	resource	NOUN
iajs-3390	32	9	to	to	PART
iajs-3390	32	10	identify	identify	VERB
iajs-3390	32	11	a	a	DET
iajs-3390	32	12	certain	certain	ADJ
iajs-3390	32	13	,	,	PUNCT
iajs-3390	32	14	sensitive	sensitive	ADJ
iajs-3390	32	15	,	,	PUNCT
iajs-3390	32	16	and	and	CCONJ
iajs-3390	32	17	specific	specific	ADJ
iajs-3390	32	18	biomarker	biomarker	NOUN
iajs-3390	32	19	for	for	ADP
iajs-3390	32	20	the	the	DET
iajs-3390	32	21	diagnosis	diagnosis	NOUN
iajs-3390	32	22	of	of	ADP
iajs-3390	32	23	oa	oa	PROPN
iajs-3390	32	24	[	[	X
iajs-3390	32	25	13–15	13–15	NUM
iajs-3390	32	26	]	]	PUNCT
iajs-3390	32	27	.	.	PUNCT
iajs-3390	33	1	it	it	PRON
iajs-3390	33	2	has	have	AUX
iajs-3390	33	3	been	be	AUX
iajs-3390	33	4	reported	report	VERB
iajs-3390	33	5	that	that	SCONJ
iajs-3390	33	6	inflammation	inflammation	NOUN
iajs-3390	33	7	is	be	AUX
iajs-3390	33	8	associated	associate	VERB
iajs-3390	33	9	with	with	ADP
iajs-3390	33	10	the	the	DET
iajs-3390	33	11	onset	onset	NOUN
iajs-3390	33	12	and	and	CCONJ
iajs-3390	33	13	progression	progression	NOUN
iajs-3390	33	14	of	of	ADP
iajs-3390	33	15	oa	oa	PROPN
iajs-3390	33	16	disease	disease	NOUN
iajs-3390	33	17	[	[	X
iajs-3390	33	18	16	16	NUM
iajs-3390	33	19	]	]	PUNCT
iajs-3390	33	20	.	.	PUNCT
iajs-3390	34	1	c	c	X
iajs-3390	34	2	-	-	PUNCT
iajs-3390	34	3	reactive	reactive	ADJ
iajs-3390	34	4	protein	protein	NOUN
iajs-3390	34	5	(	(	PUNCT
iajs-3390	34	6	crp	crp	NOUN
iajs-3390	34	7	)	)	PUNCT
iajs-3390	35	1	[	[	X
iajs-3390	35	2	17	17	NUM
iajs-3390	35	3	]	]	PUNCT
iajs-3390	35	4	and	and	CCONJ
iajs-3390	35	5	erythrocyte	erythrocyte	PROPN
iajs-3390	35	6	sedimentation	sedimentation	NOUN
iajs-3390	35	7	rate	rate	NOUN
iajs-3390	35	8	(	(	PUNCT
iajs-3390	35	9	esr	esr	PROPN
iajs-3390	35	10	)	)	PUNCT
iajs-3390	35	11	have	have	AUX
iajs-3390	35	12	been	be	AUX
iajs-3390	35	13	used	use	VERB
iajs-3390	35	14	to	to	PART
iajs-3390	35	15	determine	determine	VERB
iajs-3390	35	16	the	the	DET
iajs-3390	35	17	inflammatory	inflammatory	ADJ
iajs-3390	35	18	conditions	condition	NOUN
iajs-3390	35	19	associated	associate	VERB
iajs-3390	35	20	with	with	ADP
iajs-3390	35	21	joint	joint	ADJ
iajs-3390	35	22	inflammation	inflammation	NOUN
iajs-3390	35	23	[	[	X
iajs-3390	35	24	18	18	NUM
iajs-3390	35	25	]	]	PUNCT
iajs-3390	35	26	.	.	PUNCT
iajs-3390	36	1	nevertheless	nevertheless	ADV
iajs-3390	36	2	,	,	PUNCT
iajs-3390	36	3	these	these	DET
iajs-3390	36	4	two	two	NUM
iajs-3390	36	5	biomarkers	biomarker	NOUN
iajs-3390	36	6	lack	lack	VERB
iajs-3390	36	7	the	the	DET
iajs-3390	36	8	specificity	specificity	NOUN
iajs-3390	36	9	to	to	PART
iajs-3390	36	10	distinguish	distinguish	VERB
iajs-3390	36	11	oa	oa	PRON
iajs-3390	36	12	from	from	ADP
iajs-3390	36	13	other	other	ADJ
iajs-3390	36	14	inflammatory	inflammatory	ADJ
iajs-3390	36	15	-	-	PUNCT
iajs-3390	36	16	related	relate	VERB
iajs-3390	36	17	illnesses	illness	NOUN
iajs-3390	36	18	[	[	X
iajs-3390	36	19	19	19	NUM
iajs-3390	36	20	]	]	PUNCT
iajs-3390	36	21	.	.	PUNCT
iajs-3390	37	1	human	human	ADJ
iajs-3390	37	2	chondrogenic	chondrogenic	ADJ
iajs-3390	37	3	tissue	tissue	NOUN
iajs-3390	37	4	's	's	PART
iajs-3390	37	5	cartilage	cartilage	NOUN
iajs-3390	37	6	acidic	acidic	ADJ
iajs-3390	37	7	protein	protein	NOUN
iajs-3390	37	8	1	1	NUM
iajs-3390	37	9	(	(	PUNCT
iajs-3390	37	10	crtac1	crtac1	NOUN
iajs-3390	37	11	)	)	PUNCT
iajs-3390	37	12	,	,	PUNCT
iajs-3390	37	13	an	an	DET
iajs-3390	37	14	extracellular	extracellular	ADJ
iajs-3390	37	15	matrix	matrix	NOUN
iajs-3390	37	16	(	(	PUNCT
iajs-3390	37	17	ecm	ecm	NOUN
iajs-3390	37	18	)	)	PUNCT
iajs-3390	37	19	peptide	peptide	NOUN
iajs-3390	37	20	,	,	PUNCT
iajs-3390	37	21	has	have	AUX
iajs-3390	37	22	been	be	AUX
iajs-3390	37	23	implicated	implicate	VERB
iajs-3390	37	24	in	in	ADP
iajs-3390	37	25	several	several	ADJ
iajs-3390	37	26	illnesses	illness	NOUN
iajs-3390	37	27	.	.	PUNCT
iajs-3390	38	1	for	for	ADP
iajs-3390	38	2	instance	instance	NOUN
iajs-3390	38	3	,	,	PUNCT
iajs-3390	38	4	in	in	ADP
iajs-3390	38	5	human	human	ADJ
iajs-3390	38	6	primary	primary	ADJ
iajs-3390	38	7	fibroblast	fibroblast	ADJ
iajs-3390	38	8	cells	cell	NOUN
iajs-3390	38	9	,	,	PUNCT
iajs-3390	38	10	crtac1	crtac1	NOUN
iajs-3390	38	11	enhances	enhance	VERB
iajs-3390	38	12	cellular	cellular	ADJ
iajs-3390	38	13	proliferation	proliferation	NOUN
iajs-3390	38	14	,	,	PUNCT
iajs-3390	38	15	emigration	emigration	NOUN
iajs-3390	38	16	,	,	PUNCT
iajs-3390	38	17	ecm	ecm	NOUN
iajs-3390	38	18	repair	repair	NOUN
iajs-3390	38	19	,	,	PUNCT
iajs-3390	38	20	and	and	CCONJ
iajs-3390	38	21	reorganization	reorganization	NOUN
iajs-3390	38	22	[	[	X
iajs-3390	38	23	20	20	NUM
iajs-3390	38	24	]	]	PUNCT
iajs-3390	38	25	.	.	PUNCT
iajs-3390	39	1	the	the	DET
iajs-3390	39	2	main	main	ADJ
iajs-3390	39	3	purpose	purpose	NOUN
iajs-3390	39	4	of	of	ADP
iajs-3390	39	5	crtac1	crtac1	NOUN
iajs-3390	39	6	's	's	PART
iajs-3390	39	7	discovery	discovery	NOUN
iajs-3390	39	8	was	be	AUX
iajs-3390	39	9	to	to	PART
iajs-3390	39	10	distinguish	distinguish	VERB
iajs-3390	39	11	human	human	ADJ
iajs-3390	39	12	chondrocytes	chondrocyte	NOUN
iajs-3390	39	13	from	from	ADP
iajs-3390	39	14	mesenchymal	mesenchymal	ADJ
iajs-3390	39	15	stem	stem	NOUN
iajs-3390	39	16	cells	cell	NOUN
iajs-3390	39	17	and	and	CCONJ
iajs-3390	39	18	osteoblasts	osteoblast	NOUN
iajs-3390	39	19	[	[	X
iajs-3390	39	20	21	21	NUM
iajs-3390	39	21	]	]	PUNCT
iajs-3390	39	22	.	.	PUNCT
iajs-3390	40	1	given	give	VERB
iajs-3390	40	2	that	that	SCONJ
iajs-3390	40	3	oa	oa	PROPN
iajs-3390	40	4	is	be	AUX
iajs-3390	40	5	a	a	DET
iajs-3390	40	6	degenerative	degenerative	ADJ
iajs-3390	40	7	disease	disease	NOUN
iajs-3390	40	8	that	that	PRON
iajs-3390	40	9	causes	cause	VERB
iajs-3390	40	10	degradation	degradation	NOUN
iajs-3390	40	11	of	of	ADP
iajs-3390	40	12	the	the	DET
iajs-3390	40	13	joint	joint	ADJ
iajs-3390	40	14	cartilage	cartilage	NOUN
iajs-3390	40	15	[	[	X
iajs-3390	40	16	22	22	NUM
iajs-3390	40	17	]	]	PUNCT
iajs-3390	40	18	,	,	PUNCT
iajs-3390	40	19	and	and	CCONJ
iajs-3390	40	20	that	that	DET
iajs-3390	40	21	crtac1	crtac1	NOUN
iajs-3390	40	22	is	be	AUX
iajs-3390	40	23	an	an	DET
iajs-3390	40	24	important	important	ADJ
iajs-3390	40	25	ecm	ecm	NOUN
iajs-3390	40	26	component	component	NOUN
iajs-3390	40	27	of	of	ADP
iajs-3390	40	28	the	the	DET
iajs-3390	40	29	cartilage	cartilage	NOUN
iajs-3390	40	30	[	[	X
iajs-3390	40	31	23	23	NUM
iajs-3390	40	32	]	]	PUNCT
iajs-3390	40	33	,	,	PUNCT
iajs-3390	40	34	it	it	PRON
iajs-3390	40	35	can	can	AUX
iajs-3390	40	36	serve	serve	VERB
iajs-3390	40	37	as	as	ADP
iajs-3390	40	38	a	a	DET
iajs-3390	40	39	sensitive	sensitive	ADJ
iajs-3390	40	40	and	and	CCONJ
iajs-3390	40	41	specific	specific	ADJ
iajs-3390	40	42	biomarker	biomarker	NOUN
iajs-3390	40	43	for	for	ADP
iajs-3390	40	44	the	the	DET
iajs-3390	40	45	development	development	NOUN
iajs-3390	40	46	and	and	CCONJ
iajs-3390	40	47	progression	progression	NOUN
iajs-3390	40	48	of	of	ADP
iajs-3390	40	49	oa	oa	INTJ
iajs-3390	40	50	.	.	PUNCT
iajs-3390	41	1	we	we	PRON
iajs-3390	41	2	aimed	aim	VERB
iajs-3390	41	3	to	to	PART
iajs-3390	41	4	estimate	estimate	VERB
iajs-3390	41	5	the	the	DET
iajs-3390	41	6	serum	serum	NOUN
iajs-3390	41	7	level	level	NOUN
iajs-3390	41	8	of	of	ADP
iajs-3390	41	9	crtac1	crtac1	NOUN
iajs-3390	41	10	in	in	ADP
iajs-3390	41	11	women	woman	NOUN
iajs-3390	41	12	at	at	ADP
iajs-3390	41	13	preand	preand	NOUN
iajs-3390	41	14	postmenopausal	postmenopausal	ADJ
iajs-3390	41	15	stages	stage	NOUN
iajs-3390	41	16	to	to	PART
iajs-3390	41	17	investigate	investigate	VERB
iajs-3390	41	18	its	its	PRON
iajs-3390	41	19	relationship	relationship	NOUN
iajs-3390	41	20	with	with	ADP
iajs-3390	41	21	oa	oa	PRON
iajs-3390	41	22	at	at	ADP
iajs-3390	41	23	both	both	DET
iajs-3390	41	24	stages	stage	NOUN
iajs-3390	41	25	and	and	CCONJ
iajs-3390	41	26	predict	predict	VERB
iajs-3390	41	27	its	its	PRON
iajs-3390	41	28	sensitivity	sensitivity	NOUN
iajs-3390	41	29	in	in	ADP
iajs-3390	41	30	the	the	DET
iajs-3390	41	31	disease	disease	NOUN
iajs-3390	41	32	's	's	PART
iajs-3390	41	33	prognosis	prognosis	NOUN
iajs-3390	41	34	.	.	PUNCT
iajs-3390	42	1	moreover	moreover	ADV
iajs-3390	42	2	,	,	PUNCT
iajs-3390	42	3	this	this	DET
iajs-3390	42	4	study	study	NOUN
iajs-3390	42	5	aims	aim	VERB
iajs-3390	42	6	to	to	PART
iajs-3390	42	7	find	find	VERB
iajs-3390	42	8	the	the	DET
iajs-3390	42	9	relationship	relationship	NOUN
iajs-3390	42	10	with	with	ADP
iajs-3390	42	11	the	the	DET
iajs-3390	42	12	routine	routine	ADJ
iajs-3390	42	13	inflammatory	inflammatory	ADJ
iajs-3390	42	14	biomarkers	biomarker	NOUN
iajs-3390	42	15	,	,	PUNCT
iajs-3390	42	16	crp	crp	PROPN
iajs-3390	42	17	and	and	CCONJ
iajs-3390	42	18	esr	esr	PROPN
iajs-3390	42	19	,	,	PUNCT
iajs-3390	42	20	in	in	ADP
iajs-3390	42	21	oa	oa	ADP
iajs-3390	42	22	women	woman	NOUN
iajs-3390	42	23	.	.	PUNCT
iajs-3390	43	1	2	2	X
iajs-3390	43	2	.	.	X
iajs-3390	43	3	materials	material	NOUN
iajs-3390	43	4	and	and	CCONJ
iajs-3390	43	5	methods	method	NOUN
iajs-3390	43	6	the	the	DET
iajs-3390	43	7	consulting	consult	VERB
iajs-3390	43	8	orthopedic	orthopedic	ADJ
iajs-3390	43	9	department	department	PROPN
iajs-3390	43	10	at	at	ADP
iajs-3390	43	11	baghdad	baghdad	PROPN
iajs-3390	43	12	hospital	hospital	NOUN
iajs-3390	43	13	in	in	ADP
iajs-3390	43	14	baghdad	baghdad	PROPN
iajs-3390	43	15	medical	medical	ADJ
iajs-3390	43	16	city	city	NOUN
iajs-3390	43	17	conducted	conduct	VERB
iajs-3390	43	18	the	the	DET
iajs-3390	43	19	study	study	NOUN
iajs-3390	43	20	on	on	ADP
iajs-3390	43	21	80	80	NUM
iajs-3390	43	22	women	woman	NOUN
iajs-3390	43	23	who	who	PRON
iajs-3390	43	24	had	have	AUX
iajs-3390	43	25	previously	previously	ADV
iajs-3390	43	26	received	receive	VERB
iajs-3390	43	27	a	a	DET
iajs-3390	43	28	diagnosis	diagnosis	NOUN
iajs-3390	43	29	of	of	ADP
iajs-3390	43	30	oa	oa	NOUN
iajs-3390	43	31	disease	disease	NOUN
iajs-3390	43	32	.	.	PUNCT
iajs-3390	44	1	these	these	DET
iajs-3390	44	2	80	80	NUM
iajs-3390	44	3	women	woman	NOUN
iajs-3390	44	4	were	be	AUX
iajs-3390	44	5	divided	divide	VERB
iajs-3390	44	6	into	into	ADP
iajs-3390	44	7	two	two	NUM
iajs-3390	44	8	groups	group	NOUN
iajs-3390	44	9	based	base	VERB
iajs-3390	44	10	on	on	ADP
iajs-3390	44	11	their	their	PRON
iajs-3390	44	12	menopausal	menopausal	ADJ
iajs-3390	44	13	stage	stage	NOUN
iajs-3390	44	14	,	,	PUNCT
iajs-3390	44	15	namely	namely	ADV
iajs-3390	44	16	,	,	PUNCT
iajs-3390	44	17	oa	oa	INTJ
iajs-3390	45	1	i	i	PRON
iajs-3390	45	2	and	and	CCONJ
iajs-3390	45	3	oa	oa	PROPN
iajs-3390	45	4	ii	ii	PROPN
iajs-3390	45	5	.	.	PUNCT
iajs-3390	46	1	the	the	DET
iajs-3390	46	2	first	first	ADJ
iajs-3390	46	3	contained	contain	VERB
iajs-3390	46	4	the	the	DET
iajs-3390	46	5	premenopausal	premenopausal	NOUN
iajs-3390	46	6	women	woman	NOUN
iajs-3390	46	7	(	(	PUNCT
iajs-3390	46	8	40	40	NUM
iajs-3390	46	9	women	woman	NOUN
iajs-3390	46	10	,	,	PUNCT
iajs-3390	46	11	age	age	NOUN
iajs-3390	46	12	range	range	VERB
iajs-3390	46	13	25–42	25–42	NUM
iajs-3390	46	14	years	year	NOUN
iajs-3390	46	15	;	;	PUNCT
iajs-3390	46	16	35.93±4.36	35.93±4.36	NUM
iajs-3390	46	17	years	year	NOUN
iajs-3390	46	18	)	)	PUNCT
iajs-3390	46	19	,	,	PUNCT
iajs-3390	46	20	and	and	CCONJ
iajs-3390	46	21	the	the	DET
iajs-3390	46	22	last	last	ADJ
iajs-3390	46	23	contained	contain	VERB
iajs-3390	46	24	the	the	DET
iajs-3390	46	25	postmenopausal	postmenopausal	ADJ
iajs-3390	46	26	women	woman	NOUN
iajs-3390	46	27	(	(	PUNCT
iajs-3390	46	28	40	40	NUM
iajs-3390	46	29	women	woman	NOUN
iajs-3390	46	30	,	,	PUNCT
iajs-3390	46	31	age	age	NOUN
iajs-3390	46	32	range	range	VERB
iajs-3390	46	33	48–67	48–67	NUM
iajs-3390	46	34	years	year	NOUN
iajs-3390	46	35	;	;	PUNCT
iajs-3390	46	36	56.05±4.64	56.05±4.64	NUM
iajs-3390	46	37	years	year	NOUN
iajs-3390	46	38	)	)	PUNCT
iajs-3390	46	39	.	.	PUNCT
iajs-3390	47	1	accordingly	accordingly	ADV
iajs-3390	47	2	,	,	PUNCT
iajs-3390	47	3	the	the	DET
iajs-3390	47	4	study	study	NOUN
iajs-3390	47	5	was	be	AUX
iajs-3390	47	6	controlled	control	VERB
iajs-3390	47	7	with	with	ADP
iajs-3390	47	8	two	two	NUM
iajs-3390	47	9	sets	set	NOUN
iajs-3390	47	10	of	of	ADP
iajs-3390	47	11	healthy	healthy	ADJ
iajs-3390	47	12	women	woman	NOUN
iajs-3390	47	13	.	.	PUNCT
iajs-3390	48	1	the	the	DET
iajs-3390	48	2	first	first	ADJ
iajs-3390	48	3	group	group	NOUN
iajs-3390	48	4	was	be	AUX
iajs-3390	48	5	termed	term	VERB
iajs-3390	48	6	control	control	PROPN
iajs-3390	48	7	i	i	PRON
iajs-3390	48	8	,	,	PUNCT
iajs-3390	48	9	which	which	PRON
iajs-3390	48	10	contained	contain	VERB
iajs-3390	48	11	the	the	DET
iajs-3390	48	12	premenopausal	premenopausal	NOUN
iajs-3390	48	13	women	woman	NOUN
iajs-3390	48	14	(	(	PUNCT
iajs-3390	48	15	35	35	NUM
iajs-3390	48	16	women	woman	NOUN
iajs-3390	48	17	,	,	PUNCT
iajs-3390	48	18	age	age	NOUN
iajs-3390	48	19	range	range	NOUN
iajs-3390	48	20	25–43	25–43	NUM
iajs-3390	48	21	years	year	NOUN
iajs-3390	48	22	;	;	PUNCT
iajs-3390	48	23	34.77±5.00	34.77±5.00	NUM
iajs-3390	48	24	years	year	NOUN
iajs-3390	48	25	)	)	PUNCT
iajs-3390	48	26	,	,	PUNCT
iajs-3390	48	27	and	and	CCONJ
iajs-3390	48	28	the	the	DET
iajs-3390	48	29	second	second	ADJ
iajs-3390	48	30	group	group	NOUN
iajs-3390	48	31	was	be	AUX
iajs-3390	48	32	termed	term	VERB
iajs-3390	48	33	control	control	PROPN
iajs-3390	48	34	ii	ii	PROPN
iajs-3390	48	35	,	,	PUNCT
iajs-3390	48	36	which	which	PRON
iajs-3390	48	37	contained	contain	VERB
iajs-3390	48	38	the	the	DET
iajs-3390	48	39	postmenopausal	postmenopausal	ADJ
iajs-3390	48	40	women	woman	NOUN
iajs-3390	48	41	(	(	PUNCT
iajs-3390	48	42	35	35	NUM
iajs-3390	48	43	women	woman	NOUN
iajs-3390	48	44	,	,	PUNCT
iajs-3390	48	45	age	age	NOUN
iajs-3390	48	46	range	range	NOUN
iajs-3390	48	47	47–63	47–63	NUM
iajs-3390	48	48	years	year	NOUN
iajs-3390	48	49	;	;	PUNCT
iajs-3390	48	50	55.20±4.35	55.20±4.35	NUM
iajs-3390	48	51	years	year	NOUN
iajs-3390	48	52	)	)	PUNCT
iajs-3390	48	53	.	.	PUNCT
iajs-3390	49	1	this	this	DET
iajs-3390	49	2	study	study	NOUN
iajs-3390	49	3	calculated	calculate	VERB
iajs-3390	49	4	each	each	DET
iajs-3390	49	5	woman	woman	NOUN
iajs-3390	49	6	's	's	PART
iajs-3390	49	7	weight	weight	NOUN
iajs-3390	49	8	and	and	CCONJ
iajs-3390	49	9	height	height	NOUN
iajs-3390	49	10	to	to	PART
iajs-3390	49	11	determine	determine	VERB
iajs-3390	49	12	her	her	PRON
iajs-3390	49	13	body	body	NOUN
iajs-3390	49	14	mass	mass	NOUN
iajs-3390	49	15	index	index	NOUN
iajs-3390	49	16	(	(	PUNCT
iajs-3390	49	17	bmi	bmi	PROPN
iajs-3390	49	18	)	)	PUNCT
iajs-3390	49	19	,	,	PUNCT
iajs-3390	49	20	collected	collect	VERB
iajs-3390	49	21	her	her	PRON
iajs-3390	49	22	blood	blood	NOUN
iajs-3390	49	23	from	from	ADP
iajs-3390	49	24	the	the	DET
iajs-3390	49	25	vein	vein	NOUN
iajs-3390	49	26	,	,	PUNCT
iajs-3390	49	27	extracted	extract	VERB
iajs-3390	49	28	the	the	DET
iajs-3390	49	29	serum	serum	NOUN
iajs-3390	49	30	at	at	ADP
iajs-3390	49	31	1500	1500	NUM
iajs-3390	49	32	x	x	SYM
iajs-3390	49	33	g	g	NOUN
iajs-3390	49	34	for	for	ADP
iajs-3390	49	35	10	10	NUM
iajs-3390	49	36	minutes	minute	NOUN
iajs-3390	49	37	,	,	PUNCT
iajs-3390	49	38	and	and	CCONJ
iajs-3390	49	39	stored	store	VERB
iajs-3390	49	40	it	it	PRON
iajs-3390	49	41	until	until	ADP
iajs-3390	49	42	analysis	analysis	NOUN
iajs-3390	49	43	.	.	PUNCT
iajs-3390	50	1	at	at	ADP
iajs-3390	50	2	the	the	DET
iajs-3390	50	3	time	time	NOUN
iajs-3390	50	4	of	of	ADP
iajs-3390	50	5	blood	blood	NOUN
iajs-3390	50	6	collection	collection	NOUN
iajs-3390	50	7	,	,	PUNCT
iajs-3390	50	8	we	we	PRON
iajs-3390	50	9	determined	determine	VERB
iajs-3390	50	10	the	the	DET
iajs-3390	50	11	esr	esr	PROPN
iajs-3390	50	12	by	by	ADP
iajs-3390	50	13	analyzing	analyze	VERB
iajs-3390	50	14	a	a	DET
iajs-3390	50	15	whole	whole	ADJ
iajs-3390	50	16	blood	blood	NOUN
iajs-3390	50	17	sample	sample	NOUN
iajs-3390	50	18	against	against	ADP
iajs-3390	50	19	gravity	gravity	NOUN
iajs-3390	50	20	force	force	NOUN
iajs-3390	50	21	for	for	ADP
iajs-3390	50	22	one	one	NUM
iajs-3390	50	23	hour	hour	NOUN
iajs-3390	50	24	after	after	ADP
iajs-3390	50	25	mixing	mix	VERB
iajs-3390	50	26	it	it	PRON
iajs-3390	50	27	with	with	ADP
iajs-3390	50	28	an	an	DET
iajs-3390	50	29	anticoagulant	anticoagulant	NOUN
iajs-3390	50	30	(	(	PUNCT
iajs-3390	50	31	sodium	sodium	NOUN
iajs-3390	50	32	citrate	citrate	NOUN
iajs-3390	50	33	)	)	PUNCT
iajs-3390	50	34	.	.	PUNCT
iajs-3390	51	1	we	we	PRON
iajs-3390	51	2	analyzed	analyze	VERB
iajs-3390	51	3	crtac1	crtac1	NOUN
iajs-3390	51	4	in	in	ADP
iajs-3390	51	5	an	an	DET
iajs-3390	51	6	elisa	elisa	NOUN
iajs-3390	51	7	microplate	microplate	NOUN
iajs-3390	51	8	reader	reader	NOUN
iajs-3390	51	9	(	(	PUNCT
iajs-3390	51	10	biotech	biotech	PROPN
iajs-3390	51	11	,	,	PUNCT
iajs-3390	51	12	usa	usa	PROPN
iajs-3390	51	13	)	)	PUNCT
iajs-3390	51	14	using	use	VERB
iajs-3390	51	15	an	an	DET
iajs-3390	51	16	elisa	elisa	NOUN
iajs-3390	51	17	kit	kit	NOUN
iajs-3390	51	18	from	from	ADP
iajs-3390	51	19	mybiosource	mybiosource	PROPN
iajs-3390	51	20	(	(	PUNCT
iajs-3390	51	21	usa	usa	PROPN
iajs-3390	51	22	)	)	PUNCT
iajs-3390	51	23	.	.	PUNCT
iajs-3390	52	1	we	we	PRON
iajs-3390	52	2	used	use	VERB
iajs-3390	52	3	cobas	cobas	ADJ
iajs-3390	52	4	commercial	commercial	ADJ
iajs-3390	52	5	kits	kit	NOUN
iajs-3390	52	6	on	on	ADP
iajs-3390	52	7	the	the	DET
iajs-3390	52	8	cobas	cobas	PROPN
iajs-3390	52	9	e411	e411	PROPN
iajs-3390	52	10	auto	auto	NOUN
iajs-3390	52	11	-	-	PUNCT
iajs-3390	52	12	analyzer	analyzer	NOUN
iajs-3390	52	13	(	(	PUNCT
iajs-3390	52	14	roche	roche	PROPN
iajs-3390	52	15	,	,	PUNCT
iajs-3390	52	16	germany	germany	PROPN
iajs-3390	52	17	)	)	PUNCT
iajs-3390	52	18	to	to	PART
iajs-3390	52	19	analyze	analyze	VERB
iajs-3390	52	20	all	all	PRON
iajs-3390	52	21	of	of	ADP
iajs-3390	52	22	the	the	DET
iajs-3390	52	23	follicle	follicle	NOUN
iajs-3390	52	24	-	-	PUNCT
iajs-3390	52	25	stimulating	stimulate	VERB
iajs-3390	52	26	hormone	hormone	NOUN
iajs-3390	52	27	(	(	PUNCT
iajs-3390	52	28	fsh	fsh	NOUN
iajs-3390	52	29	)	)	PUNCT
iajs-3390	52	30	,	,	PUNCT
iajs-3390	52	31	luteinizing	luteinize	VERB
iajs-3390	52	32	hormone	hormone	NOUN
iajs-3390	52	33	(	(	PUNCT
iajs-3390	52	34	lh	lh	PROPN
iajs-3390	52	35	)	)	PUNCT
iajs-3390	52	36	,	,	PUNCT
iajs-3390	52	37	and	and	CCONJ
iajs-3390	52	38	testosterone	testosterone	NOUN
iajs-3390	52	39	,	,	PUNCT
iajs-3390	52	40	and	and	CCONJ
iajs-3390	52	41	the	the	DET
iajs-3390	52	42	cobas	cobas	ADJ
iajs-3390	52	43	b101	b101	PROPN
iajs-3390	52	44	auto	auto	NOUN
iajs-3390	52	45	-	-	PUNCT
iajs-3390	52	46	analyzer	analyzer	NOUN
iajs-3390	52	47	(	(	PUNCT
iajs-3390	52	48	roche	roche	PROPN
iajs-3390	52	49	,	,	PUNCT
iajs-3390	52	50	germany	germany	PROPN
iajs-3390	52	51	)	)	PUNCT
iajs-3390	52	52	to	to	PART
iajs-3390	52	53	analyze	analyze	VERB
iajs-3390	52	54	crp	crp	PROPN
iajs-3390	52	55	.	.	PUNCT
iajs-3390	53	1	finally	finally	ADV
iajs-3390	53	2	,	,	PUNCT
iajs-3390	53	3	linear	linear	PROPN
iajs-3390	53	4	kits	kit	NOUN
iajs-3390	53	5	detected	detect	VERB
iajs-3390	53	6	lipid	lipid	NOUN
iajs-3390	53	7	profile	profile	PROPN
iajs-3390	53	8	parameters	parameter	NOUN
iajs-3390	53	9	,	,	PUNCT
iajs-3390	53	10	including	include	VERB
iajs-3390	53	11	triglycerides	triglyceride	NOUN
iajs-3390	53	12	(	(	PUNCT
iajs-3390	53	13	tgs	tgs	NOUN
iajs-3390	53	14	)	)	PUNCT
iajs-3390	53	15	,	,	PUNCT
iajs-3390	53	16	total	total	ADJ
iajs-3390	53	17	cholesterol	cholesterol	NOUN
iajs-3390	53	18	,	,	PUNCT
iajs-3390	53	19	and	and	CCONJ
iajs-3390	53	20	high	high	ADJ
iajs-3390	53	21	-	-	PUNCT
iajs-3390	53	22	density	density	NOUN
iajs-3390	53	23	lipoprotein	lipoprotein	ADJ
iajs-3390	53	24	cholesterol	cholesterol	NOUN
iajs-3390	53	25	(	(	PUNCT
iajs-3390	53	26	hdl	hdl	NOUN
iajs-3390	53	27	-	-	PUNCT
iajs-3390	53	28	cholesterol	cholesterol	NOUN
iajs-3390	53	29	)	)	PUNCT
iajs-3390	53	30	.	.	PUNCT
iajs-3390	54	1	finally	finally	ADV
iajs-3390	54	2	,	,	PUNCT
iajs-3390	54	3	we	we	PRON
iajs-3390	54	4	statistically	statistically	ADV
iajs-3390	54	5	analyzed	analyze	VERB
iajs-3390	54	6	the	the	DET
iajs-3390	54	7	data	datum	NOUN
iajs-3390	54	8	using	use	VERB
iajs-3390	54	9	mean	mean	ADJ
iajs-3390	54	10	comparisons	comparison	NOUN
iajs-3390	54	11	(	(	PUNCT
iajs-3390	54	12	anova	anova	X
iajs-3390	54	13	and	and	CCONJ
iajs-3390	54	14	lsd	lsd	VERB
iajs-3390	54	15	post	post	ADJ
iajs-3390	54	16	-	-	ADJ
iajs-3390	54	17	hoc	hoc	ADJ
iajs-3390	54	18	test	test	NOUN
iajs-3390	54	19	)	)	PUNCT
iajs-3390	54	20	,	,	PUNCT
iajs-3390	54	21	correlation	correlation	NOUN
iajs-3390	54	22	(	(	PUNCT
iajs-3390	54	23	pearson	pearson	PROPN
iajs-3390	54	24	’s	’s	PART
iajs-3390	54	25	coefficient	coefficient	NOUN
iajs-3390	54	26	)	)	PUNCT
iajs-3390	54	27	,	,	PUNCT
iajs-3390	54	28	and	and	CCONJ
iajs-3390	54	29	receiver	receiver	ADJ
iajs-3390	54	30	operating	operating	NOUN
iajs-3390	54	31	characteristics	characteristic	NOUN
iajs-3390	54	32	(	(	PUNCT
iajs-3390	54	33	roc	roc	PROPN
iajs-3390	54	34	)	)	PUNCT
iajs-3390	54	35	in	in	ADP
iajs-3390	54	36	the	the	DET
iajs-3390	54	37	spss	spss	PROPN
iajs-3390	54	38	software	software	PROPN
iajs-3390	54	39	program	program	NOUN
iajs-3390	54	40	(	(	PUNCT
iajs-3390	54	41	version	version	NOUN
iajs-3390	54	42	26.0	26.0	NUM
iajs-3390	54	43	)	)	PUNCT
iajs-3390	54	44	.	.	PUNCT
iajs-3390	55	1	ihjpas	ihjpas	PROPN
iajs-3390	55	2	.	.	PUNCT
iajs-3390	56	1	2024	2024	NUM
iajs-3390	56	2	,	,	PUNCT
iajs-3390	56	3	37(4	37(4	NOUN
iajs-3390	56	4	)	)	PUNCT
iajs-3390	56	5	265	265	NUM
iajs-3390	56	6	3	3	NUM
iajs-3390	56	7	.	.	PUNCT
iajs-3390	56	8	results	result	VERB
iajs-3390	56	9	the	the	DET
iajs-3390	56	10	participants	participant	NOUN
iajs-3390	56	11	'	'	PART
iajs-3390	56	12	ages	age	NOUN
iajs-3390	56	13	showed	show	VERB
iajs-3390	56	14	no	no	DET
iajs-3390	56	15	significant	significant	ADJ
iajs-3390	56	16	difference	difference	NOUN
iajs-3390	56	17	between	between	ADP
iajs-3390	56	18	the	the	DET
iajs-3390	56	19	correspondence	correspondence	NOUN
iajs-3390	56	20	groups	group	NOUN
iajs-3390	56	21	of	of	ADP
iajs-3390	56	22	oa	oa	PROPN
iajs-3390	56	23	patients	patient	NOUN
iajs-3390	56	24	and	and	CCONJ
iajs-3390	56	25	control	control	NOUN
iajs-3390	56	26	women	woman	NOUN
iajs-3390	56	27	.	.	PUNCT
iajs-3390	57	1	also	also	ADV
iajs-3390	57	2	,	,	PUNCT
iajs-3390	57	3	the	the	DET
iajs-3390	57	4	differences	difference	NOUN
iajs-3390	57	5	in	in	ADP
iajs-3390	57	6	bmi	bmi	PROPN
iajs-3390	57	7	were	be	AUX
iajs-3390	57	8	non	non	ADJ
iajs-3390	57	9	-	-	ADJ
iajs-3390	57	10	significant	significant	ADJ
iajs-3390	57	11	between	between	ADP
iajs-3390	57	12	the	the	DET
iajs-3390	57	13	oa	oa	PROPN
iajs-3390	57	14	patients	patient	NOUN
iajs-3390	57	15	(	(	PUNCT
iajs-3390	57	16	28.92±2.97	28.92±2.97	PROPN
iajs-3390	57	17	kg	kg	PROPN
iajs-3390	57	18	/	/	SYM
iajs-3390	57	19	m2	m2	PROPN
iajs-3390	57	20	for	for	ADP
iajs-3390	57	21	oa	oa	INTJ
iajs-3390	57	22	i	i	PROPN
iajs-3390	57	23	and	and	CCONJ
iajs-3390	57	24	29.22±2.77	29.22±2.77	NUM
iajs-3390	57	25	kg	kg	PROPN
iajs-3390	57	26	/	/	SYM
iajs-3390	57	27	m2	m2	PROPN
iajs-3390	57	28	for	for	ADP
iajs-3390	57	29	oa	oa	PROPN
iajs-3390	57	30	ii	ii	PROPN
iajs-3390	57	31	)	)	PUNCT
iajs-3390	57	32	and	and	CCONJ
iajs-3390	57	33	the	the	DET
iajs-3390	57	34	corresponding	correspond	VERB
iajs-3390	57	35	control	control	NOUN
iajs-3390	57	36	groups	group	NOUN
iajs-3390	57	37	(	(	PUNCT
iajs-3390	57	38	27.74±3.73	27.74±3.73	NUM
iajs-3390	57	39	kg	kg	PROPN
iajs-3390	57	40	/	/	SYM
iajs-3390	57	41	m2	m2	PROPN
iajs-3390	57	42	for	for	ADP
iajs-3390	57	43	control	control	NOUN
iajs-3390	57	44	i	i	PRON
iajs-3390	57	45	and	and	CCONJ
iajs-3390	57	46	28.01±2.06	28.01±2.06	NUM
iajs-3390	57	47	kg	kg	PROPN
iajs-3390	57	48	/	/	SYM
iajs-3390	57	49	m2	m2	PROPN
iajs-3390	57	50	for	for	ADP
iajs-3390	57	51	control	control	PROPN
iajs-3390	57	52	ii	ii	PROPN
iajs-3390	57	53	)	)	PUNCT
iajs-3390	57	54	.	.	PUNCT
iajs-3390	58	1	the	the	DET
iajs-3390	58	2	oa	oa	PROPN
iajs-3390	58	3	ii	ii	PROPN
iajs-3390	58	4	group	group	NOUN
iajs-3390	58	5	had	have	VERB
iajs-3390	58	6	the	the	DET
iajs-3390	58	7	highest	high	ADJ
iajs-3390	58	8	level	level	NOUN
iajs-3390	58	9	of	of	ADP
iajs-3390	58	10	crtac1	crtac1	NOUN
iajs-3390	58	11	in	in	ADP
iajs-3390	58	12	their	their	PRON
iajs-3390	58	13	serum	serum	NOUN
iajs-3390	58	14	(	(	PUNCT
iajs-3390	58	15	16.48±3.48	16.48±3.48	PROPN
iajs-3390	58	16	ng	ng	PROPN
iajs-3390	58	17	/	/	SYM
iajs-3390	58	18	ml	ml	PROPN
iajs-3390	58	19	)	)	PUNCT
iajs-3390	58	20	,	,	PUNCT
iajs-3390	58	21	compared	compare	VERB
iajs-3390	58	22	to	to	ADP
iajs-3390	58	23	the	the	DET
iajs-3390	58	24	other	other	ADJ
iajs-3390	58	25	three	three	NUM
iajs-3390	58	26	groups	group	NOUN
iajs-3390	58	27	.	.	PUNCT
iajs-3390	59	1	this	this	DET
iajs-3390	59	2	difference	difference	NOUN
iajs-3390	59	3	was	be	AUX
iajs-3390	59	4	most	most	ADV
iajs-3390	59	5	noticeable	noticeable	ADJ
iajs-3390	59	6	when	when	SCONJ
iajs-3390	59	7	compared	compare	VERB
iajs-3390	59	8	to	to	ADP
iajs-3390	59	9	control	control	PROPN
iajs-3390	59	10	ii	ii	PROPN
iajs-3390	59	11	(	(	PUNCT
iajs-3390	59	12	5.34±1.86	5.34±1.86	PROPN
iajs-3390	59	13	ng	ng	PROPN
iajs-3390	59	14	/	/	SYM
iajs-3390	59	15	ml	ml	PROPN
iajs-3390	59	16	)	)	PUNCT
iajs-3390	59	17	and	and	CCONJ
iajs-3390	59	18	oa	oa	INTJ
iajs-3390	59	19	i	i	PROPN
iajs-3390	59	20	patients	patient	NOUN
iajs-3390	59	21	(	(	PUNCT
iajs-3390	59	22	12.23±3.02	12.23±3.02	NUM
iajs-3390	59	23	ng	ng	PROPN
iajs-3390	59	24	/	/	SYM
iajs-3390	59	25	ml	ml	NOUN
iajs-3390	59	26	)	)	PUNCT
iajs-3390	59	27	.	.	PUNCT
iajs-3390	60	1	furthermore	furthermore	ADV
iajs-3390	60	2	,	,	PUNCT
iajs-3390	60	3	crtac1	crtac1	NOUN
iajs-3390	60	4	serum	serum	NOUN
iajs-3390	60	5	levels	level	NOUN
iajs-3390	60	6	were	be	AUX
iajs-3390	60	7	significantly	significantly	ADV
iajs-3390	60	8	higher	high	ADJ
iajs-3390	60	9	in	in	ADP
iajs-3390	60	10	oa	oa	ADP
iajs-3390	60	11	i	i	PROPN
iajs-3390	60	12	patients	patient	NOUN
iajs-3390	60	13	compared	compare	VERB
iajs-3390	60	14	to	to	PART
iajs-3390	60	15	control	control	VERB
iajs-3390	60	16	i	i	PRON
iajs-3390	60	17	(	(	PUNCT
iajs-3390	60	18	4.97±1.64	4.97±1.64	PROPN
iajs-3390	60	19	ng	ng	PROPN
iajs-3390	60	20	/	/	SYM
iajs-3390	60	21	ml	ml	PROPN
iajs-3390	60	22	)	)	PUNCT
iajs-3390	60	23	,	,	PUNCT
iajs-3390	60	24	as	as	SCONJ
iajs-3390	60	25	shown	show	VERB
iajs-3390	60	26	in	in	ADP
iajs-3390	60	27	figure	figure	NOUN
iajs-3390	60	28	1	1	NUM
iajs-3390	60	29	.	.	PUNCT
iajs-3390	60	30	figure	figure	NOUN
iajs-3390	60	31	1	1	NUM
iajs-3390	60	32	.	.	PUNCT
iajs-3390	60	33	crtac1	crtac1	NOUN
iajs-3390	60	34	level	level	NOUN
iajs-3390	60	35	in	in	ADP
iajs-3390	60	36	oa	oa	PROPN
iajs-3390	60	37	and	and	CCONJ
iajs-3390	60	38	control	control	VERB
iajs-3390	60	39	for	for	ADP
iajs-3390	60	40	preand	preand	NOUN
iajs-3390	60	41	post	post	ADJ
iajs-3390	60	42	-	-	ADJ
iajs-3390	60	43	menopausal	menopausal	ADJ
iajs-3390	60	44	women	woman	NOUN
iajs-3390	60	45	.	.	PUNCT
iajs-3390	61	1	inflammatory	inflammatory	ADJ
iajs-3390	61	2	biomarkers	biomarker	NOUN
iajs-3390	61	3	,	,	PUNCT
iajs-3390	61	4	crp	crp	PROPN
iajs-3390	61	5	and	and	CCONJ
iajs-3390	61	6	esr	esr	PROPN
iajs-3390	61	7	,	,	PUNCT
iajs-3390	61	8	were	be	AUX
iajs-3390	61	9	at	at	ADP
iajs-3390	61	10	their	their	PRON
iajs-3390	61	11	highest	high	ADJ
iajs-3390	61	12	levels	level	NOUN
iajs-3390	61	13	in	in	ADP
iajs-3390	61	14	oa	oa	PROPN
iajs-3390	61	15	ii	ii	PROPN
iajs-3390	61	16	patients	patient	NOUN
iajs-3390	61	17	(	(	PUNCT
iajs-3390	61	18	crp	crp	PROPN
iajs-3390	61	19	16.90±6.22	16.90±6.22	NUM
iajs-3390	61	20	mg	mg	PROPN
iajs-3390	61	21	/	/	SYM
iajs-3390	61	22	l	l	NOUN
iajs-3390	61	23	;	;	PUNCT
iajs-3390	61	24	esr	esr	PROPN
iajs-3390	61	25	43.25±6.03	43.25±6.03	NUM
iajs-3390	61	26	mm	mm	NOUN
iajs-3390	61	27	/	/	SYM
iajs-3390	61	28	h	h	NOUN
iajs-3390	61	29	)	)	PUNCT
iajs-3390	61	30	,	,	PUNCT
iajs-3390	61	31	which	which	PRON
iajs-3390	61	32	were	be	AUX
iajs-3390	61	33	significant	significant	ADJ
iajs-3390	61	34	(	(	PUNCT
iajs-3390	61	35	p	p	X
iajs-3390	61	36	<	<	X
iajs-3390	61	37	0.05	0.05	NUM
iajs-3390	61	38	)	)	PUNCT
iajs-3390	61	39	compared	compare	VERB
iajs-3390	61	40	to	to	ADP
iajs-3390	61	41	control	control	PROPN
iajs-3390	61	42	ii	ii	PROPN
iajs-3390	61	43	(	(	PUNCT
iajs-3390	61	44	crp	crp	PROPN
iajs-3390	61	45	6.67±2.20	6.67±2.20	NUM
iajs-3390	61	46	mg	mg	PROPN
iajs-3390	61	47	/	/	SYM
iajs-3390	61	48	l	l	NOUN
iajs-3390	61	49	;	;	PUNCT
iajs-3390	61	50	esr	esr	PROPN
iajs-3390	61	51	22.77±6.52	22.77±6.52	NUM
iajs-3390	61	52	mm	mm	PROPN
iajs-3390	61	53	/	/	SYM
iajs-3390	61	54	h	h	NOUN
iajs-3390	61	55	)	)	PUNCT
iajs-3390	61	56	,	,	PUNCT
iajs-3390	61	57	and	and	CCONJ
iajs-3390	61	58	oa	oa	INTJ
iajs-3390	61	59	i	i	PROPN
iajs-3390	61	60	patients	patient	NOUN
iajs-3390	61	61	(	(	PUNCT
iajs-3390	61	62	crp	crp	PROPN
iajs-3390	61	63	13.18±5.26	13.18±5.26	NUM
iajs-3390	61	64	mg	mg	PROPN
iajs-3390	61	65	/	/	SYM
iajs-3390	61	66	l	l	PROPN
iajs-3390	61	67	;	;	PUNCT
iajs-3390	61	68	esr	esr	PROPN
iajs-3390	61	69	39.15±5.18	39.15±5.18	PROPN
iajs-3390	61	70	mm	mm	PROPN
iajs-3390	61	71	/	/	SYM
iajs-3390	61	72	h	h	NOUN
iajs-3390	61	73	)	)	PUNCT
iajs-3390	61	74	.	.	PUNCT
iajs-3390	62	1	furthermore	furthermore	ADV
iajs-3390	62	2	,	,	PUNCT
iajs-3390	62	3	oa	oa	INTJ
iajs-3390	62	4	i	i	PRON
iajs-3390	62	5	patients	patient	NOUN
iajs-3390	62	6	have	have	AUX
iajs-3390	62	7	shown	show	VERB
iajs-3390	62	8	significantly	significantly	ADV
iajs-3390	62	9	higher	high	ADJ
iajs-3390	62	10	levels	level	NOUN
iajs-3390	62	11	of	of	ADP
iajs-3390	62	12	crp	crp	PROPN
iajs-3390	62	13	and	and	CCONJ
iajs-3390	62	14	esr	esr	PROPN
iajs-3390	62	15	compared	compare	VERB
iajs-3390	62	16	to	to	PART
iajs-3390	62	17	control	control	VERB
iajs-3390	62	18	i	i	PRON
iajs-3390	62	19	(	(	PUNCT
iajs-3390	62	20	crp	crp	PROPN
iajs-3390	62	21	3.72	3.72	NUM
iajs-3390	62	22	1.49	1.49	NUM
iajs-3390	62	23	mg	mg	PROPN
iajs-3390	62	24	/	/	SYM
iajs-3390	62	25	l	l	NOUN
iajs-3390	62	26	;	;	PUNCT
iajs-3390	62	27	esr	esr	PROPN
iajs-3390	62	28	18.37	18.37	NUM
iajs-3390	62	29	8.35	8.35	NUM
iajs-3390	62	30	mm	mm	NOUN
iajs-3390	62	31	/	/	SYM
iajs-3390	62	32	h	h	NOUN
iajs-3390	62	33	)	)	PUNCT
iajs-3390	62	34	,	,	PUNCT
iajs-3390	62	35	as	as	SCONJ
iajs-3390	62	36	shown	show	VERB
iajs-3390	62	37	in	in	ADP
iajs-3390	62	38	figure	figure	NOUN
iajs-3390	62	39	2	2	NUM
iajs-3390	62	40	.	.	PUNCT
iajs-3390	63	1	the	the	DET
iajs-3390	63	2	levels	level	NOUN
iajs-3390	63	3	of	of	ADP
iajs-3390	63	4	fsh	fsh	NOUN
iajs-3390	63	5	,	,	PUNCT
iajs-3390	63	6	lh	lh	NOUN
iajs-3390	63	7	,	,	PUNCT
iajs-3390	63	8	and	and	CCONJ
iajs-3390	63	9	testosterone	testosterone	NOUN
iajs-3390	63	10	were	be	AUX
iajs-3390	63	11	non	non	ADJ
iajs-3390	63	12	-	-	ADJ
iajs-3390	63	13	significantly	significantly	ADV
iajs-3390	63	14	(	(	PUNCT
iajs-3390	63	15	p	p	X
iajs-3390	63	16	>	>	X
iajs-3390	63	17	0.05	0.05	NUM
iajs-3390	63	18	)	)	PUNCT
iajs-3390	63	19	different	different	ADJ
iajs-3390	63	20	between	between	ADP
iajs-3390	63	21	oa	oa	PROPN
iajs-3390	63	22	patients	patient	NOUN
iajs-3390	63	23	and	and	CCONJ
iajs-3390	63	24	the	the	DET
iajs-3390	63	25	corresponding	corresponding	ADJ
iajs-3390	63	26	control	control	NOUN
iajs-3390	63	27	groups	group	NOUN
iajs-3390	63	28	.	.	PUNCT
iajs-3390	64	1	yet	yet	ADV
iajs-3390	64	2	,	,	PUNCT
iajs-3390	64	3	according	accord	VERB
iajs-3390	64	4	to	to	ADP
iajs-3390	64	5	their	their	PRON
iajs-3390	64	6	age	age	NOUN
iajs-3390	64	7	,	,	PUNCT
iajs-3390	64	8	oa	oa	PROPN
iajs-3390	64	9	ii	ii	PROPN
iajs-3390	64	10	patients	patient	NOUN
iajs-3390	64	11	have	have	AUX
iajs-3390	64	12	shown	show	VERB
iajs-3390	64	13	significant	significant	ADJ
iajs-3390	64	14	(	(	PUNCT
iajs-3390	64	15	p	p	X
iajs-3390	64	16	<	<	X
iajs-3390	64	17	0.05	0.05	NUM
iajs-3390	64	18	)	)	PUNCT
iajs-3390	64	19	higher	high	ADJ
iajs-3390	64	20	levels	level	NOUN
iajs-3390	64	21	of	of	ADP
iajs-3390	64	22	fsh	fsh	NOUN
iajs-3390	64	23	and	and	CCONJ
iajs-3390	64	24	lh	lh	PROPN
iajs-3390	64	25	compared	compare	VERB
iajs-3390	64	26	to	to	ADP
iajs-3390	64	27	oa	oa	PROPN
iajs-3390	64	28	i	i	PROPN
iajs-3390	64	29	,	,	PUNCT
iajs-3390	64	30	while	while	SCONJ
iajs-3390	64	31	the	the	DET
iajs-3390	64	32	differences	difference	NOUN
iajs-3390	64	33	in	in	ADP
iajs-3390	64	34	testosterone	testosterone	NOUN
iajs-3390	64	35	levels	level	NOUN
iajs-3390	64	36	have	have	AUX
iajs-3390	64	37	remained	remain	VERB
iajs-3390	64	38	non	non	ADJ
iajs-3390	64	39	-	-	ADJ
iajs-3390	64	40	significant	significant	ADJ
iajs-3390	64	41	.	.	PUNCT
iajs-3390	65	1	the	the	DET
iajs-3390	65	2	levels	level	NOUN
iajs-3390	65	3	for	for	ADP
iajs-3390	65	4	fsh	fsh	NOUN
iajs-3390	65	5	,	,	PUNCT
iajs-3390	65	6	lh	lh	NOUN
iajs-3390	65	7	,	,	PUNCT
iajs-3390	65	8	and	and	CCONJ
iajs-3390	65	9	testosterone	testosterone	NOUN
iajs-3390	65	10	,	,	PUNCT
iajs-3390	65	11	respectively	respectively	ADV
iajs-3390	65	12	,	,	PUNCT
iajs-3390	65	13	were	be	AUX
iajs-3390	65	14	5.10±2.75	5.10±2.75	PROPN
iajs-3390	65	15	miu	miu	PROPN
iajs-3390	65	16	/	/	SYM
iajs-3390	65	17	ml	ml	PROPN
iajs-3390	65	18	,	,	PUNCT
iajs-3390	65	19	6.80±3.85	6.80±3.85	VERB
iajs-3390	65	20	iu	iu	NOUN
iajs-3390	65	21	/	/	SYM
iajs-3390	65	22	l	l	NOUN
iajs-3390	65	23	,	,	PUNCT
iajs-3390	65	24	and	and	CCONJ
iajs-3390	65	25	0.88±0.25	0.88±0.25	PROPN
iajs-3390	65	26	nmol	nmol	PROPN
iajs-3390	65	27	/	/	SYM
iajs-3390	65	28	l	l	PROPN
iajs-3390	65	29	for	for	ADP
iajs-3390	65	30	control	control	NOUN
iajs-3390	65	31	i	i	PRON
iajs-3390	65	32	,	,	PUNCT
iajs-3390	65	33	34.12±8.19	34.12±8.19	NUM
iajs-3390	65	34	miu	miu	PROPN
iajs-3390	65	35	/	/	SYM
iajs-3390	65	36	ml	ml	PROPN
iajs-3390	65	37	,	,	PUNCT
iajs-3390	65	38	31.07±8.72	31.07±8.72	PROPN
iajs-3390	65	39	iu	iu	PROPN
iajs-3390	65	40	/	/	SYM
iajs-3390	65	41	l	l	NOUN
iajs-3390	65	42	,	,	PUNCT
iajs-3390	65	43	and	and	CCONJ
iajs-3390	65	44	0.85±0.32	0.85±0.32	NUM
iajs-3390	65	45	nmol	nmol	PROPN
iajs-3390	65	46	/	/	SYM
iajs-3390	65	47	l	l	PROPN
iajs-3390	65	48	for	for	ADP
iajs-3390	65	49	control	control	PROPN
iajs-3390	65	50	ii	ii	PROPN
iajs-3390	65	51	,	,	PUNCT
iajs-3390	65	52	6.77±2.60	6.77±2.60	PROPN
iajs-3390	65	53	miu	miu	PROPN
iajs-3390	65	54	/	/	SYM
iajs-3390	65	55	ml	ml	PROPN
iajs-3390	65	56	,	,	PUNCT
iajs-3390	65	57	5.84±3.56	5.84±3.56	NOUN
iajs-3390	65	58	iu	iu	PROPN
iajs-3390	65	59	/	/	SYM
iajs-3390	65	60	l	l	NOUN
iajs-3390	65	61	,	,	PUNCT
iajs-3390	65	62	and	and	CCONJ
iajs-3390	65	63	0.80±0.29	0.80±0.29	NOUN
iajs-3390	65	64	nmol	nmol	PROPN
iajs-3390	65	65	/	/	SYM
iajs-3390	65	66	l	l	NOUN
iajs-3390	65	67	for	for	ADP
iajs-3390	65	68	oa	oa	INTJ
iajs-3390	65	69	i	i	PROPN
iajs-3390	65	70	patients	patient	NOUN
iajs-3390	65	71	,	,	PUNCT
iajs-3390	65	72	and	and	CCONJ
iajs-3390	65	73	35.11±8.58	35.11±8.58	NUM
iajs-3390	65	74	miu	miu	PROPN
iajs-3390	65	75	/	/	SYM
iajs-3390	65	76	ml	ml	PROPN
iajs-3390	65	77	,	,	PUNCT
iajs-3390	65	78	30.00±7.65	30.00±7.65	PROPN
iajs-3390	65	79	iu	iu	PROPN
iajs-3390	65	80	/	/	SYM
iajs-3390	65	81	l	l	NOUN
iajs-3390	65	82	,	,	PUNCT
iajs-3390	65	83	and	and	CCONJ
iajs-3390	65	84	0.89±0.32	0.89±0.32	NUM
iajs-3390	65	85	nmol	nmol	PROPN
iajs-3390	65	86	/	/	SYM
iajs-3390	65	87	l	l	NOUN
iajs-3390	65	88	for	for	ADP
iajs-3390	65	89	oa	oa	PROPN
iajs-3390	65	90	ii	ii	PROPN
iajs-3390	65	91	patients	patient	NOUN
iajs-3390	65	92	,	,	PUNCT
iajs-3390	65	93	as	as	SCONJ
iajs-3390	65	94	shown	show	VERB
iajs-3390	65	95	in	in	ADP
iajs-3390	65	96	figure	figure	NOUN
iajs-3390	65	97	3	3	NUM
iajs-3390	65	98	.	.	NOUN
iajs-3390	65	99	0	0	NUM
iajs-3390	65	100	5	5	NUM
iajs-3390	65	101	10	10	NUM
iajs-3390	65	102	15	15	NUM
iajs-3390	65	103	20	20	NUM
iajs-3390	65	104	25	25	NUM
iajs-3390	65	105	control	control	NOUN
iajs-3390	66	1	i	i	PRON
iajs-3390	66	2	oa	oa	INTJ
iajs-3390	66	3	i	i	PRON
iajs-3390	66	4	control	control	VERB
iajs-3390	67	1	ii	ii	PROPN
iajs-3390	67	2	oa	oa	PROPN
iajs-3390	67	3	ii	ii	PROPN
iajs-3390	67	4	pre	pre	X
iajs-3390	67	5	post	post	PROPN
iajs-3390	67	6	c	c	NOUN
iajs-3390	67	7	r	r	NOUN
iajs-3390	67	8	t	t	PROPN
iajs-3390	67	9	a	a	DET
iajs-3390	67	10	c	c	NOUN
iajs-3390	67	11	1	1	NUM
iajs-3390	67	12	(	(	PUNCT
iajs-3390	67	13	n	n	CCONJ
iajs-3390	67	14	g	g	NOUN
iajs-3390	67	15	/	/	SYM
iajs-3390	67	16	,	,	PUNCT
iajs-3390	67	17	l	l	NOUN
iajs-3390	67	18	)	)	PUNCT
iajs-3390	67	19	ihjpas	ihjpas	PROPN
iajs-3390	67	20	.	.	PUNCT
iajs-3390	68	1	2024	2024	NUM
iajs-3390	68	2	,	,	PUNCT
iajs-3390	68	3	37(4	37(4	NOUN
iajs-3390	68	4	)	)	PUNCT
iajs-3390	68	5	266	266	NUM
iajs-3390	68	6	figure	figure	NOUN
iajs-3390	68	7	2	2	NUM
iajs-3390	68	8	.	.	PUNCT
iajs-3390	69	1	the	the	DET
iajs-3390	69	2	levels	level	NOUN
iajs-3390	69	3	of	of	ADP
iajs-3390	69	4	crp	crp	PROPN
iajs-3390	69	5	and	and	CCONJ
iajs-3390	69	6	esr	esr	PROPN
iajs-3390	69	7	in	in	ADP
iajs-3390	69	8	oa	oa	PROPN
iajs-3390	69	9	and	and	CCONJ
iajs-3390	69	10	control	control	VERB
iajs-3390	69	11	preand	preand	VERB
iajs-3390	69	12	post	post	ADJ
iajs-3390	69	13	-	-	ADJ
iajs-3390	69	14	menopausal	menopausal	ADJ
iajs-3390	69	15	women	woman	NOUN
iajs-3390	69	16	.	.	PUNCT
iajs-3390	70	1	figure	figure	VERB
iajs-3390	70	2	3	3	NUM
iajs-3390	70	3	.	.	PUNCT
iajs-3390	71	1	the	the	DET
iajs-3390	71	2	levels	level	NOUN
iajs-3390	71	3	of	of	ADP
iajs-3390	71	4	fsh	fsh	NOUN
iajs-3390	71	5	,	,	PUNCT
iajs-3390	71	6	lh	lh	NOUN
iajs-3390	71	7	,	,	PUNCT
iajs-3390	71	8	and	and	CCONJ
iajs-3390	71	9	testosterone	testosterone	NOUN
iajs-3390	71	10	in	in	ADP
iajs-3390	71	11	oa	oa	PROPN
iajs-3390	71	12	and	and	CCONJ
iajs-3390	71	13	control	control	VERB
iajs-3390	71	14	preand	preand	VERB
iajs-3390	71	15	post	post	ADJ
iajs-3390	71	16	-	-	ADJ
iajs-3390	71	17	menopausal	menopausal	ADJ
iajs-3390	71	18	women	woman	NOUN
iajs-3390	71	19	.	.	PUNCT
iajs-3390	72	1	the	the	DET
iajs-3390	72	2	concentration	concentration	NOUN
iajs-3390	72	3	of	of	ADP
iajs-3390	72	4	serum	serum	NOUN
iajs-3390	72	5	tgs	tgs	PROPN
iajs-3390	72	6	was	be	AUX
iajs-3390	72	7	observed	observe	VERB
iajs-3390	72	8	to	to	PART
iajs-3390	72	9	be	be	AUX
iajs-3390	72	10	significantly	significantly	ADV
iajs-3390	72	11	(	(	PUNCT
iajs-3390	72	12	p	p	X
iajs-3390	72	13	<	<	X
iajs-3390	72	14	0.05	0.05	NUM
iajs-3390	72	15	)	)	PUNCT
iajs-3390	72	16	higher	high	ADJ
iajs-3390	72	17	in	in	ADP
iajs-3390	72	18	oa	oa	INTJ
iajs-3390	72	19	i	i	PRON
iajs-3390	72	20	(	(	PUNCT
iajs-3390	72	21	139.23±31.68	139.23±31.68	PROPN
iajs-3390	72	22	mg	mg	PROPN
iajs-3390	72	23	/	/	SYM
iajs-3390	72	24	dl	dl	NOUN
iajs-3390	72	25	)	)	PUNCT
iajs-3390	72	26	than	than	ADP
iajs-3390	72	27	in	in	ADP
iajs-3390	72	28	control	control	NOUN
iajs-3390	73	1	i	i	PRON
iajs-3390	73	2	(	(	PUNCT
iajs-3390	73	3	125.03±26.78	125.03±26.78	PROPN
iajs-3390	73	4	mg	mg	PROPN
iajs-3390	73	5	/	/	SYM
iajs-3390	73	6	dl	dl	PROPN
iajs-3390	73	7	)	)	PUNCT
iajs-3390	73	8	and	and	CCONJ
iajs-3390	73	9	in	in	ADP
iajs-3390	73	10	oa	oa	PROPN
iajs-3390	73	11	ii	ii	PROPN
iajs-3390	73	12	(	(	PUNCT
iajs-3390	73	13	143.30±27.56	143.30±27.56	NUM
iajs-3390	73	14	mg	mg	PROPN
iajs-3390	73	15	/	/	SYM
iajs-3390	73	16	dl	dl	NOUN
iajs-3390	73	17	)	)	PUNCT
iajs-3390	73	18	than	than	ADP
iajs-3390	73	19	in	in	ADP
iajs-3390	73	20	control	control	PROPN
iajs-3390	73	21	ii	ii	PROPN
iajs-3390	73	22	(	(	PUNCT
iajs-3390	73	23	126.58±23.88	126.58±23.88	NUM
iajs-3390	73	24	mg	mg	PROPN
iajs-3390	73	25	/	/	SYM
iajs-3390	73	26	dl	dl	PROPN
iajs-3390	73	27	)	)	PUNCT
iajs-3390	73	28	.	.	PUNCT
iajs-3390	74	1	on	on	ADP
iajs-3390	74	2	the	the	DET
iajs-3390	74	3	other	other	ADJ
iajs-3390	74	4	hand	hand	NOUN
iajs-3390	74	5	,	,	PUNCT
iajs-3390	74	6	both	both	DET
iajs-3390	74	7	total	total	ADJ
iajs-3390	74	8	cholesterol	cholesterol	NOUN
iajs-3390	74	9	and	and	CCONJ
iajs-3390	74	10	hdl	hdl	PROPN
iajs-3390	74	11	-	-	PUNCT
iajs-3390	74	12	cholesterol	cholesterol	NOUN
iajs-3390	74	13	have	have	AUX
iajs-3390	74	14	shown	show	VERB
iajs-3390	74	15	non	non	ADJ
iajs-3390	74	16	-	-	ADJ
iajs-3390	74	17	significant	significant	ADJ
iajs-3390	74	18	differences	difference	NOUN
iajs-3390	74	19	in	in	ADP
iajs-3390	74	20	the	the	DET
iajs-3390	74	21	serum	serum	NOUN
iajs-3390	74	22	of	of	ADP
iajs-3390	74	23	oa	oa	PROPN
iajs-3390	74	24	patients	patient	NOUN
iajs-3390	74	25	and	and	CCONJ
iajs-3390	74	26	the	the	DET
iajs-3390	74	27	corresponding	corresponding	ADJ
iajs-3390	74	28	control	control	NOUN
iajs-3390	74	29	groups	group	NOUN
iajs-3390	74	30	.	.	PUNCT
iajs-3390	75	1	the	the	DET
iajs-3390	75	2	levels	level	NOUN
iajs-3390	75	3	of	of	ADP
iajs-3390	75	4	total	total	ADJ
iajs-3390	75	5	cholesterol	cholesterol	NOUN
iajs-3390	75	6	and	and	CCONJ
iajs-3390	75	7	hdl	hdl	NOUN
iajs-3390	75	8	-	-	PUNCT
iajs-3390	75	9	cholesterol	cholesterol	NOUN
iajs-3390	75	10	,	,	PUNCT
iajs-3390	75	11	respectively	respectively	ADV
iajs-3390	75	12	,	,	PUNCT
iajs-3390	75	13	were	be	AUX
iajs-3390	75	14	163.69±26.34	163.69±26.34	NUM
iajs-3390	75	15	mg	mg	PROPN
iajs-3390	75	16	/	/	SYM
iajs-3390	75	17	dl	dl	PROPN
iajs-3390	75	18	and	and	CCONJ
iajs-3390	75	19	41.04±6.58	41.04±6.58	NOUN
iajs-3390	75	20	mg	mg	PROPN
iajs-3390	75	21	/	/	SYM
iajs-3390	75	22	dl	dl	PROPN
iajs-3390	75	23	for	for	ADP
iajs-3390	75	24	control	control	NOUN
iajs-3390	75	25	i	i	PRON
iajs-3390	75	26	,	,	PUNCT
iajs-3390	75	27	171.60±24.08	171.60±24.08	NUM
iajs-3390	75	28	mg	mg	PROPN
iajs-3390	75	29	/	/	SYM
iajs-3390	75	30	dl	dl	PROPN
iajs-3390	75	31	and	and	CCONJ
iajs-3390	75	32	38.09±5.42	38.09±5.42	NUM
iajs-3390	75	33	mg	mg	PROPN
iajs-3390	75	34	/	/	SYM
iajs-3390	75	35	dl	dl	PROPN
iajs-3390	75	36	for	for	ADP
iajs-3390	75	37	control	control	PROPN
iajs-3390	75	38	ii	ii	PROPN
iajs-3390	75	39	,	,	PUNCT
iajs-3390	75	40	168.98±26.50	168.98±26.50	NUM
iajs-3390	75	41	mg	mg	PROPN
iajs-3390	75	42	/	/	SYM
iajs-3390	75	43	dl	dl	PROPN
iajs-3390	75	44	and	and	CCONJ
iajs-3390	75	45	38.80±6.92	38.80±6.92	NUM
iajs-3390	75	46	mg	mg	PROPN
iajs-3390	75	47	/	/	SYM
iajs-3390	75	48	dl	dl	PROPN
iajs-3390	75	49	for	for	ADP
iajs-3390	75	50	oa	oa	INTJ
iajs-3390	75	51	i	i	PROPN
iajs-3390	75	52	,	,	PUNCT
iajs-3390	75	53	and	and	CCONJ
iajs-3390	75	54	174.38±24.80	174.38±24.80	NUM
iajs-3390	75	55	mg	mg	PROPN
iajs-3390	75	56	/	/	SYM
iajs-3390	75	57	dl	dl	PROPN
iajs-3390	75	58	and	and	CCONJ
iajs-3390	75	59	39.30±5.32	39.30±5.32	NUM
iajs-3390	75	60	mg	mg	PROPN
iajs-3390	75	61	/	/	SYM
iajs-3390	75	62	dl	dl	PROPN
iajs-3390	75	63	for	for	ADP
iajs-3390	75	64	oa	oa	PROPN
iajs-3390	75	65	ii	ii	PROPN
iajs-3390	75	66	,	,	PUNCT
iajs-3390	75	67	as	as	SCONJ
iajs-3390	75	68	illustrated	illustrate	VERB
iajs-3390	75	69	in	in	ADP
iajs-3390	75	70	figure	figure	NOUN
iajs-3390	75	71	4	4	NUM
iajs-3390	75	72	.	.	NOUN
iajs-3390	75	73	0	0	NUM
iajs-3390	75	74	10	10	NUM
iajs-3390	75	75	20	20	NUM
iajs-3390	75	76	30	30	NUM
iajs-3390	75	77	40	40	NUM
iajs-3390	75	78	50	50	NUM
iajs-3390	75	79	60	60	NUM
iajs-3390	75	80	control	control	NOUN
iajs-3390	76	1	i	i	PRON
iajs-3390	76	2	oa	oa	INTJ
iajs-3390	77	1	i	i	PRON
iajs-3390	77	2	control	control	VERB
iajs-3390	77	3	ii	ii	PROPN
iajs-3390	77	4	oa	oa	PROPN
iajs-3390	77	5	ii	ii	PROPN
iajs-3390	77	6	pre	pre	X
iajs-3390	77	7	post	post	X
iajs-3390	77	8	l	l	PROPN
iajs-3390	77	9	ev	ev	PROPN
iajs-3390	77	10	el	el	PROPN
iajs-3390	77	11	crp	crp	PROPN
iajs-3390	77	12	mg	mg	PROPN
iajs-3390	77	13	/	/	SYM
iajs-3390	77	14	l	l	NOUN
iajs-3390	77	15	esr	esr	PROPN
iajs-3390	77	16	mm	mm	PROPN
iajs-3390	77	17	/	/	SYM
iajs-3390	77	18	h	h	NOUN
iajs-3390	77	19	0	0	NUM
iajs-3390	77	20	5	5	NUM
iajs-3390	77	21	10	10	NUM
iajs-3390	77	22	15	15	NUM
iajs-3390	77	23	20	20	NUM
iajs-3390	77	24	25	25	NUM
iajs-3390	77	25	30	30	NUM
iajs-3390	77	26	35	35	NUM
iajs-3390	77	27	40	40	NUM
iajs-3390	77	28	45	45	NUM
iajs-3390	77	29	control	control	NOUN
iajs-3390	78	1	i	i	PRON
iajs-3390	78	2	oa	oa	INTJ
iajs-3390	78	3	i	i	PRON
iajs-3390	78	4	control	control	VERB
iajs-3390	79	1	ii	ii	PROPN
iajs-3390	79	2	oa	oa	PROPN
iajs-3390	79	3	ii	ii	PROPN
iajs-3390	79	4	pre	pre	X
iajs-3390	79	5	post	post	X
iajs-3390	79	6	l	l	PROPN
iajs-3390	79	7	ev	ev	PROPN
iajs-3390	79	8	el	el	PROPN
iajs-3390	79	9	fsh	fsh	PROPN
iajs-3390	79	10	miu	miu	PROPN
iajs-3390	79	11	/	/	SYM
iajs-3390	79	12	ml	ml	PROPN
iajs-3390	79	13	lh	lh	PROPN
iajs-3390	79	14	iu	iu	PROPN
iajs-3390	79	15	/	/	SYM
iajs-3390	79	16	l	l	NOUN
iajs-3390	79	17	testosterone	testosterone	NOUN
iajs-3390	79	18	nmol	nmol	PROPN
iajs-3390	79	19	/	/	SYM
iajs-3390	79	20	l	l	NOUN
iajs-3390	79	21	ihjpas	ihjpas	PROPN
iajs-3390	79	22	.	.	PUNCT
iajs-3390	80	1	2024	2024	NUM
iajs-3390	80	2	,	,	PUNCT
iajs-3390	80	3	37(4	37(4	NOUN
iajs-3390	80	4	)	)	PUNCT
iajs-3390	80	5	267	267	NUM
iajs-3390	80	6	figure	figure	NOUN
iajs-3390	80	7	4	4	NUM
iajs-3390	80	8	.	.	PUNCT
iajs-3390	81	1	the	the	DET
iajs-3390	81	2	levels	level	NOUN
iajs-3390	81	3	of	of	ADP
iajs-3390	81	4	tgs	tgs	PROPN
iajs-3390	81	5	,	,	PUNCT
iajs-3390	81	6	total	total	ADJ
iajs-3390	81	7	cholesterol	cholesterol	NOUN
iajs-3390	81	8	,	,	PUNCT
iajs-3390	81	9	and	and	CCONJ
iajs-3390	81	10	hdl	hdl	NOUN
iajs-3390	81	11	-	-	PUNCT
iajs-3390	81	12	cholesterol	cholesterol	NOUN
iajs-3390	81	13	in	in	ADP
iajs-3390	81	14	oa	oa	PROPN
iajs-3390	81	15	and	and	CCONJ
iajs-3390	81	16	control	control	VERB
iajs-3390	81	17	preand	preand	VERB
iajs-3390	81	18	post	post	ADJ
iajs-3390	81	19	-	-	ADJ
iajs-3390	81	20	menopausal	menopausal	ADJ
iajs-3390	81	21	women	woman	NOUN
iajs-3390	81	22	.	.	PUNCT
iajs-3390	82	1	table	table	NOUN
iajs-3390	82	2	1	1	NUM
iajs-3390	82	3	estimates	estimate	VERB
iajs-3390	82	4	the	the	DET
iajs-3390	82	5	pearson	pearson	NOUN
iajs-3390	82	6	correlation	correlation	NOUN
iajs-3390	82	7	between	between	ADP
iajs-3390	82	8	crtac1	crtac1	NOUN
iajs-3390	82	9	and	and	CCONJ
iajs-3390	82	10	the	the	DET
iajs-3390	82	11	other	other	ADJ
iajs-3390	82	12	biomarkers	biomarker	NOUN
iajs-3390	82	13	tested	test	VERB
iajs-3390	82	14	in	in	ADP
iajs-3390	82	15	both	both	DET
iajs-3390	82	16	preand	preand	NOUN
iajs-3390	82	17	post	post	ADJ
iajs-3390	82	18	-	-	ADJ
iajs-3390	82	19	menopausal	menopausal	ADJ
iajs-3390	82	20	oa	oa	NOUN
iajs-3390	82	21	patients	patient	NOUN
iajs-3390	82	22	.	.	PUNCT
iajs-3390	83	1	it	it	PRON
iajs-3390	83	2	has	have	AUX
iajs-3390	83	3	been	be	AUX
iajs-3390	83	4	observed	observe	VERB
iajs-3390	83	5	that	that	SCONJ
iajs-3390	83	6	there	there	PRON
iajs-3390	83	7	is	be	VERB
iajs-3390	83	8	no	no	DET
iajs-3390	83	9	significant	significant	ADJ
iajs-3390	83	10	correlation	correlation	NOUN
iajs-3390	83	11	at	at	ADV
iajs-3390	83	12	all	all	ADV
iajs-3390	83	13	.	.	PUNCT
iajs-3390	84	1	table	table	NOUN
iajs-3390	84	2	1	1	NUM
iajs-3390	84	3	.	.	PUNCT
iajs-3390	84	4	correlation	correlation	NOUN
iajs-3390	84	5	of	of	ADP
iajs-3390	84	6	crtac1	crtac1	NOUN
iajs-3390	84	7	with	with	ADP
iajs-3390	84	8	the	the	DET
iajs-3390	84	9	other	other	ADJ
iajs-3390	84	10	variables	variable	NOUN
iajs-3390	84	11	in	in	ADP
iajs-3390	84	12	oa	oa	ADP
iajs-3390	84	13	patients	patient	NOUN
iajs-3390	84	14	.	.	PUNCT
iajs-3390	85	1	variables	variable	NOUN
iajs-3390	85	2	pre	pre	ADJ
iajs-3390	85	3	-	-	ADJ
iajs-3390	85	4	menopausal	menopausal	ADJ
iajs-3390	85	5	post	post	ADJ
iajs-3390	85	6	-	-	ADJ
iajs-3390	85	7	menopausal	menopausal	ADJ
iajs-3390	85	8	r	r	NOUN
iajs-3390	85	9	p	p	NOUN
iajs-3390	85	10	r	r	NOUN
iajs-3390	85	11	p	p	NOUN
iajs-3390	85	12	age	age	NOUN
iajs-3390	85	13	0.132	0.132	NUM
iajs-3390	85	14	0.418	0.418	NUM
iajs-3390	85	15	0.042	0.042	NUM
iajs-3390	85	16	0.799	0.799	NUM
iajs-3390	85	17	bmi	bmi	PROPN
iajs-3390	85	18	-0.286	-0.286	PROPN
iajs-3390	85	19	0.074	0.074	PROPN
iajs-3390	85	20	-0.184	-0.184	NUM
iajs-3390	85	21	0.256	0.256	NUM
iajs-3390	85	22	esr	esr	PROPN
iajs-3390	85	23	0.100	0.100	NUM
iajs-3390	85	24	0.541	0.541	NUM
iajs-3390	85	25	0.260	0.260	NUM
iajs-3390	85	26	0.105	0.105	NUM
iajs-3390	85	27	crp	crp	PROPN
iajs-3390	85	28	-0.236	-0.236	PUNCT
iajs-3390	85	29	0.143	0.143	NUM
iajs-3390	85	30	-0.003	-0.003	NOUN
iajs-3390	85	31	0.985	0.985	NUM
iajs-3390	85	32	fsh	fsh	NOUN
iajs-3390	85	33	-0.087	-0.087	ADP
iajs-3390	85	34	0.594	0.594	NUM
iajs-3390	85	35	-0.157	-0.157	NOUN
iajs-3390	85	36	0.333	0.333	NUM
iajs-3390	85	37	lh	lh	PROPN
iajs-3390	85	38	0.157	0.157	NUM
iajs-3390	85	39	0.334	0.334	NUM
iajs-3390	85	40	0.024	0.024	NUM
iajs-3390	85	41	0.881	0.881	NUM
iajs-3390	85	42	testosterone	testosterone	NOUN
iajs-3390	85	43	0.116	0.116	NUM
iajs-3390	85	44	0.476	0.476	NUM
iajs-3390	85	45	-0.065	-0.065	NUM
iajs-3390	85	46	0.692	0.692	NUM
iajs-3390	85	47	tgs	tgs	PROPN
iajs-3390	85	48	-0.198	-0.198	VERB
iajs-3390	85	49	0.221	0.221	NUM
iajs-3390	85	50	-0.215	-0.215	VERB
iajs-3390	85	51	0.183	0.183	NUM
iajs-3390	85	52	total	total	ADJ
iajs-3390	85	53	cholesterol	cholesterol	NOUN
iajs-3390	85	54	-0.291	-0.291	PUNCT
iajs-3390	85	55	0.068	0.068	NUM
iajs-3390	85	56	0.118	0.118	NUM
iajs-3390	85	57	0.467	0.467	NUM
iajs-3390	85	58	hdl	hdl	NOUN
iajs-3390	85	59	-	-	PUNCT
iajs-3390	85	60	cholesterol	cholesterol	NOUN
iajs-3390	85	61	0.088	0.088	NUM
iajs-3390	85	62	0.589	0.589	NUM
iajs-3390	85	63	-0.217	-0.217	NUM
iajs-3390	85	64	0.178	0.178	NUM
iajs-3390	85	65	with	with	ADP
iajs-3390	85	66	an	an	DET
iajs-3390	85	67	area	area	NOUN
iajs-3390	85	68	under	under	ADP
iajs-3390	85	69	the	the	DET
iajs-3390	85	70	curve	curve	NOUN
iajs-3390	85	71	(	(	PUNCT
iajs-3390	85	72	auc	auc	NOUN
iajs-3390	85	73	)	)	PUNCT
iajs-3390	85	74	of	of	ADP
iajs-3390	85	75	0.985	0.985	NUM
iajs-3390	85	76	,	,	PUNCT
iajs-3390	85	77	the	the	DET
iajs-3390	85	78	roc	roc	PROPN
iajs-3390	85	79	analysis	analysis	NOUN
iajs-3390	85	80	yielded	yield	VERB
iajs-3390	85	81	excellent	excellent	ADJ
iajs-3390	85	82	sensitivity	sensitivity	NOUN
iajs-3390	85	83	from	from	ADP
iajs-3390	85	84	crtac1	crtac1	NOUN
iajs-3390	85	85	as	as	ADP
iajs-3390	85	86	a	a	DET
iajs-3390	85	87	biomarker	biomarker	NOUN
iajs-3390	85	88	for	for	ADP
iajs-3390	85	89	the	the	DET
iajs-3390	85	90	prognosis	prognosis	NOUN
iajs-3390	85	91	of	of	ADP
iajs-3390	85	92	oa	oa	PROPN
iajs-3390	85	93	degenerative	degenerative	ADJ
iajs-3390	85	94	disease	disease	NOUN
iajs-3390	85	95	in	in	ADP
iajs-3390	85	96	pre	pre	ADJ
iajs-3390	85	97	-	-	ADJ
iajs-3390	85	98	menopausal	menopausal	ADJ
iajs-3390	85	99	women	woman	NOUN
iajs-3390	85	100	.	.	PUNCT
iajs-3390	86	1	the	the	DET
iajs-3390	86	2	cut	cut	VERB
iajs-3390	86	3	-	-	PUNCT
iajs-3390	86	4	off	off	ADP
iajs-3390	86	5	value	value	NOUN
iajs-3390	86	6	of	of	ADP
iajs-3390	86	7	the	the	DET
iajs-3390	86	8	test	test	NOUN
iajs-3390	86	9	was	be	AUX
iajs-3390	86	10	7.15	7.15	NUM
iajs-3390	86	11	ng	ng	PROPN
iajs-3390	86	12	/	/	SYM
iajs-3390	86	13	ml	ml	PROPN
iajs-3390	86	14	,	,	PUNCT
iajs-3390	86	15	with	with	ADP
iajs-3390	86	16	97.5	97.5	NUM
iajs-3390	86	17	%	%	NOUN
iajs-3390	86	18	sensitivity	sensitivity	NOUN
iajs-3390	86	19	and	and	CCONJ
iajs-3390	86	20	91.4	91.4	NUM
iajs-3390	86	21	%	%	NOUN
iajs-3390	86	22	specificity	specificity	NOUN
iajs-3390	86	23	(	(	PUNCT
iajs-3390	86	24	figure	figure	NOUN
iajs-3390	86	25	5a	5a	NUM
iajs-3390	86	26	)	)	PUNCT
iajs-3390	86	27	.	.	PUNCT
iajs-3390	87	1	additionally	additionally	ADV
iajs-3390	87	2	,	,	PUNCT
iajs-3390	87	3	the	the	DET
iajs-3390	87	4	crtac1	crtac1	NOUN
iajs-3390	87	5	exhibits	exhibit	VERB
iajs-3390	87	6	exceptional	exceptional	ADJ
iajs-3390	87	7	sensitivity	sensitivity	NOUN
iajs-3390	87	8	in	in	ADP
iajs-3390	87	9	predicting	predict	VERB
iajs-3390	87	10	the	the	DET
iajs-3390	87	11	prognosis	prognosis	NOUN
iajs-3390	87	12	of	of	ADP
iajs-3390	87	13	oa	oa	PROPN
iajs-3390	87	14	degenerative	degenerative	ADJ
iajs-3390	87	15	disease	disease	NOUN
iajs-3390	87	16	in	in	ADP
iajs-3390	87	17	post	post	ADJ
iajs-3390	87	18	-	-	ADJ
iajs-3390	87	19	menopausal	menopausal	ADJ
iajs-3390	87	20	women	woman	NOUN
iajs-3390	87	21	,	,	PUNCT
iajs-3390	87	22	with	with	ADP
iajs-3390	87	23	an	an	DET
iajs-3390	87	24	auc	auc	NOUN
iajs-3390	87	25	of	of	ADP
iajs-3390	87	26	1.000	1.000	NUM
iajs-3390	87	27	.	.	PUNCT
iajs-3390	88	1	the	the	DET
iajs-3390	88	2	test	test	NOUN
iajs-3390	88	3	's	's	PART
iajs-3390	88	4	cut	cut	NOUN
iajs-3390	88	5	-	-	PUNCT
iajs-3390	88	6	off	off	ADP
iajs-3390	88	7	value	value	NOUN
iajs-3390	88	8	was	be	AUX
iajs-3390	88	9	10.05	10.05	NUM
iajs-3390	88	10	ng	ng	NOUN
iajs-3390	88	11	/	/	SYM
iajs-3390	88	12	ml	ml	NOUN
iajs-3390	88	13	with	with	ADP
iajs-3390	88	14	100	100	NUM
iajs-3390	88	15	%	%	NOUN
iajs-3390	88	16	sensitivity	sensitivity	NOUN
iajs-3390	88	17	and	and	CCONJ
iajs-3390	88	18	100	100	NUM
iajs-3390	88	19	%	%	NOUN
iajs-3390	88	20	specificity	specificity	NOUN
iajs-3390	88	21	(	(	PUNCT
iajs-3390	88	22	figure	figure	NOUN
iajs-3390	88	23	5b	5b	NUM
iajs-3390	88	24	)	)	PUNCT
iajs-3390	88	25	.	.	PUNCT
iajs-3390	89	1	0	0	NUM
iajs-3390	89	2	50	50	NUM
iajs-3390	89	3	100	100	NUM
iajs-3390	89	4	150	150	NUM
iajs-3390	89	5	200	200	NUM
iajs-3390	89	6	250	250	NUM
iajs-3390	89	7	control	control	NOUN
iajs-3390	89	8	i	i	PRON
iajs-3390	89	9	oa	oa	INTJ
iajs-3390	90	1	i	i	PRON
iajs-3390	90	2	control	control	VERB
iajs-3390	90	3	ii	ii	PROPN
iajs-3390	90	4	oa	oa	PROPN
iajs-3390	90	5	ii	ii	PROPN
iajs-3390	90	6	pre	pre	X
iajs-3390	90	7	post	post	X
iajs-3390	91	1	l	l	PROPN
iajs-3390	91	2	ev	ev	PROPN
iajs-3390	91	3	el	el	PROPN
iajs-3390	91	4	(	(	PUNCT
iajs-3390	91	5	m	m	PROPN
iajs-3390	91	6	g	g	NOUN
iajs-3390	91	7	/d	/d	SYM
iajs-3390	91	8	l	l	NOUN
iajs-3390	91	9	)	)	PUNCT
iajs-3390	92	1	tgs	tgs	PROPN
iajs-3390	92	2	total	total	ADJ
iajs-3390	92	3	cholesterol	cholesterol	PROPN
iajs-3390	92	4	hdl	hdl	PROPN
iajs-3390	92	5	-	-	PUNCT
iajs-3390	92	6	cholesterol	cholesterol	NOUN
iajs-3390	92	7	ihjpas	ihjpa	NOUN
iajs-3390	92	8	.	.	PUNCT
iajs-3390	93	1	2024	2024	NUM
iajs-3390	93	2	,	,	PUNCT
iajs-3390	93	3	37(4	37(4	NOUN
iajs-3390	93	4	)	)	PUNCT
iajs-3390	93	5	268	268	NUM
iajs-3390	93	6	figure	figure	NOUN
iajs-3390	93	7	5	5	NUM
iajs-3390	93	8	.	.	PUNCT
iajs-3390	94	1	the	the	DET
iajs-3390	94	2	roc	roc	PROPN
iajs-3390	94	3	curve	curve	NOUN
iajs-3390	94	4	of	of	ADP
iajs-3390	94	5	crtac1	crtac1	NOUN
iajs-3390	94	6	in	in	ADP
iajs-3390	94	7	the	the	DET
iajs-3390	94	8	prognosis	prognosis	NOUN
iajs-3390	94	9	of	of	ADP
iajs-3390	94	10	oa	oa	PRON
iajs-3390	94	11	for	for	ADP
iajs-3390	94	12	a	a	DET
iajs-3390	94	13	)	)	PUNCT
iajs-3390	94	14	pre	pre	ADJ
iajs-3390	94	15	-	-	ADJ
iajs-3390	94	16	menopausal	menopausal	ADJ
iajs-3390	94	17	women	woman	NOUN
iajs-3390	94	18	,	,	PUNCT
iajs-3390	94	19	and	and	CCONJ
iajs-3390	94	20	b	b	X
iajs-3390	94	21	)	)	PUNCT
iajs-3390	94	22	postmenopausal	postmenopausal	ADJ
iajs-3390	94	23	women	woman	NOUN
iajs-3390	94	24	.	.	PUNCT
iajs-3390	95	1	4	4	X
iajs-3390	95	2	.	.	X
iajs-3390	95	3	discussion	discussion	NOUN
iajs-3390	95	4	the	the	DET
iajs-3390	95	5	inflammatory	inflammatory	ADJ
iajs-3390	95	6	biomarkers	biomarker	NOUN
iajs-3390	95	7	crp	crp	PROPN
iajs-3390	95	8	and	and	CCONJ
iajs-3390	95	9	esr	esr	PROPN
iajs-3390	95	10	have	have	AUX
iajs-3390	95	11	shown	show	VERB
iajs-3390	95	12	a	a	DET
iajs-3390	95	13	significant	significant	ADJ
iajs-3390	95	14	increase	increase	NOUN
iajs-3390	95	15	in	in	ADP
iajs-3390	95	16	women	woman	NOUN
iajs-3390	95	17	with	with	ADP
iajs-3390	95	18	oa	oa	PROPN
iajs-3390	95	19	disease	disease	NOUN
iajs-3390	95	20	,	,	PUNCT
iajs-3390	95	21	regardless	regardless	ADV
iajs-3390	95	22	of	of	ADP
iajs-3390	95	23	their	their	PRON
iajs-3390	95	24	age	age	NOUN
iajs-3390	95	25	.	.	PUNCT
iajs-3390	96	1	it	it	PRON
iajs-3390	96	2	has	have	AUX
iajs-3390	96	3	been	be	AUX
iajs-3390	96	4	reported	report	VERB
iajs-3390	96	5	that	that	SCONJ
iajs-3390	96	6	the	the	DET
iajs-3390	96	7	crp	crp	NOUN
iajs-3390	96	8	indicates	indicate	VERB
iajs-3390	96	9	systemic	systemic	ADJ
iajs-3390	96	10	inflammation	inflammation	NOUN
iajs-3390	96	11	in	in	ADP
iajs-3390	96	12	oa	oa	ADP
iajs-3390	96	13	patients	patient	NOUN
iajs-3390	96	14	,	,	PUNCT
iajs-3390	96	15	in	in	ADP
iajs-3390	96	16	which	which	PRON
iajs-3390	96	17	the	the	DET
iajs-3390	96	18	level	level	NOUN
iajs-3390	96	19	of	of	ADP
iajs-3390	96	20	crp	crp	NOUN
iajs-3390	96	21	increased	increase	VERB
iajs-3390	96	22	slightly	slightly	ADV
iajs-3390	96	23	but	but	CCONJ
iajs-3390	96	24	significantly	significantly	ADV
iajs-3390	96	25	in	in	ADP
iajs-3390	96	26	oa	oa	ADP
iajs-3390	96	27	patients	patient	NOUN
iajs-3390	96	28	,	,	PUNCT
iajs-3390	96	29	indicating	indicate	VERB
iajs-3390	96	30	low	low	ADJ
iajs-3390	96	31	-	-	PUNCT
iajs-3390	96	32	grade	grade	NOUN
iajs-3390	96	33	systemic	systemic	ADJ
iajs-3390	96	34	inflammation	inflammation	NOUN
iajs-3390	96	35	in	in	ADP
iajs-3390	96	36	these	these	DET
iajs-3390	96	37	patients	patient	NOUN
iajs-3390	96	38	[	[	X
iajs-3390	96	39	24	24	NUM
iajs-3390	96	40	]	]	PUNCT
iajs-3390	96	41	.	.	PUNCT
iajs-3390	97	1	other	other	ADJ
iajs-3390	97	2	studies	study	NOUN
iajs-3390	97	3	have	have	AUX
iajs-3390	97	4	shown	show	VERB
iajs-3390	97	5	similar	similar	ADJ
iajs-3390	97	6	results	result	NOUN
iajs-3390	97	7	[	[	X
iajs-3390	97	8	25	25	NUM
iajs-3390	97	9	,	,	PUNCT
iajs-3390	97	10	26	26	NUM
iajs-3390	97	11	]	]	PUNCT
iajs-3390	97	12	.	.	PUNCT
iajs-3390	98	1	a	a	DET
iajs-3390	98	2	recent	recent	ADJ
iajs-3390	98	3	systematic	systematic	ADJ
iajs-3390	98	4	review	review	NOUN
iajs-3390	98	5	has	have	AUX
iajs-3390	98	6	found	find	VERB
iajs-3390	98	7	that	that	SCONJ
iajs-3390	98	8	inflammation	inflammation	NOUN
iajs-3390	98	9	and	and	CCONJ
iajs-3390	98	10	pain	pain	NOUN
iajs-3390	98	11	in	in	ADP
iajs-3390	98	12	knee	knee	NOUN
iajs-3390	98	13	oa	oa	PROPN
iajs-3390	99	1	patients	patient	NOUN
iajs-3390	99	2	show	show	VERB
iajs-3390	99	3	a	a	DET
iajs-3390	99	4	moderate	moderate	ADJ
iajs-3390	99	5	association	association	NOUN
iajs-3390	99	6	,	,	PUNCT
iajs-3390	99	7	depending	depend	VERB
iajs-3390	99	8	on	on	ADP
iajs-3390	99	9	crp	crp	PROPN
iajs-3390	99	10	and	and	CCONJ
iajs-3390	99	11	other	other	ADJ
iajs-3390	99	12	inflammatory	inflammatory	ADJ
iajs-3390	99	13	biomarkers	biomarker	NOUN
iajs-3390	99	14	[	[	X
iajs-3390	99	15	27	27	NUM
iajs-3390	99	16	]	]	PUNCT
iajs-3390	99	17	.	.	PUNCT
iajs-3390	100	1	in	in	ADP
iajs-3390	100	2	wolfe	wolfe	PROPN
iajs-3390	100	3	's	's	PART
iajs-3390	100	4	study	study	NOUN
iajs-3390	100	5	,	,	PUNCT
iajs-3390	100	6	esr	esr	PROPN
iajs-3390	100	7	did	do	AUX
iajs-3390	100	8	not	not	PART
iajs-3390	100	9	show	show	VERB
iajs-3390	100	10	any	any	DET
iajs-3390	100	11	association	association	NOUN
iajs-3390	100	12	with	with	ADP
iajs-3390	100	13	oa	oa	PROPN
iajs-3390	100	14	patients	patient	NOUN
iajs-3390	100	15	'	'	PART
iajs-3390	100	16	signs	sign	NOUN
iajs-3390	100	17	and	and	CCONJ
iajs-3390	100	18	symptoms	symptom	NOUN
iajs-3390	100	19	[	[	X
iajs-3390	100	20	28	28	NUM
iajs-3390	100	21	]	]	PUNCT
iajs-3390	100	22	.	.	PUNCT
iajs-3390	101	1	previous	previous	ADJ
iajs-3390	101	2	study	study	NOUN
iajs-3390	101	3	has	have	AUX
iajs-3390	101	4	reported	report	VERB
iajs-3390	101	5	that	that	SCONJ
iajs-3390	101	6	both	both	CCONJ
iajs-3390	101	7	esr	esr	PROPN
iajs-3390	101	8	and	and	CCONJ
iajs-3390	101	9	crp	crp	PROPN
iajs-3390	101	10	were	be	AUX
iajs-3390	101	11	associated	associate	VERB
iajs-3390	101	12	with	with	ADP
iajs-3390	101	13	the	the	DET
iajs-3390	101	14	clinical	clinical	ADJ
iajs-3390	101	15	symptoms	symptom	NOUN
iajs-3390	101	16	of	of	ADP
iajs-3390	101	17	knee	knee	NOUN
iajs-3390	101	18	oa	oa	INTJ
iajs-3390	101	19	,	,	PUNCT
iajs-3390	101	20	and	and	CCONJ
iajs-3390	101	21	their	their	PRON
iajs-3390	101	22	levels	level	NOUN
iajs-3390	101	23	were	be	AUX
iajs-3390	101	24	significantly	significantly	ADV
iajs-3390	101	25	higher	high	ADJ
iajs-3390	101	26	in	in	ADP
iajs-3390	101	27	these	these	DET
iajs-3390	101	28	patients	patient	NOUN
iajs-3390	102	1	[	[	X
iajs-3390	102	2	18	18	NUM
iajs-3390	102	3	]	]	PUNCT
iajs-3390	102	4	.	.	PUNCT
iajs-3390	103	1	however	however	ADV
iajs-3390	103	2	,	,	PUNCT
iajs-3390	103	3	while	while	SCONJ
iajs-3390	103	4	they	they	PRON
iajs-3390	103	5	both	both	PRON
iajs-3390	103	6	signify	signify	VERB
iajs-3390	103	7	systemic	systemic	ADJ
iajs-3390	103	8	inflammation	inflammation	NOUN
iajs-3390	103	9	,	,	PUNCT
iajs-3390	103	10	they	they	PRON
iajs-3390	103	11	fall	fall	VERB
iajs-3390	103	12	short	short	ADV
iajs-3390	103	13	of	of	ADP
iajs-3390	103	14	accurately	accurately	ADV
iajs-3390	103	15	diagnosing	diagnose	VERB
iajs-3390	103	16	oa	oa	ADP
iajs-3390	103	17	disease	disease	NOUN
iajs-3390	103	18	.	.	PUNCT
iajs-3390	104	1	the	the	DET
iajs-3390	104	2	crtac1	crtac1	NOUN
iajs-3390	104	3	is	be	AUX
iajs-3390	104	4	a	a	DET
iajs-3390	104	5	member	member	NOUN
iajs-3390	104	6	of	of	ADP
iajs-3390	104	7	the	the	DET
iajs-3390	104	8	cartilage	cartilage	NOUN
iajs-3390	104	9	's	's	PART
iajs-3390	104	10	ecm	ecm	NOUN
iajs-3390	104	11	[	[	X
iajs-3390	104	12	21	21	NUM
iajs-3390	104	13	]	]	PUNCT
iajs-3390	104	14	,	,	PUNCT
iajs-3390	104	15	and	and	CCONJ
iajs-3390	104	16	its	its	PRON
iajs-3390	104	17	release	release	NOUN
iajs-3390	104	18	into	into	ADP
iajs-3390	104	19	the	the	DET
iajs-3390	104	20	blood	blood	NOUN
iajs-3390	104	21	during	during	ADP
iajs-3390	104	22	oa	oa	ADP
iajs-3390	104	23	degeneration	degeneration	NOUN
iajs-3390	104	24	stress	stress	NOUN
iajs-3390	104	25	is	be	AUX
iajs-3390	104	26	sufficient	sufficient	ADJ
iajs-3390	104	27	to	to	PART
iajs-3390	104	28	use	use	VERB
iajs-3390	104	29	as	as	ADP
iajs-3390	104	30	a	a	DET
iajs-3390	104	31	biomarker	biomarker	NOUN
iajs-3390	104	32	for	for	ADP
iajs-3390	104	33	the	the	DET
iajs-3390	104	34	disease	disease	NOUN
iajs-3390	104	35	.	.	PUNCT
iajs-3390	105	1	according	accord	VERB
iajs-3390	105	2	to	to	ADP
iajs-3390	105	3	previous	previous	ADJ
iajs-3390	105	4	study	study	NOUN
iajs-3390	105	5	,	,	PUNCT
iajs-3390	105	6	crtac1	crtac1	PROPN
iajs-3390	105	7	,	,	PUNCT
iajs-3390	105	8	among	among	ADP
iajs-3390	105	9	the	the	DET
iajs-3390	105	10	4792	4792	NUM
iajs-3390	105	11	proteins	protein	NOUN
iajs-3390	105	12	tested	test	VERB
iajs-3390	105	13	to	to	PART
iajs-3390	105	14	predict	predict	VERB
iajs-3390	105	15	a	a	DET
iajs-3390	105	16	biomarker	biomarker	NOUN
iajs-3390	105	17	for	for	ADP
iajs-3390	105	18	oa	oa	NOUN
iajs-3390	105	19	,	,	PUNCT
iajs-3390	105	20	was	be	AUX
iajs-3390	105	21	the	the	DET
iajs-3390	105	22	most	most	ADV
iajs-3390	105	23	sensitive	sensitive	ADJ
iajs-3390	105	24	and	and	CCONJ
iajs-3390	105	25	specific	specific	ADJ
iajs-3390	105	26	for	for	ADP
iajs-3390	105	27	oa	oa	NOUN
iajs-3390	105	28	disease	disease	NOUN
iajs-3390	105	29	.	.	PUNCT
iajs-3390	106	1	they	they	PRON
iajs-3390	106	2	discovered	discover	VERB
iajs-3390	106	3	a	a	DET
iajs-3390	106	4	link	link	NOUN
iajs-3390	106	5	between	between	ADP
iajs-3390	106	6	crtac1	crtac1	NOUN
iajs-3390	106	7	and	and	CCONJ
iajs-3390	106	8	the	the	DET
iajs-3390	106	9	onset	onset	NOUN
iajs-3390	106	10	and	and	CCONJ
iajs-3390	106	11	progression	progression	NOUN
iajs-3390	106	12	of	of	ADP
iajs-3390	106	13	oa	oa	PRON
iajs-3390	106	14	[	[	X
iajs-3390	106	15	29	29	NUM
iajs-3390	106	16	]	]	PUNCT
iajs-3390	106	17	.	.	PUNCT
iajs-3390	107	1	according	accord	VERB
iajs-3390	107	2	to	to	ADP
iajs-3390	107	3	preceding	precede	VERB
iajs-3390	107	4	data	datum	NOUN
iajs-3390	107	5	,	,	PUNCT
iajs-3390	107	6	crtac1	crtac1	NOUN
iajs-3390	107	7	was	be	AUX
iajs-3390	107	8	the	the	DET
iajs-3390	107	9	most	most	ADV
iajs-3390	107	10	significant	significant	ADJ
iajs-3390	107	11	in	in	ADP
iajs-3390	107	12	the	the	DET
iajs-3390	107	13	overall	overall	ADJ
iajs-3390	107	14	oa	oa	PROPN
iajs-3390	107	15	prognosis	prognosis	NOUN
iajs-3390	107	16	in	in	ADP
iajs-3390	107	17	patients	patient	NOUN
iajs-3390	107	18	.	.	PUNCT
iajs-3390	108	1	mutar	mutar	PROPN
iajs-3390	108	2	et	et	PROPN
iajs-3390	108	3	al	al	PROPN
iajs-3390	108	4	.	.	PROPN
iajs-3390	108	5	,	,	PUNCT
iajs-3390	108	6	have	have	AUX
iajs-3390	108	7	reported	report	VERB
iajs-3390	108	8	a	a	DET
iajs-3390	108	9	significant	significant	ADJ
iajs-3390	108	10	increase	increase	NOUN
iajs-3390	108	11	in	in	ADP
iajs-3390	108	12	crtac1	crtac1	NOUN
iajs-3390	108	13	levels	level	NOUN
iajs-3390	108	14	in	in	ADP
iajs-3390	108	15	the	the	DET
iajs-3390	108	16	serum	serum	NOUN
iajs-3390	108	17	of	of	ADP
iajs-3390	108	18	oa	oa	PROPN
iajs-3390	108	19	patients	patient	NOUN
iajs-3390	108	20	compared	compare	VERB
iajs-3390	108	21	to	to	ADP
iajs-3390	108	22	non	non	ADJ
iajs-3390	108	23	-	-	ADJ
iajs-3390	108	24	oa	oa	ADJ
iajs-3390	108	25	controls	control	NOUN
iajs-3390	108	26	[	[	X
iajs-3390	108	27	30	30	NUM
iajs-3390	108	28	]	]	PUNCT
iajs-3390	108	29	.	.	PUNCT
iajs-3390	109	1	the	the	DET
iajs-3390	109	2	severity	severity	NOUN
iajs-3390	109	3	of	of	ADP
iajs-3390	109	4	the	the	DET
iajs-3390	109	5	disease	disease	NOUN
iajs-3390	109	6	and	and	CCONJ
iajs-3390	109	7	the	the	DET
iajs-3390	109	8	need	need	NOUN
iajs-3390	109	9	for	for	ADP
iajs-3390	109	10	joint	joint	ADJ
iajs-3390	109	11	replacement	replacement	NOUN
iajs-3390	109	12	therapy	therapy	NOUN
iajs-3390	109	13	in	in	ADP
iajs-3390	109	14	oa	oa	PROPN
iajs-3390	109	15	patients	patient	NOUN
iajs-3390	109	16	also	also	ADV
iajs-3390	109	17	showed	show	VERB
iajs-3390	109	18	a	a	DET
iajs-3390	109	19	linear	linear	ADJ
iajs-3390	109	20	increase	increase	NOUN
iajs-3390	109	21	in	in	ADP
iajs-3390	109	22	crtac1	crtac1	NOUN
iajs-3390	110	1	[	[	X
iajs-3390	110	2	31	31	NUM
iajs-3390	110	3	]	]	PUNCT
iajs-3390	110	4	.	.	PUNCT
iajs-3390	111	1	oa	oa	PROPN
iajs-3390	111	2	patients	patient	NOUN
iajs-3390	111	3	'	'	PART
iajs-3390	111	4	cartilage	cartilage	NOUN
iajs-3390	111	5	degeneration	degeneration	NOUN
iajs-3390	111	6	,	,	PUNCT
iajs-3390	111	7	which	which	PRON
iajs-3390	111	8	releases	release	VERB
iajs-3390	111	9	crtac1	crtac1	NOUN
iajs-3390	111	10	into	into	ADP
iajs-3390	111	11	the	the	DET
iajs-3390	111	12	circulation	circulation	NOUN
iajs-3390	111	13	,	,	PUNCT
iajs-3390	111	14	establishes	establish	VERB
iajs-3390	111	15	a	a	DET
iajs-3390	111	16	complex	complex	ADJ
iajs-3390	111	17	relationship	relationship	NOUN
iajs-3390	111	18	between	between	ADP
iajs-3390	111	19	crtac1	crtac1	NOUN
iajs-3390	111	20	and	and	CCONJ
iajs-3390	111	21	oa	oa	INTJ
iajs-3390	111	22	.	.	PUNCT
iajs-3390	112	1	therefore	therefore	ADV
iajs-3390	112	2	,	,	PUNCT
iajs-3390	112	3	we	we	PRON
iajs-3390	112	4	can	can	AUX
iajs-3390	112	5	use	use	VERB
iajs-3390	112	6	the	the	DET
iajs-3390	112	7	latter	latter	ADJ
iajs-3390	112	8	to	to	PART
iajs-3390	112	9	provide	provide	VERB
iajs-3390	112	10	a	a	DET
iajs-3390	112	11	highly	highly	ADV
iajs-3390	112	12	sensitive	sensitive	ADJ
iajs-3390	112	13	indication	indication	NOUN
iajs-3390	112	14	of	of	ADP
iajs-3390	112	15	the	the	DET
iajs-3390	112	16	presence	presence	NOUN
iajs-3390	112	17	and	and	CCONJ
iajs-3390	112	18	severity	severity	NOUN
iajs-3390	112	19	of	of	ADP
iajs-3390	112	20	oa	oa	PROPN
iajs-3390	112	21	disease	disease	NOUN
iajs-3390	112	22	.	.	PUNCT
iajs-3390	113	1	the	the	DET
iajs-3390	113	2	results	result	NOUN
iajs-3390	113	3	of	of	ADP
iajs-3390	113	4	the	the	DET
iajs-3390	113	5	roc	roc	PROPN
iajs-3390	113	6	analysis	analysis	NOUN
iajs-3390	113	7	proved	prove	VERB
iajs-3390	113	8	this	this	PRON
iajs-3390	113	9	,	,	PUNCT
iajs-3390	113	10	as	as	SCONJ
iajs-3390	113	11	crtac1	crtac1	NOUN
iajs-3390	113	12	demonstrated	demonstrate	VERB
iajs-3390	113	13	excellent	excellent	ADJ
iajs-3390	113	14	sensitivity	sensitivity	NOUN
iajs-3390	113	15	for	for	ADP
iajs-3390	113	16	oa	oa	PROPN
iajs-3390	113	17	disease	disease	NOUN
iajs-3390	113	18	prognosis	prognosis	NOUN
iajs-3390	113	19	,	,	PUNCT
iajs-3390	113	20	particularly	particularly	ADV
iajs-3390	113	21	in	in	ADP
iajs-3390	113	22	post	post	ADJ
iajs-3390	113	23	-	-	ADJ
iajs-3390	113	24	menopausal	menopausal	ADJ
iajs-3390	113	25	women	woman	NOUN
iajs-3390	113	26	.	.	PUNCT
iajs-3390	114	1	ihjpas	ihjpas	PROPN
iajs-3390	114	2	.	.	PUNCT
iajs-3390	115	1	2024	2024	NUM
iajs-3390	115	2	,	,	PUNCT
iajs-3390	115	3	37(4	37(4	NOUN
iajs-3390	115	4	)	)	PUNCT
iajs-3390	115	5	269	269	NUM
iajs-3390	115	6	between	between	ADP
iajs-3390	115	7	oa	oa	PROPN
iajs-3390	115	8	patients	patient	NOUN
iajs-3390	115	9	and	and	CCONJ
iajs-3390	115	10	the	the	DET
iajs-3390	115	11	age	age	NOUN
iajs-3390	115	12	-	-	PUNCT
iajs-3390	115	13	appropriate	appropriate	ADJ
iajs-3390	115	14	control	control	NOUN
iajs-3390	115	15	groups	group	NOUN
iajs-3390	115	16	,	,	PUNCT
iajs-3390	115	17	there	there	PRON
iajs-3390	115	18	were	be	VERB
iajs-3390	115	19	no	no	DET
iajs-3390	115	20	appreciable	appreciable	ADJ
iajs-3390	115	21	differences	difference	NOUN
iajs-3390	115	22	in	in	ADP
iajs-3390	115	23	the	the	DET
iajs-3390	115	24	levels	level	NOUN
iajs-3390	115	25	of	of	ADP
iajs-3390	115	26	fsh	fsh	NOUN
iajs-3390	115	27	,	,	PUNCT
iajs-3390	115	28	lh	lh	NOUN
iajs-3390	115	29	,	,	PUNCT
iajs-3390	115	30	or	or	CCONJ
iajs-3390	115	31	testosterone	testosterone	NOUN
iajs-3390	115	32	.	.	PUNCT
iajs-3390	116	1	however	however	ADV
iajs-3390	116	2	,	,	PUNCT
iajs-3390	116	3	studies	study	NOUN
iajs-3390	116	4	have	have	AUX
iajs-3390	116	5	shown	show	VERB
iajs-3390	116	6	that	that	DET
iajs-3390	116	7	fsh	fsh	NOUN
iajs-3390	116	8	in	in	ADP
iajs-3390	116	9	post	post	ADJ
iajs-3390	116	10	-	-	ADJ
iajs-3390	116	11	menopausal	menopausal	ADJ
iajs-3390	116	12	women	woman	NOUN
iajs-3390	116	13	with	with	ADP
iajs-3390	116	14	oa	oa	PROPN
iajs-3390	116	15	conditions	condition	NOUN
iajs-3390	116	16	may	may	AUX
iajs-3390	116	17	aggravate	aggravate	VERB
iajs-3390	116	18	pain	pain	NOUN
iajs-3390	116	19	by	by	ADP
iajs-3390	116	20	lowering	lower	VERB
iajs-3390	116	21	the	the	DET
iajs-3390	116	22	level	level	NOUN
iajs-3390	116	23	of	of	ADP
iajs-3390	116	24	type	type	NOUN
iajs-3390	116	25	ii	ii	PROPN
iajs-3390	116	26	collagen	collagen	NOUN
iajs-3390	116	27	in	in	ADP
iajs-3390	116	28	the	the	DET
iajs-3390	116	29	knee	knee	NOUN
iajs-3390	116	30	cartilage	cartilage	NOUN
iajs-3390	116	31	[	[	X
iajs-3390	116	32	32	32	NUM
iajs-3390	116	33	]	]	PUNCT
iajs-3390	116	34	.	.	PUNCT
iajs-3390	117	1	however	however	ADV
iajs-3390	117	2	,	,	PUNCT
iajs-3390	117	3	in	in	ADP
iajs-3390	117	4	post	post	ADJ
iajs-3390	117	5	-	-	ADJ
iajs-3390	117	6	menopausal	menopausal	ADJ
iajs-3390	117	7	women	woman	NOUN
iajs-3390	117	8	with	with	ADP
iajs-3390	117	9	oa	oa	PROPN
iajs-3390	117	10	conditions	condition	NOUN
iajs-3390	117	11	,	,	PUNCT
iajs-3390	117	12	we	we	PRON
iajs-3390	117	13	failed	fail	VERB
iajs-3390	117	14	to	to	PART
iajs-3390	117	15	find	find	VERB
iajs-3390	117	16	a	a	DET
iajs-3390	117	17	relationship	relationship	NOUN
iajs-3390	117	18	between	between	ADP
iajs-3390	117	19	crtac1	crtac1	NOUN
iajs-3390	117	20	and	and	CCONJ
iajs-3390	117	21	fsh	fsh	NOUN
iajs-3390	117	22	.	.	PUNCT
iajs-3390	118	1	this	this	PRON
iajs-3390	118	2	could	could	AUX
iajs-3390	118	3	potentially	potentially	ADV
iajs-3390	118	4	explain	explain	VERB
iajs-3390	118	5	why	why	SCONJ
iajs-3390	118	6	the	the	DET
iajs-3390	118	7	level	level	NOUN
iajs-3390	118	8	of	of	ADP
iajs-3390	118	9	oa	oa	PROPN
iajs-3390	118	10	ii	ii	PROPN
iajs-3390	118	11	is	be	AUX
iajs-3390	118	12	significantly	significantly	ADV
iajs-3390	118	13	higher	high	ADJ
iajs-3390	118	14	than	than	ADP
iajs-3390	118	15	that	that	PRON
iajs-3390	118	16	of	of	ADP
iajs-3390	118	17	oa	oa	PROPN
iajs-3390	118	18	i.	i.	PROPN
iajs-3390	118	19	similar	similar	ADJ
iajs-3390	118	20	to	to	ADP
iajs-3390	118	21	fsh	fsh	PROPN
iajs-3390	118	22	,	,	PUNCT
iajs-3390	118	23	post	post	ADJ
iajs-3390	118	24	-	-	ADJ
iajs-3390	118	25	menopausal	menopausal	ADJ
iajs-3390	118	26	women	woman	NOUN
iajs-3390	118	27	with	with	ADP
iajs-3390	118	28	oa	oa	PROPN
iajs-3390	118	29	have	have	VERB
iajs-3390	118	30	elevated	elevated	ADJ
iajs-3390	118	31	levels	level	NOUN
iajs-3390	118	32	of	of	ADP
iajs-3390	118	33	lh	lh	PROPN
iajs-3390	118	34	,	,	PUNCT
iajs-3390	118	35	which	which	PRON
iajs-3390	118	36	may	may	AUX
iajs-3390	118	37	speed	speed	VERB
iajs-3390	118	38	up	up	ADP
iajs-3390	118	39	the	the	DET
iajs-3390	118	40	disease	disease	NOUN
iajs-3390	118	41	's	's	PART
iajs-3390	118	42	severity	severity	NOUN
iajs-3390	118	43	[	[	X
iajs-3390	118	44	33	33	NUM
iajs-3390	118	45	]	]	PUNCT
iajs-3390	118	46	.	.	PUNCT
iajs-3390	119	1	additionally	additionally	ADV
iajs-3390	119	2	,	,	PUNCT
iajs-3390	119	3	preand	preand	VERB
iajs-3390	119	4	post	post	ADJ
iajs-3390	119	5	-	-	ADJ
iajs-3390	119	6	menopausal	menopausal	ADJ
iajs-3390	119	7	oa	oa	PROPN
iajs-3390	119	8	patients	patient	NOUN
iajs-3390	119	9	had	have	VERB
iajs-3390	119	10	significantly	significantly	ADV
iajs-3390	119	11	higher	high	ADJ
iajs-3390	119	12	tg	tg	PROPN
iajs-3390	119	13	levels	level	NOUN
iajs-3390	119	14	than	than	ADP
iajs-3390	119	15	healthy	healthy	ADJ
iajs-3390	119	16	women	woman	NOUN
iajs-3390	119	17	.	.	PUNCT
iajs-3390	120	1	people	people	NOUN
iajs-3390	120	2	's	's	PART
iajs-3390	120	3	lifestyles	lifestyle	NOUN
iajs-3390	120	4	are	be	AUX
iajs-3390	120	5	mostly	mostly	ADV
iajs-3390	120	6	associated	associate	VERB
iajs-3390	120	7	with	with	ADP
iajs-3390	120	8	hypertriglyceridemia	hypertriglyceridemia	NOUN
iajs-3390	120	9	[	[	X
iajs-3390	120	10	34	34	NUM
iajs-3390	120	11	]	]	PUNCT
iajs-3390	120	12	.	.	PUNCT
iajs-3390	121	1	other	other	ADJ
iajs-3390	121	2	investigations	investigation	NOUN
iajs-3390	121	3	[	[	X
iajs-3390	121	4	35,36	35,36	NUM
iajs-3390	121	5	]	]	PUNCT
iajs-3390	121	6	report	report	NOUN
iajs-3390	121	7	that	that	SCONJ
iajs-3390	121	8	all	all	PRON
iajs-3390	121	9	of	of	ADP
iajs-3390	121	10	the	the	DET
iajs-3390	121	11	included	include	VERB
iajs-3390	121	12	women	woman	NOUN
iajs-3390	121	13	were	be	AUX
iajs-3390	121	14	overweight	overweight	ADJ
iajs-3390	121	15	,	,	PUNCT
iajs-3390	121	16	which	which	PRON
iajs-3390	121	17	predicts	predict	VERB
iajs-3390	121	18	high	high	ADJ
iajs-3390	121	19	tgs	tgs	PROPN
iajs-3390	121	20	.	.	PUNCT
iajs-3390	122	1	patients	patient	NOUN
iajs-3390	122	2	with	with	ADP
iajs-3390	122	3	oa	oa	PRON
iajs-3390	122	4	with	with	ADP
iajs-3390	122	5	higher	high	ADJ
iajs-3390	122	6	tg	tg	PROPN
iajs-3390	122	7	levels	level	NOUN
iajs-3390	122	8	have	have	VERB
iajs-3390	122	9	more	more	ADJ
iajs-3390	122	10	inflammation	inflammation	NOUN
iajs-3390	122	11	[	[	X
iajs-3390	122	12	37	37	NUM
iajs-3390	122	13	]	]	PUNCT
iajs-3390	122	14	,	,	PUNCT
iajs-3390	122	15	which	which	PRON
iajs-3390	122	16	may	may	AUX
iajs-3390	122	17	increase	increase	VERB
iajs-3390	122	18	the	the	DET
iajs-3390	122	19	pain	pain	NOUN
iajs-3390	122	20	associated	associate	VERB
iajs-3390	122	21	with	with	ADP
iajs-3390	122	22	the	the	DET
iajs-3390	122	23	disease	disease	NOUN
iajs-3390	122	24	.	.	PUNCT
iajs-3390	123	1	5	5	X
iajs-3390	123	2	.	.	X
iajs-3390	123	3	conclusion	conclusion	NOUN
iajs-3390	123	4	using	use	VERB
iajs-3390	123	5	crtac1	crtac1	NOUN
iajs-3390	123	6	as	as	ADP
iajs-3390	123	7	a	a	DET
iajs-3390	123	8	biomarker	biomarker	NOUN
iajs-3390	123	9	to	to	PART
iajs-3390	123	10	predict	predict	VERB
iajs-3390	123	11	when	when	SCONJ
iajs-3390	123	12	oa	oa	PROPN
iajs-3390	123	13	will	will	AUX
iajs-3390	123	14	start	start	VERB
iajs-3390	123	15	and	and	CCONJ
iajs-3390	123	16	how	how	SCONJ
iajs-3390	123	17	bad	bad	ADJ
iajs-3390	123	18	it	it	PRON
iajs-3390	123	19	will	will	AUX
iajs-3390	123	20	get	get	VERB
iajs-3390	123	21	has	have	AUX
iajs-3390	123	22	shown	show	VERB
iajs-3390	123	23	that	that	SCONJ
iajs-3390	123	24	it	it	PRON
iajs-3390	123	25	works	work	VERB
iajs-3390	123	26	well	well	ADV
iajs-3390	123	27	as	as	ADP
iajs-3390	123	28	a	a	DET
iajs-3390	123	29	very	very	ADV
iajs-3390	123	30	sensitive	sensitive	ADJ
iajs-3390	123	31	and	and	CCONJ
iajs-3390	123	32	specific	specific	ADJ
iajs-3390	123	33	biomarker	biomarker	NOUN
iajs-3390	123	34	for	for	ADP
iajs-3390	123	35	the	the	DET
iajs-3390	123	36	disease	disease	NOUN
iajs-3390	123	37	in	in	ADP
iajs-3390	123	38	women	woman	NOUN
iajs-3390	123	39	before	before	ADP
iajs-3390	123	40	and	and	CCONJ
iajs-3390	123	41	after	after	ADP
iajs-3390	123	42	menopause	menopause	NOUN
iajs-3390	123	43	.	.	PUNCT
iajs-3390	124	1	it	it	PRON
iajs-3390	124	2	could	could	AUX
iajs-3390	124	3	be	be	AUX
iajs-3390	124	4	linked	link	VERB
iajs-3390	124	5	with	with	ADP
iajs-3390	124	6	the	the	DET
iajs-3390	124	7	clinical	clinical	ADJ
iajs-3390	124	8	symptoms	symptom	NOUN
iajs-3390	124	9	of	of	ADP
iajs-3390	124	10	oa	oa	NOUN
iajs-3390	124	11	disease	disease	NOUN
iajs-3390	124	12	,	,	PUNCT
iajs-3390	124	13	but	but	CCONJ
iajs-3390	124	14	further	further	ADJ
iajs-3390	124	15	investigations	investigation	NOUN
iajs-3390	124	16	are	be	AUX
iajs-3390	124	17	necessary	necessary	ADJ
iajs-3390	124	18	to	to	PART
iajs-3390	124	19	assure	assure	VERB
iajs-3390	124	20	these	these	DET
iajs-3390	124	21	predictions	prediction	NOUN
iajs-3390	124	22	.	.	PUNCT
iajs-3390	125	1	acknowledgment	acknowledgment	NOUN
iajs-3390	125	2	the	the	DET
iajs-3390	125	3	authors	author	NOUN
iajs-3390	125	4	thank	thank	VERB
iajs-3390	125	5	the	the	DET
iajs-3390	125	6	medical	medical	ADJ
iajs-3390	125	7	staff	staff	NOUN
iajs-3390	125	8	at	at	ADP
iajs-3390	125	9	baghdad	baghdad	PROPN
iajs-3390	125	10	teaching	teach	VERB
iajs-3390	125	11	hospital	hospital	NOUN
iajs-3390	125	12	for	for	ADP
iajs-3390	125	13	their	their	PRON
iajs-3390	125	14	assistance	assistance	NOUN
iajs-3390	125	15	in	in	ADP
iajs-3390	125	16	completing	complete	VERB
iajs-3390	125	17	this	this	DET
iajs-3390	125	18	work	work	NOUN
iajs-3390	125	19	.	.	PUNCT
iajs-3390	126	1	conflict	conflict	NOUN
iajs-3390	126	2	of	of	ADP
iajs-3390	126	3	interest	interest	NOUN
iajs-3390	126	4	there	there	PRON
iajs-3390	126	5	are	be	VERB
iajs-3390	126	6	no	no	DET
iajs-3390	126	7	conflicts	conflict	NOUN
iajs-3390	126	8	of	of	ADP
iajs-3390	126	9	interest	interest	NOUN
iajs-3390	126	10	.	.	PUNCT
iajs-3390	127	1	funding	fund	VERB
iajs-3390	127	2	none	none	NOUN
iajs-3390	127	3	.	.	PUNCT
iajs-3390	128	1	ethical	ethical	ADJ
iajs-3390	128	2	clearance	clearance	NOUN
iajs-3390	128	3	the	the	DET
iajs-3390	128	4	scientific	scientific	ADJ
iajs-3390	128	5	committee	committee	NOUN
iajs-3390	128	6	in	in	ADP
iajs-3390	128	7	the	the	DET
iajs-3390	128	8	college	college	NOUN
iajs-3390	128	9	of	of	ADP
iajs-3390	128	10	science	science	NOUN
iajs-3390	128	11	for	for	ADP
iajs-3390	128	12	women/	women/	NUM
iajs-3390	128	13	university	university	NOUN
iajs-3390	128	14	of	of	ADP
iajs-3390	128	15	baghdad	baghdad	PROPN
iajs-3390	128	16	and	and	CCONJ
iajs-3390	128	17	the	the	DET
iajs-3390	128	18	medical	medical	ADJ
iajs-3390	128	19	city	city	PROPN
iajs-3390	128	20	hospital	hospital	NOUN
iajs-3390	128	21	approved	approve	VERB
iajs-3390	128	22	this	this	DET
iajs-3390	128	23	study	study	NOUN
iajs-3390	128	24	,	,	PUNCT
iajs-3390	128	25	and	and	CCONJ
iajs-3390	128	26	a	a	DET
iajs-3390	128	27	verbal	verbal	ADJ
iajs-3390	128	28	agreement	agreement	NOUN
iajs-3390	128	29	was	be	AUX
iajs-3390	128	30	received	receive	VERB
iajs-3390	128	31	from	from	ADP
iajs-3390	128	32	each	each	DET
iajs-3390	128	33	person	person	NOUN
iajs-3390	128	34	included	include	VERB
iajs-3390	128	35	in	in	ADP
iajs-3390	128	36	the	the	DET
iajs-3390	128	37	study	study	NOUN
iajs-3390	128	38	.	.	PUNCT
iajs-3390	129	1	references	reference	NOUN
iajs-3390	129	2	1	1	NUM
iajs-3390	129	3	.	.	NOUN
iajs-3390	129	4	1	1	NUM
iajs-3390	129	5	.	.	X
iajs-3390	129	6	buckwalter	buckwalter	NOUN
iajs-3390	129	7	,	,	PUNCT
iajs-3390	129	8	j.a.;saltzman	j.a.;saltzman	PROPN
iajs-3390	129	9	,	,	PUNCT
iajs-3390	129	10	c.	c.	PROPN
iajs-3390	129	11	;	;	PUNCT
iajs-3390	129	12	brown	brown	ADJ
iajs-3390	129	13	,	,	PUNCT
iajs-3390	129	14	t.	t.	NOUN
iajs-3390	129	15	the	the	DET
iajs-3390	129	16	impact	impact	NOUN
iajs-3390	129	17	of	of	ADP
iajs-3390	129	18	osteoarthritis	osteoarthritis	NOUN
iajs-3390	129	19	:	:	PUNCT
iajs-3390	129	20	implications	implication	NOUN
iajs-3390	129	21	for	for	ADP
iajs-3390	129	22	research	research	NOUN
iajs-3390	129	23	.	.	PUNCT
iajs-3390	130	1	clinical	clinical	ADJ
iajs-3390	130	2	orthopaedics	orthopaedic	NOUN
iajs-3390	130	3	and	and	CCONJ
iajs-3390	130	4	related	related	ADJ
iajs-3390	130	5	research	research	NOUN
iajs-3390	130	6	(	(	PUNCT
iajs-3390	130	7	1976	1976	NUM
iajs-3390	130	8	-	-	SYM
iajs-3390	130	9	2007	2007	NUM
iajs-3390	130	10	)	)	PUNCT
iajs-3390	130	11	2004	2004	NUM
iajs-3390	130	12	,	,	PUNCT
iajs-3390	130	13	427	427	NUM
iajs-3390	130	14	,	,	PUNCT
iajs-3390	130	15	s6	s6	PROPN
iajs-3390	130	16	-	-	PUNCT
iajs-3390	130	17	s15	s15	NOUN
iajs-3390	130	18	.	.	PUNCT
iajs-3390	131	1	https://doi.org/10.1097/01.blo.0000143938.30681.9d	https://doi.org/10.1097/01.blo.0000143938.30681.9d	PROPN
iajs-3390	131	2	.	.	NOUN
iajs-3390	131	3	2	2	NUM
iajs-3390	131	4	.	.	X
iajs-3390	131	5	chow	chow	PROPN
iajs-3390	131	6	,	,	PUNCT
iajs-3390	131	7	y.y.;chin	y.y.;chin	PROPN
iajs-3390	131	8	,	,	PUNCT
iajs-3390	132	1	k.y	k.y	PROPN
iajs-3390	132	2	.	.	PROPN
iajs-3390	133	1	the	the	DET
iajs-3390	133	2	role	role	NOUN
iajs-3390	133	3	of	of	ADP
iajs-3390	133	4	inflammation	inflammation	NOUN
iajs-3390	133	5	in	in	ADP
iajs-3390	133	6	the	the	DET
iajs-3390	133	7	pathogenesis	pathogenesis	NOUN
iajs-3390	133	8	of	of	ADP
iajs-3390	133	9	osteoarthritis	osteoarthritis	NOUN
iajs-3390	133	10	.	.	PUNCT
iajs-3390	134	1	mediators	mediator	NOUN
iajs-3390	134	2	of	of	ADP
iajs-3390	134	3	inflammation	inflammation	NOUN
iajs-3390	134	4	2020	2020	NUM
iajs-3390	134	5	,	,	PUNCT
iajs-3390	134	6	1	1	NUM
iajs-3390	134	7	,	,	PUNCT
iajs-3390	134	8	1	1	NUM
iajs-3390	134	9	-	-	SYM
iajs-3390	134	10	19	19	NUM
iajs-3390	134	11	.	.	PUNCT
iajs-3390	135	1	https://doi.org/10.1155/2020/8293921	https://doi.org/10.1155/2020/8293921	NOUN
iajs-3390	135	2	.	.	PUNCT
iajs-3390	136	1	3	3	NUM
iajs-3390	136	2	.	.	X
iajs-3390	136	3	lindler	lindl	ADJ
iajs-3390	136	4	,	,	PUNCT
iajs-3390	136	5	b.n	b.n	PROPN
iajs-3390	136	6	.	.	PROPN
iajs-3390	136	7	;	;	PUNCT
iajs-3390	137	1	long	long	X
iajs-3390	137	2	,	,	PUNCT
iajs-3390	137	3	k.e	k.e	PROPN
iajs-3390	137	4	.	.	PROPN
iajs-3390	137	5	;	;	PUNCT
iajs-3390	138	1	taylor	taylor	PROPN
iajs-3390	138	2	,	,	PUNCT
iajs-3390	138	3	n.a	n.a	PROPN
iajs-3390	138	4	.	.	PROPN
iajs-3390	138	5	;	;	PUNCT
iajs-3390	138	6	lei	lei	PROPN
iajs-3390	138	7	,	,	PUNCT
iajs-3390	138	8	w.	w.	NOUN
iajs-3390	138	9	use	use	NOUN
iajs-3390	138	10	of	of	ADP
iajs-3390	138	11	herbal	herbal	ADJ
iajs-3390	138	12	medications	medication	NOUN
iajs-3390	138	13	for	for	ADP
iajs-3390	138	14	treatment	treatment	NOUN
iajs-3390	138	15	of	of	ADP
iajs-3390	138	16	osteoarthritis	osteoarthritis	NOUN
iajs-3390	138	17	and	and	CCONJ
iajs-3390	138	18	rheumatoid	rheumatoid	VERB
iajs-3390	138	19	arthritis	arthritis	NOUN
iajs-3390	138	20	.	.	PUNCT
iajs-3390	139	1	medicines	medicine	NOUN
iajs-3390	139	2	2020	2020	NUM
iajs-3390	139	3	,	,	PUNCT
iajs-3390	139	4	7(11	7(11	NUM
iajs-3390	139	5	)	)	PUNCT
iajs-3390	139	6	,	,	PUNCT
iajs-3390	139	7	67	67	NUM
iajs-3390	139	8	.	.	PUNCT
iajs-3390	139	9	https://doi.org/10.3390/medicines7110067	https://doi.org/10.3390/medicines7110067	NOUN
iajs-3390	139	10	.	.	PUNCT
iajs-3390	140	1	4	4	X
iajs-3390	140	2	.	.	X
iajs-3390	140	3	allen	allen	PROPN
iajs-3390	140	4	,	,	PUNCT
iajs-3390	140	5	k.	k.	PROPN
iajs-3390	140	6	;	;	PUNCT
iajs-3390	140	7	thoma	thoma	PROPN
iajs-3390	140	8	,	,	PUNCT
iajs-3390	140	9	l.	l.	PROPN
iajs-3390	140	10	;	;	PUNCT
iajs-3390	140	11	golightly	golightly	ADV
iajs-3390	140	12	,	,	PUNCT
iajs-3390	140	13	y.	y.	PROPN
iajs-3390	140	14	epidemiology	epidemiology	NOUN
iajs-3390	140	15	of	of	ADP
iajs-3390	140	16	osteoarthritis	osteoarthritis	NOUN
iajs-3390	140	17	.	.	PUNCT
iajs-3390	141	1	osteoarthritis	osteoarthritis	NOUN
iajs-3390	141	2	and	and	CCONJ
iajs-3390	141	3	cartilage	cartilage	NOUN
iajs-3390	141	4	2022	2022	NUM
iajs-3390	141	5	,	,	PUNCT
iajs-3390	141	6	30	30	NUM
iajs-3390	141	7	,	,	PUNCT
iajs-3390	141	8	184	184	NUM
iajs-3390	141	9	-	-	SYM
iajs-3390	141	10	195	195	NUM
iajs-3390	141	11	.	.	PUNCT
iajs-3390	142	1	https://doi.org/10.1016/j.joca.2021.04.020	https://doi.org/10.1016/j.joca.2021.04.020	NOUN
iajs-3390	142	2	.	.	PUNCT
iajs-3390	143	1	https://doi.org/10.1097/01.blo.0000143938.30681.9d	https://doi.org/10.1097/01.blo.0000143938.30681.9d	PROPN
iajs-3390	143	2	.	.	PUNCT
iajs-3390	144	1	https://doi.org/10.1155/2020/8293921	https://doi.org/10.1155/2020/8293921	VERB
iajs-3390	144	2	https://doi.org/10.3390/medicines7110067	https://doi.org/10.3390/medicines7110067	NOUN
iajs-3390	144	3	https://doi.org/10.1016/j.joca.2021.04.020	https://doi.org/10.1016/j.joca.2021.04.020	VERB
iajs-3390	144	4	ihjpas	ihjpa	NOUN
iajs-3390	144	5	.	.	PUNCT
iajs-3390	145	1	2024	2024	NUM
iajs-3390	145	2	,	,	PUNCT
iajs-3390	145	3	37(4	37(4	NOUN
iajs-3390	145	4	)	)	PUNCT
iajs-3390	145	5	270	270	NUM
iajs-3390	145	6	5	5	NUM
iajs-3390	145	7	.	.	PUNCT
iajs-3390	145	8	quicke	quicke	PROPN
iajs-3390	145	9	,	,	PUNCT
iajs-3390	145	10	j.	j.	PROPN
iajs-3390	145	11	;	;	PUNCT
iajs-3390	145	12	conaghan	conaghan	PROPN
iajs-3390	145	13	,	,	PUNCT
iajs-3390	145	14	p.	p.	PROPN
iajs-3390	145	15	;	;	PUNCT
iajs-3390	145	16	corp	corp	PROPN
iajs-3390	145	17	,	,	PUNCT
iajs-3390	145	18	n.	n.	NOUN
iajs-3390	145	19	;	;	PUNCT
iajs-3390	145	20	peat	peat	NOUN
iajs-3390	145	21	,	,	PUNCT
iajs-3390	145	22	g.	g.	PROPN
iajs-3390	145	23	osteoarthritis	osteoarthritis	PROPN
iajs-3390	145	24	year	year	NOUN
iajs-3390	145	25	in	in	ADP
iajs-3390	145	26	review	review	NOUN
iajs-3390	145	27	2021	2021	NUM
iajs-3390	145	28	:	:	PUNCT
iajs-3390	145	29	epidemiology	epidemiology	NOUN
iajs-3390	145	30	&	&	CCONJ
iajs-3390	145	31	therapy	therapy	NOUN
iajs-3390	145	32	.	.	PUNCT
iajs-3390	146	1	osteoarthritis	osteoarthritis	NOUN
iajs-3390	146	2	and	and	CCONJ
iajs-3390	146	3	cartilage	cartilage	NOUN
iajs-3390	146	4	2022	2022	NUM
iajs-3390	146	5	,	,	PUNCT
iajs-3390	146	6	30(2	30(2	NUM
iajs-3390	146	7	)	)	PUNCT
iajs-3390	146	8	,	,	PUNCT
iajs-3390	146	9	196	196	NUM
iajs-3390	146	10	-	-	SYM
iajs-3390	146	11	206	206	NUM
iajs-3390	146	12	.	.	PUNCT
iajs-3390	147	1	https://doi.org/10.1016/j.joca.2021.10.003	https://doi.org/10.1016/j.joca.2021.10.003	NOUN
iajs-3390	147	2	.	.	PROPN
iajs-3390	148	1	6	6	NUM
iajs-3390	148	2	.	.	PUNCT
iajs-3390	148	3	kloppenburg	kloppenburg	PROPN
iajs-3390	148	4	,	,	PUNCT
iajs-3390	148	5	m.;berenbaum	m.;berenbaum	PROPN
iajs-3390	148	6	,	,	PUNCT
iajs-3390	148	7	f.	f.	PROPN
iajs-3390	148	8	osteoarthritis	osteoarthritis	PROPN
iajs-3390	148	9	year	year	NOUN
iajs-3390	148	10	in	in	ADP
iajs-3390	148	11	review	review	NOUN
iajs-3390	148	12	2019	2019	NUM
iajs-3390	148	13	:	:	PUNCT
iajs-3390	148	14	epidemiology	epidemiology	NOUN
iajs-3390	148	15	and	and	CCONJ
iajs-3390	148	16	therapy	therapy	NOUN
iajs-3390	148	17	.	.	PUNCT
iajs-3390	149	1	osteoarthritis	osteoarthritis	NOUN
iajs-3390	149	2	and	and	CCONJ
iajs-3390	149	3	cartilage	cartilage	NOUN
iajs-3390	149	4	2020	2020	NUM
iajs-3390	149	5	,	,	PUNCT
iajs-3390	149	6	28(3	28(3	NUM
iajs-3390	149	7	)	)	PUNCT
iajs-3390	149	8	,	,	PUNCT
iajs-3390	149	9	242	242	NUM
iajs-3390	149	10	-	-	SYM
iajs-3390	149	11	248	248	NUM
iajs-3390	149	12	.	.	PUNCT
iajs-3390	150	1	https://doi.org/10.1016/j.joca.2020.01.002	https://doi.org/10.1016/j.joca.2020.01.002	NOUN
iajs-3390	150	2	.	.	PUNCT
iajs-3390	151	1	7	7	X
iajs-3390	151	2	.	.	X
iajs-3390	151	3	wise	wise	ADJ
iajs-3390	151	4	,	,	PUNCT
iajs-3390	151	5	b.l	b.l	PROPN
iajs-3390	151	6	.	.	PROPN
iajs-3390	151	7	;	;	PUNCT
iajs-3390	151	8	niu	niu	PROPN
iajs-3390	151	9	,	,	PUNCT
iajs-3390	151	10	j.	j.	PROPN
iajs-3390	151	11	;	;	PUNCT
iajs-3390	151	12	yang	yang	PROPN
iajs-3390	151	13	,	,	PUNCT
iajs-3390	151	14	m.;lane	m.;lane	PROPN
iajs-3390	151	15	,	,	PUNCT
iajs-3390	151	16	n.e	n.e	PROPN
iajs-3390	151	17	.	.	PROPN
iajs-3390	151	18	;	;	PUNCT
iajs-3390	151	19	harvey	harvey	PROPN
iajs-3390	151	20	,	,	PUNCT
iajs-3390	151	21	w.	w.	PROPN
iajs-3390	151	22	;	;	PUNCT
iajs-3390	151	23	felson	felson	NOUN
iajs-3390	151	24	,	,	PUNCT
iajs-3390	151	25	d.t	d.t	PROPN
iajs-3390	151	26	.	.	PROPN
iajs-3390	151	27	;	;	PUNCT
iajs-3390	151	28	hietpas	hietpas	PROPN
iajs-3390	151	29	,	,	PUNCT
iajs-3390	151	30	j.	j.	PROPN
iajs-3390	151	31	;	;	PUNCT
iajs-3390	151	32	nevitt	nevitt	PROPN
iajs-3390	151	33	,	,	PUNCT
iajs-3390	151	34	m.	m.	NOUN
iajs-3390	151	35	;	;	PUNCT
iajs-3390	151	36	sharma	sharma	PROPN
iajs-3390	151	37	,	,	PUNCT
iajs-3390	151	38	l.	l.	PROPN
iajs-3390	151	39	;	;	PUNCT
iajs-3390	151	40	torner	torner	PROPN
iajs-3390	151	41	,	,	PUNCT
iajs-3390	151	42	j.	j.	PROPN
iajs-3390	151	43	patterns	pattern	NOUN
iajs-3390	151	44	of	of	ADP
iajs-3390	151	45	compartment	compartment	NOUN
iajs-3390	151	46	involvement	involvement	NOUN
iajs-3390	151	47	in	in	ADP
iajs-3390	151	48	tibiofemoral	tibiofemoral	ADJ
iajs-3390	151	49	osteoarthritis	osteoarthritis	NOUN
iajs-3390	151	50	in	in	ADP
iajs-3390	151	51	men	man	NOUN
iajs-3390	151	52	and	and	CCONJ
iajs-3390	151	53	women	woman	NOUN
iajs-3390	151	54	and	and	CCONJ
iajs-3390	151	55	in	in	ADP
iajs-3390	151	56	whites	white	NOUN
iajs-3390	151	57	and	and	CCONJ
iajs-3390	151	58	african	african	ADJ
iajs-3390	151	59	americans	americans	PROPN
iajs-3390	151	60	.	.	PUNCT
iajs-3390	152	1	arthritis	arthritis	NOUN
iajs-3390	152	2	care	care	PROPN
iajs-3390	152	3	&	&	CCONJ
iajs-3390	152	4	research	research	PROPN
iajs-3390	152	5	2012	2012	NUM
iajs-3390	152	6	,	,	PUNCT
iajs-3390	152	7	64(6	64(6	NUM
iajs-3390	152	8	)	)	PUNCT
iajs-3390	152	9	,	,	PUNCT
iajs-3390	152	10	847	847	NUM
iajs-3390	152	11	-	-	SYM
iajs-3390	152	12	852	852	NUM
iajs-3390	152	13	.	.	PUNCT
iajs-3390	153	1	https://doi.org/10.1002/acr.21606	https://doi.org/10.1002/acr.21606	NOUN
iajs-3390	153	2	.	.	PROPN
iajs-3390	154	1	8	8	NUM
iajs-3390	154	2	.	.	X
iajs-3390	155	1	johnson	johnson	PROPN
iajs-3390	155	2	,	,	PUNCT
iajs-3390	155	3	v.l	v.l	PROPN
iajs-3390	155	4	.	.	PROPN
iajs-3390	155	5	;	;	PUNCT
iajs-3390	155	6	hunter	hunter	NOUN
iajs-3390	155	7	,	,	PUNCT
iajs-3390	155	8	d.j	d.j	PROPN
iajs-3390	155	9	.	.	PROPN
iajs-3390	155	10	the	the	DET
iajs-3390	155	11	epidemiology	epidemiology	NOUN
iajs-3390	155	12	of	of	ADP
iajs-3390	155	13	osteoarthritis	osteoarthritis	NOUN
iajs-3390	155	14	.	.	PUNCT
iajs-3390	156	1	best	good	ADJ
iajs-3390	156	2	practice	practice	PROPN
iajs-3390	156	3	&	&	CCONJ
iajs-3390	156	4	research	research	PROPN
iajs-3390	156	5	clinical	clinical	ADJ
iajs-3390	156	6	rheumatology	rheumatology	NOUN
iajs-3390	156	7	2014	2014	NUM
iajs-3390	156	8	,	,	PUNCT
iajs-3390	156	9	28(1	28(1	NOUN
iajs-3390	156	10	)	)	PUNCT
iajs-3390	156	11	,	,	PUNCT
iajs-3390	156	12	5	5	NUM
iajs-3390	156	13	-	-	SYM
iajs-3390	156	14	15	15	NUM
iajs-3390	156	15	.	.	PUNCT
iajs-3390	157	1	https://doi.org/10.1016/j.berh.2014.01.004	https://doi.org/10.1016/j.berh.2014.01.004	NOUN
iajs-3390	157	2	.	.	PUNCT
iajs-3390	158	1	9	9	X
iajs-3390	158	2	.	.	X
iajs-3390	158	3	hunter	hunter	NOUN
iajs-3390	158	4	,	,	PUNCT
iajs-3390	158	5	d.j.;march	d.j.;march	PROPN
iajs-3390	158	6	,	,	PUNCT
iajs-3390	158	7	l.;chew	l.;chew	VERB
iajs-3390	158	8	,	,	PUNCT
iajs-3390	158	9	m.	m.	NOUN
iajs-3390	158	10	osteoarthritis	osteoarthritis	NOUN
iajs-3390	158	11	in	in	ADP
iajs-3390	158	12	2020	2020	NUM
iajs-3390	158	13	and	and	CCONJ
iajs-3390	158	14	beyond	beyond	ADP
iajs-3390	158	15	:	:	PUNCT
iajs-3390	158	16	a	a	DET
iajs-3390	158	17	lancet	lancet	PROPN
iajs-3390	158	18	commission	commission	PROPN
iajs-3390	158	19	.	.	PUNCT
iajs-3390	159	1	the	the	DET
iajs-3390	159	2	lancet	lancet	PROPN
iajs-3390	159	3	2020	2020	NUM
iajs-3390	159	4	,	,	PUNCT
iajs-3390	159	5	396(10264	396(10264	NUM
iajs-3390	159	6	)	)	PUNCT
iajs-3390	159	7	,	,	PUNCT
iajs-3390	159	8	1711	1711	NUM
iajs-3390	159	9	-	-	SYM
iajs-3390	159	10	1712	1712	NUM
iajs-3390	159	11	.	.	PUNCT
iajs-3390	160	1	https://doi.org/10.1016/s0140-6736(20)32230-3	https://doi.org/10.1016/s0140-6736(20)32230-3	PROPN
iajs-3390	160	2	.	.	PUNCT
iajs-3390	161	1	10	10	NUM
iajs-3390	161	2	.	.	X
iajs-3390	161	3	slavich	slavich	PROPN
iajs-3390	161	4	,	,	PUNCT
iajs-3390	161	5	g.m	g.m	PROPN
iajs-3390	161	6	.	.	PROPN
iajs-3390	161	7	;	;	PUNCT
iajs-3390	161	8	sacher	sacher	PROPN
iajs-3390	161	9	,	,	PUNCT
iajs-3390	161	10	j.	j.	PROPN
iajs-3390	161	11	stress	stress	PROPN
iajs-3390	161	12	,	,	PUNCT
iajs-3390	161	13	sex	sex	NOUN
iajs-3390	161	14	hormones	hormone	NOUN
iajs-3390	161	15	,	,	PUNCT
iajs-3390	161	16	inflammation	inflammation	NOUN
iajs-3390	161	17	,	,	PUNCT
iajs-3390	161	18	and	and	CCONJ
iajs-3390	161	19	major	major	ADJ
iajs-3390	161	20	depressive	depressive	ADJ
iajs-3390	161	21	disorder	disorder	NOUN
iajs-3390	161	22	:	:	PUNCT
iajs-3390	161	23	extending	extend	VERB
iajs-3390	161	24	social	social	ADJ
iajs-3390	161	25	signal	signal	NOUN
iajs-3390	161	26	transduction	transduction	NOUN
iajs-3390	161	27	theory	theory	NOUN
iajs-3390	161	28	of	of	ADP
iajs-3390	161	29	depression	depression	NOUN
iajs-3390	161	30	to	to	PART
iajs-3390	161	31	account	account	VERB
iajs-3390	161	32	for	for	ADP
iajs-3390	161	33	sex	sex	NOUN
iajs-3390	161	34	differences	difference	NOUN
iajs-3390	161	35	in	in	ADP
iajs-3390	161	36	mood	mood	NOUN
iajs-3390	161	37	disorders	disorder	NOUN
iajs-3390	161	38	.	.	PUNCT
iajs-3390	162	1	psychopharmacology	psychopharmacology	NOUN
iajs-3390	162	2	2019	2019	NUM
iajs-3390	162	3	,	,	PUNCT
iajs-3390	162	4	236(10),3063	236(10),3063	NUM
iajs-3390	162	5	-	-	SYM
iajs-3390	162	6	3079	3079	NUM
iajs-3390	162	7	.	.	PUNCT
iajs-3390	163	1	https://doi.org/10.1007/s00213-01905326-9	https://doi.org/10.1007/s00213-01905326-9	NOUN
iajs-3390	163	2	.	.	PUNCT
iajs-3390	164	1	11	11	NUM
iajs-3390	164	2	.	.	PUNCT
iajs-3390	164	3	hughes	hughes	PROPN
iajs-3390	164	4	-	-	PUNCT
iajs-3390	164	5	fulford	fulford	PROPN
iajs-3390	164	6	,	,	PUNCT
iajs-3390	164	7	m.	m.	NOUN
iajs-3390	164	8	signal	signal	PROPN
iajs-3390	164	9	transduction	transduction	NOUN
iajs-3390	164	10	and	and	CCONJ
iajs-3390	164	11	mechanical	mechanical	ADJ
iajs-3390	164	12	stress	stress	NOUN
iajs-3390	164	13	.	.	PUNCT
iajs-3390	165	1	science	science	NOUN
iajs-3390	165	2	's	's	PART
iajs-3390	165	3	stke	stke	NOUN
iajs-3390	165	4	2004	2004	NUM
iajs-3390	165	5	,	,	PUNCT
iajs-3390	165	6	249	249	NUM
iajs-3390	165	7	,	,	PUNCT
iajs-3390	165	8	re12re12	re12re12	NOUN
iajs-3390	165	9	.	.	PUNCT
iajs-3390	166	1	https://doi.org/10.1126/stke.2492004re12	https://doi.org/10.1126/stke.2492004re12	PROPN
iajs-3390	166	2	.	.	PROPN
iajs-3390	167	1	12	12	NUM
iajs-3390	167	2	.	.	PUNCT
iajs-3390	168	1	taleb	taleb	NOUN
iajs-3390	168	2	-	-	PUNCT
iajs-3390	168	3	belkadi	belkadi	NOUN
iajs-3390	168	4	,	,	PUNCT
iajs-3390	168	5	o.	o.	PROPN
iajs-3390	168	6	;	;	PUNCT
iajs-3390	168	7	chaib	chaib	PROPN
iajs-3390	168	8	,	,	PUNCT
iajs-3390	168	9	h.	h.	PROPN
iajs-3390	168	10	;	;	PUNCT
iajs-3390	168	11	zemour	zemour	X
iajs-3390	168	12	,	,	PUNCT
iajs-3390	168	13	l.	l.	PROPN
iajs-3390	168	14	;	;	PUNCT
iajs-3390	168	15	fatah	fatah	PROPN
iajs-3390	168	16	,	,	PUNCT
iajs-3390	168	17	a.	a.	PROPN
iajs-3390	168	18	;	;	PUNCT
iajs-3390	168	19	chafi	chafi	PROPN
iajs-3390	168	20	,	,	PUNCT
iajs-3390	168	21	b.	b.	PROPN
iajs-3390	168	22	;	;	PUNCT
iajs-3390	168	23	mekki	mekki	PROPN
iajs-3390	168	24	,	,	PUNCT
iajs-3390	168	25	k.	k.	PROPN
iajs-3390	168	26	lipid	lipid	PROPN
iajs-3390	168	27	profile	profile	NOUN
iajs-3390	168	28	,	,	PUNCT
iajs-3390	168	29	inflammation	inflammation	NOUN
iajs-3390	168	30	,	,	PUNCT
iajs-3390	168	31	and	and	CCONJ
iajs-3390	168	32	oxidative	oxidative	ADJ
iajs-3390	168	33	status	status	NOUN
iajs-3390	168	34	in	in	ADP
iajs-3390	168	35	peri	peri	NOUN
iajs-3390	168	36	-	-	PUNCT
iajs-3390	168	37	and	and	CCONJ
iajs-3390	168	38	postmenopausal	postmenopausal	ADJ
iajs-3390	168	39	women	woman	NOUN
iajs-3390	168	40	.	.	PUNCT
iajs-3390	169	1	gynecological	gynecological	ADJ
iajs-3390	169	2	endocrinology	endocrinology	NOUN
iajs-3390	169	3	2016	2016	NUM
iajs-3390	169	4	,	,	PUNCT
iajs-3390	169	5	32(12	32(12	NUM
iajs-3390	169	6	)	)	PUNCT
iajs-3390	169	7	,	,	PUNCT
iajs-3390	169	8	982	982	NUM
iajs-3390	169	9	-	-	SYM
iajs-3390	169	10	985	985	NUM
iajs-3390	169	11	.	.	PUNCT
iajs-3390	170	1	https://doi.org/10.1080/09513590.2016.1214257	https://doi.org/10.1080/09513590.2016.1214257	NOUN
iajs-3390	170	2	.	.	PROPN
iajs-3390	170	3	13	13	NUM
iajs-3390	170	4	.	.	PUNCT
iajs-3390	171	1	kumavat	kumavat	NOUN
iajs-3390	171	2	,	,	PUNCT
iajs-3390	171	3	r.	r.	PROPN
iajs-3390	171	4	;	;	PUNCT
iajs-3390	171	5	kumar	kumar	PROPN
iajs-3390	171	6	,	,	PUNCT
iajs-3390	171	7	v.	v.	PROPN
iajs-3390	171	8	;	;	PUNCT
iajs-3390	171	9	malhotra	malhotra	PROPN
iajs-3390	171	10	,	,	PUNCT
iajs-3390	171	11	r.	r.	PROPN
iajs-3390	171	12	;	;	PUNCT
iajs-3390	171	13	pandit	pandit	PROPN
iajs-3390	171	14	,	,	PUNCT
iajs-3390	171	15	h.	h.	PROPN
iajs-3390	171	16	;	;	PUNCT
iajs-3390	171	17	jones	jones	PROPN
iajs-3390	171	18	,	,	PUNCT
iajs-3390	171	19	e.	e.	PROPN
iajs-3390	171	20	;	;	PUNCT
iajs-3390	171	21	ponchel	ponchel	PROPN
iajs-3390	171	22	,	,	PUNCT
iajs-3390	171	23	f.	f.	PROPN
iajs-3390	171	24	;	;	PUNCT
iajs-3390	171	25	biswas	biswas	PROPN
iajs-3390	171	26	,	,	PUNCT
iajs-3390	171	27	s.	s.	PROPN
iajs-3390	171	28	biomarkers	biomarker	NOUN
iajs-3390	171	29	of	of	ADP
iajs-3390	171	30	joint	joint	ADJ
iajs-3390	171	31	damage	damage	NOUN
iajs-3390	171	32	in	in	ADP
iajs-3390	171	33	osteoarthritis	osteoarthritis	NOUN
iajs-3390	171	34	:	:	PUNCT
iajs-3390	171	35	current	current	ADJ
iajs-3390	171	36	status	status	NOUN
iajs-3390	171	37	and	and	CCONJ
iajs-3390	171	38	future	future	ADJ
iajs-3390	171	39	directions	direction	NOUN
iajs-3390	171	40	.	.	PUNCT
iajs-3390	172	1	mediators	mediator	NOUN
iajs-3390	172	2	of	of	ADP
iajs-3390	172	3	inflammation	inflammation	NOUN
iajs-3390	172	4	2021	2021	NUM
iajs-3390	172	5	,	,	PUNCT
iajs-3390	172	6	2021(1	2021(1	NUM
iajs-3390	172	7	)	)	PUNCT
iajs-3390	172	8	,	,	PUNCT
iajs-3390	172	9	1	1	NUM
iajs-3390	172	10	-	-	SYM
iajs-3390	172	11	15	15	NUM
iajs-3390	172	12	.	.	PUNCT
iajs-3390	173	1	https://doi.org/10.1155/2021/5574582	https://doi.org/10.1155/2021/5574582	PROPN
iajs-3390	173	2	.	.	PROPN
iajs-3390	174	1	14	14	NUM
iajs-3390	174	2	.	.	PUNCT
iajs-3390	175	1	kraus	kraus	PROPN
iajs-3390	175	2	,	,	PUNCT
iajs-3390	175	3	v.b	v.b	PROPN
iajs-3390	175	4	.	.	PROPN
iajs-3390	175	5	;	;	PUNCT
iajs-3390	175	6	karsdal	karsdal	ADJ
iajs-3390	175	7	,	,	PUNCT
iajs-3390	175	8	m.a	m.a	PROPN
iajs-3390	175	9	.	.	PROPN
iajs-3390	175	10	osteoarthritis	osteoarthritis	NOUN
iajs-3390	175	11	:	:	PUNCT
iajs-3390	175	12	current	current	ADJ
iajs-3390	175	13	molecular	molecular	ADJ
iajs-3390	175	14	biomarkers	biomarker	NOUN
iajs-3390	175	15	and	and	CCONJ
iajs-3390	175	16	the	the	DET
iajs-3390	175	17	way	way	NOUN
iajs-3390	175	18	forward	forward	ADV
iajs-3390	175	19	.	.	PUNCT
iajs-3390	176	1	calcified	calcified	ADJ
iajs-3390	176	2	tissue	tissue	NOUN
iajs-3390	176	3	international	international	ADJ
iajs-3390	176	4	2021	2021	NUM
iajs-3390	176	5	,	,	PUNCT
iajs-3390	176	6	109(3	109(3	NUM
iajs-3390	176	7	)	)	PUNCT
iajs-3390	176	8	,	,	PUNCT
iajs-3390	176	9	329	329	NUM
iajs-3390	176	10	-	-	SYM
iajs-3390	176	11	338	338	NUM
iajs-3390	176	12	.	.	PUNCT
iajs-3390	177	1	https://doi.org/10.1007/s00223-020-00701-7	https://doi.org/10.1007/s00223-020-00701-7	NUM
iajs-3390	177	2	.	.	PUNCT
iajs-3390	178	1	15	15	NUM
iajs-3390	178	2	.	.	X
iajs-3390	179	1	roemer	roemer	PROPN
iajs-3390	179	2	,	,	PUNCT
iajs-3390	179	3	f.	f.	PROPN
iajs-3390	179	4	;	;	PUNCT
iajs-3390	179	5	collins	collins	PROPN
iajs-3390	179	6	,	,	PUNCT
iajs-3390	179	7	j.	j.	PROPN
iajs-3390	179	8	;	;	PUNCT
iajs-3390	179	9	neogi	neogi	PROPN
iajs-3390	179	10	,	,	PUNCT
iajs-3390	179	11	t.	t.	PROPN
iajs-3390	179	12	;	;	PUNCT
iajs-3390	179	13	crema	crema	ADJ
iajs-3390	179	14	,	,	PUNCT
iajs-3390	179	15	m.	m.	NOUN
iajs-3390	179	16	;	;	PUNCT
iajs-3390	179	17	guermazi	guermazi	PROPN
iajs-3390	179	18	,	,	PUNCT
iajs-3390	179	19	a.	a.	NOUN
iajs-3390	179	20	association	association	PROPN
iajs-3390	179	21	of	of	ADP
iajs-3390	179	22	knee	knee	NOUN
iajs-3390	179	23	oa	oa	PROPN
iajs-3390	179	24	structural	structural	ADJ
iajs-3390	179	25	phenotypes	phenotype	NOUN
iajs-3390	179	26	to	to	PART
iajs-3390	179	27	risk	risk	VERB
iajs-3390	179	28	for	for	ADP
iajs-3390	179	29	progression	progression	NOUN
iajs-3390	179	30	:	:	PUNCT
iajs-3390	179	31	a	a	DET
iajs-3390	179	32	secondary	secondary	ADJ
iajs-3390	179	33	analysis	analysis	NOUN
iajs-3390	179	34	from	from	ADP
iajs-3390	179	35	the	the	DET
iajs-3390	179	36	foundation	foundation	NOUN
iajs-3390	179	37	for	for	ADP
iajs-3390	179	38	national	national	ADJ
iajs-3390	179	39	institutes	institutes	PROPN
iajs-3390	179	40	of	of	ADP
iajs-3390	179	41	health	health	NOUN
iajs-3390	179	42	osteoarthritis	osteoarthritis	NOUN
iajs-3390	179	43	biomarkers	biomarker	NOUN
iajs-3390	179	44	study	study	NOUN
iajs-3390	179	45	(	(	PUNCT
iajs-3390	179	46	fnih	fnih	PROPN
iajs-3390	179	47	)	)	PUNCT
iajs-3390	179	48	.	.	PUNCT
iajs-3390	180	1	osteoarthritis	osteoarthritis	NOUN
iajs-3390	180	2	and	and	CCONJ
iajs-3390	180	3	cartilage	cartilage	NOUN
iajs-3390	180	4	2020	2020	NUM
iajs-3390	180	5	,	,	PUNCT
iajs-3390	180	6	28(9	28(9	NOUN
iajs-3390	180	7	)	)	PUNCT
iajs-3390	180	8	,	,	PUNCT
iajs-3390	180	9	12201228	12201228	NUM
iajs-3390	180	10	.	.	PUNCT
iajs-3390	181	1	https://doi.org/10.1016/j.joca.2020.05.008	https://doi.org/10.1016/j.joca.2020.05.008	NOUN
iajs-3390	181	2	.	.	PUNCT
iajs-3390	182	1	16	16	NUM
iajs-3390	182	2	.	.	PUNCT
iajs-3390	182	3	berenbaum	berenbaum	PROPN
iajs-3390	182	4	,	,	PUNCT
iajs-3390	182	5	f.	f.	PROPN
iajs-3390	182	6	;	;	PUNCT
iajs-3390	182	7	walker	walker	PROPN
iajs-3390	182	8	,	,	PUNCT
iajs-3390	182	9	c.	c.	PROPN
iajs-3390	182	10	osteoarthritis	osteoarthritis	PROPN
iajs-3390	182	11	and	and	CCONJ
iajs-3390	182	12	inflammation	inflammation	NOUN
iajs-3390	182	13	:	:	PUNCT
iajs-3390	182	14	a	a	DET
iajs-3390	182	15	serious	serious	ADJ
iajs-3390	182	16	disease	disease	NOUN
iajs-3390	182	17	with	with	ADP
iajs-3390	182	18	overlapping	overlap	VERB
iajs-3390	182	19	phenotypic	phenotypic	ADJ
iajs-3390	182	20	patterns	pattern	NOUN
iajs-3390	182	21	.	.	PUNCT
iajs-3390	183	1	postgraduate	postgraduate	VERB
iajs-3390	183	2	medicine	medicine	NOUN
iajs-3390	183	3	2020	2020	NUM
iajs-3390	183	4	,	,	PUNCT
iajs-3390	183	5	132(4	132(4	NUM
iajs-3390	183	6	)	)	PUNCT
iajs-3390	183	7	,	,	PUNCT
iajs-3390	183	8	377	377	NUM
iajs-3390	183	9	-	-	SYM
iajs-3390	183	10	384	384	NUM
iajs-3390	183	11	.	.	PUNCT
iajs-3390	183	12	https://doi.org/10.1080/00325481.2020.173066918	https://doi.org/10.1080/00325481.2020.173066918	PROPN
iajs-3390	183	13	.	.	PROPN
iajs-3390	183	14	17	17	NUM
iajs-3390	183	15	.	.	PUNCT
iajs-3390	184	1	chow	chow	PROPN
iajs-3390	184	2	,	,	PUNCT
iajs-3390	184	3	y.y	y.y	PROPN
iajs-3390	184	4	.	.	PROPN
iajs-3390	184	5	;	;	PUNCT
iajs-3390	184	6	chin	chin	PROPN
iajs-3390	184	7	,	,	PUNCT
iajs-3390	184	8	k.y	k.y	PROPN
iajs-3390	184	9	.	.	PUNCT
iajs-3390	185	1	the	the	DET
iajs-3390	185	2	role	role	NOUN
iajs-3390	185	3	of	of	ADP
iajs-3390	185	4	inflammation	inflammation	NOUN
iajs-3390	185	5	in	in	ADP
iajs-3390	185	6	the	the	DET
iajs-3390	185	7	pathogenesis	pathogenesis	NOUN
iajs-3390	185	8	of	of	ADP
iajs-3390	185	9	osteoarthritis	osteoarthritis	NOUN
iajs-3390	185	10	.	.	PUNCT
iajs-3390	186	1	mediators	mediator	NOUN
iajs-3390	186	2	of	of	ADP
iajs-3390	186	3	inflammation	inflammation	NOUN
iajs-3390	186	4	2020	2020	NUM
iajs-3390	186	5	,	,	PUNCT
iajs-3390	186	6	2020(1	2020(1	NUM
iajs-3390	186	7	)	)	PUNCT
iajs-3390	186	8	,	,	PUNCT
iajs-3390	186	9	1	1	NUM
iajs-3390	186	10	-	-	SYM
iajs-3390	186	11	19	19	NUM
iajs-3390	186	12	.	.	PUNCT
iajs-3390	187	1	https://doi.org/10.1177/0004563215610142	https://doi.org/10.1177/0004563215610142	PRON
iajs-3390	187	2	.	.	PROPN
iajs-3390	188	1	18	18	NUM
iajs-3390	188	2	.	.	X
iajs-3390	188	3	tennant	tennant	PROPN
iajs-3390	188	4	,	,	PUNCT
iajs-3390	188	5	f.	f.	PROPN
iajs-3390	188	6	erythrocyte	erythrocyte	PROPN
iajs-3390	188	7	sedimentation	sedimentation	NOUN
iajs-3390	188	8	rate	rate	NOUN
iajs-3390	188	9	and	and	CCONJ
iajs-3390	188	10	c	c	NOUN
iajs-3390	188	11	-	-	PUNCT
iajs-3390	188	12	reactive	reactive	ADJ
iajs-3390	188	13	protein	protein	NOUN
iajs-3390	188	14	:	:	PUNCT
iajs-3390	188	15	old	old	ADJ
iajs-3390	188	16	but	but	CCONJ
iajs-3390	188	17	useful	useful	ADJ
iajs-3390	188	18	biomarkers	biomarker	NOUN
iajs-3390	188	19	for	for	ADP
iajs-3390	188	20	pain	pain	NOUN
iajs-3390	188	21	treatment	treatment	NOUN
iajs-3390	188	22	.	.	PUNCT
iajs-3390	189	1	practical	practical	ADJ
iajs-3390	189	2	pain	pain	NOUN
iajs-3390	189	3	management	management	NOUN
iajs-3390	189	4	2013	2013	NUM
iajs-3390	189	5	,	,	PUNCT
iajs-3390	189	6	13(2	13(2	PROPN
iajs-3390	189	7	)	)	PUNCT
iajs-3390	189	8	,	,	PUNCT
iajs-3390	189	9	61	61	NUM
iajs-3390	189	10	-	-	SYM
iajs-3390	189	11	65	65	NUM
iajs-3390	189	12	.	.	PROPN
iajs-3390	190	1	19	19	NUM
iajs-3390	190	2	.	.	X
iajs-3390	190	3	yang	yang	PROPN
iajs-3390	190	4	,	,	PUNCT
iajs-3390	190	5	j.	j.	PROPN
iajs-3390	190	6	;	;	PUNCT
iajs-3390	190	7	fan	fan	PROPN
iajs-3390	190	8	,	,	PUNCT
iajs-3390	190	9	l.	l.	PROPN
iajs-3390	190	10	;	;	PUNCT
iajs-3390	190	11	liao	liao	PROPN
iajs-3390	190	12	,	,	PUNCT
iajs-3390	190	13	x.	x.	NOUN
iajs-3390	190	14	;	;	PUNCT
iajs-3390	190	15	cui	cui	PROPN
iajs-3390	190	16	,	,	PUNCT
iajs-3390	190	17	g.	g.	PROPN
iajs-3390	190	18	;	;	PUNCT
iajs-3390	190	19	hu	hu	PROPN
iajs-3390	190	20	,	,	PUNCT
iajs-3390	190	21	h.	h.	PROPN
iajs-3390	190	22	crtac1	crtac1	PROPN
iajs-3390	190	23	(	(	PUNCT
iajs-3390	190	24	cartilage	cartilage	NOUN
iajs-3390	190	25	acidic	acidic	ADJ
iajs-3390	190	26	protein	protein	NOUN
iajs-3390	190	27	1	1	NUM
iajs-3390	190	28	)	)	PUNCT
iajs-3390	190	29	inhibits	inhibit	VERB
iajs-3390	190	30	cell	cell	NOUN
iajs-3390	190	31	proliferation	proliferation	NOUN
iajs-3390	190	32	,	,	PUNCT
iajs-3390	190	33	migration	migration	NOUN
iajs-3390	190	34	,	,	PUNCT
iajs-3390	190	35	invasion	invasion	NOUN
iajs-3390	190	36	and	and	CCONJ
iajs-3390	190	37	epithelial	epithelial	ADJ
iajs-3390	190	38	-	-	PUNCT
iajs-3390	190	39	mesenchymal	mesenchymal	NOUN
iajs-3390	190	40	transition	transition	NOUN
iajs-3390	190	41	(	(	PUNCT
iajs-3390	190	42	emt	emt	NOUN
iajs-3390	190	43	)	)	PUNCT
iajs-3390	190	44	process	process	NOUN
iajs-3390	190	45	in	in	ADP
iajs-3390	190	46	bladder	bladder	NOUN
iajs-3390	190	47	cancer	cancer	NOUN
iajs-3390	190	48	by	by	ADP
iajs-3390	190	49	downregulating	downregulating	PROPN
iajs-3390	190	50	yin	yin	PROPN
iajs-3390	190	51	yang	yang	PROPN
iajs-3390	190	52	1	1	PROPN
iajs-3390	190	53	(	(	PUNCT
iajs-3390	190	54	yy1	yy1	NOUN
iajs-3390	190	55	)	)	PUNCT
iajs-3390	190	56	to	to	PART
iajs-3390	190	57	inactivate	inactivate	VERB
iajs-3390	190	58	the	the	DET
iajs-3390	190	59	tgf	tgf	PROPN
iajs-3390	190	60	-	-	PUNCT
iajs-3390	190	61	β	β	NOUN
iajs-3390	190	62	pathway	pathway	NOUN
iajs-3390	190	63	.	.	PUNCT
iajs-3390	191	1	bioengineered	bioengineere	VERB
iajs-3390	191	2	2021	2021	NUM
iajs-3390	191	3	,	,	PUNCT
iajs-3390	191	4	12(2	12(2	NUM
iajs-3390	191	5	)	)	PUNCT
iajs-3390	191	6	,	,	PUNCT
iajs-3390	191	7	9377	9377	NUM
iajs-3390	191	8	-	-	SYM
iajs-3390	191	9	9389	9389	NUM
iajs-3390	191	10	.	.	PUNCT
iajs-3390	192	1	https://doi.org/10.1080/21655979.2021.1974645	https://doi.org/10.1080/21655979.2021.1974645	PUNCT
iajs-3390	192	2	.	.	PUNCT
iajs-3390	193	1	20	20	NUM
iajs-3390	193	2	.	.	X
iajs-3390	193	3	steck	steck	PROPN
iajs-3390	193	4	,	,	PUNCT
iajs-3390	193	5	e.	e.	PROPN
iajs-3390	193	6	;	;	PUNCT
iajs-3390	193	7	bräun	bräun	ADV
iajs-3390	193	8	,	,	PUNCT
iajs-3390	193	9	j.	j.	PROPN
iajs-3390	193	10	;	;	PUNCT
iajs-3390	193	11	pelttari	pelttari	PROPN
iajs-3390	193	12	,	,	PUNCT
iajs-3390	193	13	k.	k.	PROPN
iajs-3390	193	14	;	;	PUNCT
iajs-3390	193	15	kadel	kadel	PROPN
iajs-3390	193	16	,	,	PUNCT
iajs-3390	193	17	s.	s.	PROPN
iajs-3390	193	18	;	;	PUNCT
iajs-3390	193	19	kalbacher	kalbacher	PROPN
iajs-3390	193	20	,	,	PUNCT
iajs-3390	193	21	h.	h.	PROPN
iajs-3390	193	22	;	;	PUNCT
iajs-3390	193	23	richter	richter	PROPN
iajs-3390	193	24	,	,	PUNCT
iajs-3390	193	25	w.	w.	PROPN
iajs-3390	193	26	chondrocyte	chondrocyte	PROPN
iajs-3390	193	27	secreted	secrete	VERB
iajs-3390	193	28	crtac1	crtac1	NOUN
iajs-3390	193	29	:	:	PUNCT
iajs-3390	193	30	a	a	DET
iajs-3390	193	31	glycosylated	glycosylated	ADJ
iajs-3390	193	32	extracellular	extracellular	ADJ
iajs-3390	193	33	matrix	matrix	NOUN
iajs-3390	193	34	molecule	molecule	NOUN
iajs-3390	193	35	of	of	ADP
iajs-3390	193	36	human	human	ADJ
iajs-3390	193	37	articular	articular	ADJ
iajs-3390	193	38	cartilage	cartilage	NOUN
iajs-3390	193	39	.	.	PUNCT
iajs-3390	194	1	matrix	matrix	NOUN
iajs-3390	194	2	biology	biology	NOUN
iajs-3390	194	3	2007	2007	NUM
iajs-3390	194	4	,	,	PUNCT
iajs-3390	194	5	26(1	26(1	NUM
iajs-3390	194	6	)	)	PUNCT
iajs-3390	194	7	,	,	PUNCT
iajs-3390	194	8	30	30	NUM
iajs-3390	194	9	-	-	SYM
iajs-3390	194	10	41	41	NUM
iajs-3390	194	11	.	.	PUNCT
iajs-3390	195	1	https://doi.org/10.1016/j.matbio.2006.09.006	https://doi.org/10.1016/j.matbio.2006.09.006	NOUN
iajs-3390	195	2	.	.	PUNCT
iajs-3390	196	1	21	21	NUM
iajs-3390	196	2	.	.	X
iajs-3390	196	3	palmieri	palmieri	PROPN
iajs-3390	196	4	,	,	PUNCT
iajs-3390	196	5	b.	b.	PROPN
iajs-3390	196	6	;	;	PUNCT
iajs-3390	196	7	lodi	lodi	PROPN
iajs-3390	196	8	,	,	PUNCT
iajs-3390	196	9	d.	d.	PROPN
iajs-3390	196	10	;	;	PUNCT
iajs-3390	196	11	capone	capone	PROPN
iajs-3390	196	12	,	,	PUNCT
iajs-3390	196	13	s.	s.	PROPN
iajs-3390	196	14	osteoarthritis	osteoarthritis	PROPN
iajs-3390	196	15	and	and	CCONJ
iajs-3390	196	16	degenerative	degenerative	ADJ
iajs-3390	196	17	joint	joint	ADJ
iajs-3390	196	18	disease	disease	NOUN
iajs-3390	196	19	:	:	PUNCT
iajs-3390	196	20	local	local	ADJ
iajs-3390	196	21	treatment	treatment	NOUN
iajs-3390	196	22	options	option	NOUN
iajs-3390	196	23	update	update	NOUN
iajs-3390	196	24	.	.	PUNCT
iajs-3390	197	1	acta	acta	PROPN
iajs-3390	197	2	biomed	biome	VERB
iajs-3390	197	3	2010	2010	NUM
iajs-3390	197	4	,	,	PUNCT
iajs-3390	197	5	81(2	81(2	NUM
iajs-3390	197	6	)	)	PUNCT
iajs-3390	197	7	,	,	PUNCT
iajs-3390	197	8	94	94	NUM
iajs-3390	197	9	-	-	SYM
iajs-3390	197	10	100	100	NUM
iajs-3390	197	11	.	.	PUNCT
iajs-3390	198	1	pmid	pmid	NOUN
iajs-3390	198	2	:	:	PUNCT
iajs-3390	198	3	21305873	21305873	NUM
iajs-3390	198	4	.	.	PUNCT
iajs-3390	199	1	https://doi.org/10.1016/j.joca.2021.10.003	https://doi.org/10.1016/j.joca.2021.10.003	NOUN
iajs-3390	199	2	https://doi.org/10.1016/j.joca.2020.01.002	https://doi.org/10.1016/j.joca.2020.01.002	NOUN
iajs-3390	199	3	https://doi.org/10.1002/acr.21606	https://doi.org/10.1002/acr.21606	PROPN
iajs-3390	199	4	https://doi.org/10.1016/j.berh.2014.01.004	https://doi.org/10.1016/j.berh.2014.01.004	PROPN
iajs-3390	199	5	https://doi.org/10.1016/s0140-6736(20)32230-3	https://doi.org/10.1016/s0140-6736(20)32230-3	PROPN
iajs-3390	199	6	https://doi.org/10.1007/s00213-019-05326-9	https://doi.org/10.1007/s00213-019-05326-9	NUM
iajs-3390	199	7	https://doi.org/10.1007/s00213-019-05326-9	https://doi.org/10.1007/s00213-019-05326-9	PROPN
iajs-3390	199	8	https://doi.org/10.1126/stke.2492004re12	https://doi.org/10.1126/stke.2492004re12	PROPN
iajs-3390	199	9	https://doi.org/10.1080/09513590.2016.1214257	https://doi.org/10.1080/09513590.2016.1214257	PROPN
iajs-3390	199	10	https://doi.org/10.1155/2021/5574582	https://doi.org/10.1155/2021/5574582	PROPN
iajs-3390	199	11	https://doi.org/10.1007/s00223-020-00701-7	https://doi.org/10.1007/s00223-020-00701-7	NUM
iajs-3390	199	12	https://doi.org/10.1016/j.joca.2020.05.008	https://doi.org/10.1016/j.joca.2020.05.008	PROPN
iajs-3390	199	13	https://doi.org/10.1080/00325481.2020.173066918	https://doi.org/10.1080/00325481.2020.173066918	PROPN
iajs-3390	199	14	.	.	PUNCT
iajs-3390	200	1	https://doi.org/10.1177/0004563215610142	https://doi.org/10.1177/0004563215610142	DET
iajs-3390	200	2	https://doi.org/10.1080/21655979.2021.1974645	https://doi.org/10.1080/21655979.2021.1974645	ADJ
iajs-3390	200	3	https://doi.org/10.1016/j.matbio.2006.09.006	https://doi.org/10.1016/j.matbio.2006.09.006	NUM
iajs-3390	200	4	ihjpas	ihjpa	NOUN
iajs-3390	200	5	.	.	PUNCT
iajs-3390	201	1	2024	2024	NUM
iajs-3390	201	2	,	,	PUNCT
iajs-3390	201	3	37(4	37(4	NUM
iajs-3390	201	4	)	)	PUNCT
iajs-3390	201	5	271	271	NUM
iajs-3390	201	6	22	22	NUM
iajs-3390	201	7	.	.	PUNCT
iajs-3390	201	8	letsiou	letsiou	NOUN
iajs-3390	201	9	,	,	PUNCT
iajs-3390	201	10	s.	s.	PROPN
iajs-3390	201	11	;	;	PUNCT
iajs-3390	201	12	félix	félix	PROPN
iajs-3390	201	13	,	,	PUNCT
iajs-3390	201	14	r.c	r.c	PROPN
iajs-3390	201	15	.	.	PROPN
iajs-3390	201	16	;	;	PUNCT
iajs-3390	201	17	cardoso	cardoso	PROPN
iajs-3390	201	18	,	,	PUNCT
iajs-3390	201	19	j.c	j.c	PROPN
iajs-3390	201	20	.	.	PROPN
iajs-3390	201	21	;	;	PUNCT
iajs-3390	201	22	anjos	anjos	PROPN
iajs-3390	201	23	,	,	PUNCT
iajs-3390	201	24	l.	l.	PROPN
iajs-3390	201	25	;	;	PUNCT
iajs-3390	201	26	mestre	mestre	PROPN
iajs-3390	201	27	,	,	PUNCT
iajs-3390	201	28	a.l	a.l	PROPN
iajs-3390	201	29	.	.	PROPN
iajs-3390	201	30	;	;	PUNCT
iajs-3390	201	31	gomes	gomes	PROPN
iajs-3390	201	32	,	,	PUNCT
iajs-3390	201	33	h.l	h.l	PROPN
iajs-3390	201	34	.	.	PROPN
iajs-3390	201	35	;	;	PUNCT
iajs-3390	201	36	power	power	NOUN
iajs-3390	201	37	,	,	PUNCT
iajs-3390	201	38	d.m	d.m	PROPN
iajs-3390	201	39	.	.	PROPN
iajs-3390	201	40	cartilage	cartilage	NOUN
iajs-3390	201	41	acidic	acidic	ADJ
iajs-3390	201	42	protein	protein	NOUN
iajs-3390	201	43	1	1	NUM
iajs-3390	201	44	promotes	promote	VERB
iajs-3390	201	45	increased	increase	VERB
iajs-3390	201	46	cell	cell	NOUN
iajs-3390	201	47	viability	viability	NOUN
iajs-3390	201	48	,	,	PUNCT
iajs-3390	201	49	cell	cell	NOUN
iajs-3390	201	50	proliferation	proliferation	NOUN
iajs-3390	201	51	and	and	CCONJ
iajs-3390	201	52	energy	energy	NOUN
iajs-3390	201	53	metabolism	metabolism	NOUN
iajs-3390	201	54	in	in	ADP
iajs-3390	201	55	primary	primary	ADJ
iajs-3390	201	56	human	human	ADJ
iajs-3390	201	57	dermal	dermal	NOUN
iajs-3390	201	58	fibroblasts	fibroblast	NOUN
iajs-3390	201	59	.	.	PUNCT
iajs-3390	202	1	biochimie	biochimie	PROPN
iajs-3390	202	2	2020	2020	NUM
iajs-3390	202	3	,	,	PUNCT
iajs-3390	202	4	171	171	NUM
iajs-3390	202	5	,	,	PUNCT
iajs-3390	202	6	72	72	NUM
iajs-3390	202	7	-	-	SYM
iajs-3390	202	8	78	78	NUM
iajs-3390	202	9	.	.	PUNCT
iajs-3390	203	1	https://doi.org/10.1016/j.biochi.2020.02.008	https://doi.org/10.1016/j.biochi.2020.02.008	NOUN
iajs-3390	203	2	.	.	PUNCT
iajs-3390	204	1	23	23	NUM
iajs-3390	204	2	.	.	PUNCT
iajs-3390	205	1	jin	jin	NOUN
iajs-3390	205	2	,	,	PUNCT
iajs-3390	205	3	x.	x.	NOUN
iajs-3390	205	4	;	;	PUNCT
iajs-3390	205	5	beguerie	beguerie	PROPN
iajs-3390	205	6	,	,	PUNCT
iajs-3390	205	7	j.r	j.r	PROPN
iajs-3390	205	8	.	.	PROPN
iajs-3390	205	9	;	;	PUNCT
iajs-3390	205	10	zhang	zhang	PROPN
iajs-3390	205	11	,	,	PUNCT
iajs-3390	205	12	w.	w.	PROPN
iajs-3390	205	13	;	;	PUNCT
iajs-3390	205	14	blizzard	blizzard	PROPN
iajs-3390	205	15	,	,	PUNCT
iajs-3390	205	16	l.	l.	PROPN
iajs-3390	205	17	;	;	PUNCT
iajs-3390	205	18	otahal	otahal	NOUN
iajs-3390	205	19	,	,	PUNCT
iajs-3390	205	20	p.	p.	NOUN
iajs-3390	205	21	;	;	PUNCT
iajs-3390	206	1	jones	jones	PROPN
iajs-3390	206	2	,	,	PUNCT
iajs-3390	206	3	g.	g.	PROPN
iajs-3390	206	4	;	;	PUNCT
iajs-3390	206	5	ding	ding	NOUN
iajs-3390	206	6	,	,	PUNCT
iajs-3390	206	7	c.	c.	PROPN
iajs-3390	206	8	circulating	circulate	VERB
iajs-3390	206	9	c	c	PROPN
iajs-3390	206	10	reactive	reactive	ADJ
iajs-3390	206	11	protein	protein	NOUN
iajs-3390	206	12	in	in	ADP
iajs-3390	206	13	osteoarthritis	osteoarthritis	NOUN
iajs-3390	206	14	:	:	PUNCT
iajs-3390	206	15	a	a	DET
iajs-3390	206	16	systematic	systematic	ADJ
iajs-3390	206	17	review	review	NOUN
iajs-3390	206	18	and	and	CCONJ
iajs-3390	206	19	meta	meta	ADJ
iajs-3390	206	20	-	-	PUNCT
iajs-3390	206	21	analysis	analysis	NOUN
iajs-3390	206	22	.	.	PUNCT
iajs-3390	207	1	annals	annal	NOUN
iajs-3390	207	2	of	of	ADP
iajs-3390	207	3	the	the	DET
iajs-3390	207	4	rheumatic	rheumatic	ADJ
iajs-3390	207	5	diseases	disease	NOUN
iajs-3390	207	6	2015	2015	NUM
iajs-3390	207	7	,	,	PUNCT
iajs-3390	207	8	74(4	74(4	NUM
iajs-3390	207	9	)	)	PUNCT
iajs-3390	207	10	,	,	PUNCT
iajs-3390	207	11	703	703	NUM
iajs-3390	207	12	-	-	SYM
iajs-3390	207	13	710	710	NUM
iajs-3390	207	14	.	.	PUNCT
iajs-3390	208	1	https://doi.org/10.1136/annrheumdis-2013-204494	https://doi.org/10.1136/annrheumdis-2013-204494	NOUN
iajs-3390	208	2	.	.	NOUN
iajs-3390	208	3	24	24	NUM
iajs-3390	208	4	.	.	PUNCT
iajs-3390	208	5	smith	smith	PROPN
iajs-3390	208	6	,	,	PUNCT
iajs-3390	208	7	j.w	j.w	PROPN
iajs-3390	208	8	.	.	PROPN
iajs-3390	208	9	;	;	PUNCT
iajs-3390	208	10	martins	martin	NOUN
iajs-3390	208	11	,	,	PUNCT
iajs-3390	208	12	t.b	t.b	PROPN
iajs-3390	208	13	.	.	PROPN
iajs-3390	208	14	;	;	PUNCT
iajs-3390	208	15	gopez	gopez	PROPN
iajs-3390	208	16	,	,	PUNCT
iajs-3390	208	17	e.	e.	PROPN
iajs-3390	208	18	;	;	PUNCT
iajs-3390	208	19	johnson	johnson	PROPN
iajs-3390	208	20	,	,	PUNCT
iajs-3390	208	21	t.	t.	PROPN
iajs-3390	208	22	;	;	PUNCT
iajs-3390	208	23	hill	hill	PROPN
iajs-3390	208	24	,	,	PUNCT
iajs-3390	208	25	h.r	h.r	PROPN
iajs-3390	208	26	.	.	PROPN
iajs-3390	208	27	;	;	PUNCT
iajs-3390	208	28	rosenberg	rosenberg	PROPN
iajs-3390	208	29	,	,	PUNCT
iajs-3390	208	30	t.d	t.d	PROPN
iajs-3390	208	31	.	.	PROPN
iajs-3390	208	32	significance	significance	NOUN
iajs-3390	208	33	of	of	ADP
iajs-3390	208	34	creactive	creactive	ADJ
iajs-3390	208	35	protein	protein	NOUN
iajs-3390	208	36	in	in	ADP
iajs-3390	208	37	osteoarthritis	osteoarthritis	NOUN
iajs-3390	208	38	and	and	CCONJ
iajs-3390	208	39	total	total	ADJ
iajs-3390	208	40	knee	knee	NOUN
iajs-3390	208	41	arthroplasty	arthroplasty	NOUN
iajs-3390	208	42	outcomes	outcome	NOUN
iajs-3390	208	43	.	.	PUNCT
iajs-3390	209	1	therapeutic	therapeutic	ADJ
iajs-3390	209	2	advances	advance	NOUN
iajs-3390	209	3	in	in	ADP
iajs-3390	209	4	musculoskeletal	musculoskeletal	ADJ
iajs-3390	209	5	disease	disease	NOUN
iajs-3390	209	6	2012	2012	NUM
iajs-3390	209	7	,	,	PUNCT
iajs-3390	209	8	4(5	4(5	NUM
iajs-3390	209	9	)	)	PUNCT
iajs-3390	209	10	,	,	PUNCT
iajs-3390	209	11	315	315	NUM
iajs-3390	209	12	-	-	SYM
iajs-3390	209	13	325	325	NUM
iajs-3390	209	14	.	.	PUNCT
iajs-3390	210	1	https://doi.org/10.1177/1759720x12455959	https://doi.org/10.1177/1759720x12455959	NOUN
iajs-3390	210	2	.	.	NOUN
iajs-3390	210	3	25	25	NUM
iajs-3390	210	4	.	.	PUNCT
iajs-3390	211	1	kerkhof	kerkhof	NOUN
iajs-3390	211	2	,	,	PUNCT
iajs-3390	211	3	h.j	h.j	PROPN
iajs-3390	211	4	.	.	PROPN
iajs-3390	211	5	;	;	PUNCT
iajs-3390	211	6	bierma	bierma	NOUN
iajs-3390	211	7	-	-	PUNCT
iajs-3390	211	8	zeinstra	zeinstra	PROPN
iajs-3390	211	9	,	,	PUNCT
iajs-3390	211	10	s.m	s.m	PROPN
iajs-3390	211	11	.	.	PROPN
iajs-3390	211	12	;	;	PUNCT
iajs-3390	211	13	castano	castano	PROPN
iajs-3390	211	14	-	-	PUNCT
iajs-3390	211	15	betancourt	betancourt	NOUN
iajs-3390	211	16	,	,	PUNCT
iajs-3390	211	17	m.c	m.c	PROPN
iajs-3390	211	18	.	.	PROPN
iajs-3390	211	19	;	;	PUNCT
iajs-3390	211	20	de	de	X
iajs-3390	211	21	maat	maat	X
iajs-3390	211	22	,	,	PUNCT
iajs-3390	211	23	m.p	m.p	PROPN
iajs-3390	211	24	.	.	PROPN
iajs-3390	211	25	;	;	PUNCT
iajs-3390	211	26	hofman	hofman	PROPN
iajs-3390	211	27	,	,	PUNCT
iajs-3390	211	28	a.	a.	NOUN
iajs-3390	211	29	;	;	PUNCT
iajs-3390	211	30	pols	pol	NOUN
iajs-3390	211	31	,	,	PUNCT
iajs-3390	211	32	h.a	h.a	PROPN
iajs-3390	211	33	.	.	PROPN
iajs-3390	211	34	;	;	PUNCT
iajs-3390	211	35	rivadeneira	rivadeneira	PROPN
iajs-3390	211	36	,	,	PUNCT
iajs-3390	211	37	f.	f.	PROPN
iajs-3390	211	38	;	;	PUNCT
iajs-3390	211	39	witteman	witteman	PROPN
iajs-3390	211	40	,	,	PUNCT
iajs-3390	211	41	j.c	j.c	PROPN
iajs-3390	211	42	.	.	PROPN
iajs-3390	211	43	;	;	PUNCT
iajs-3390	211	44	uitterlinden	uitterlinden	ADJ
iajs-3390	211	45	,	,	PUNCT
iajs-3390	211	46	a.g	a.g	PROPN
iajs-3390	211	47	.	.	PROPN
iajs-3390	211	48	;	;	PUNCT
iajs-3390	211	49	van	van	PROPN
iajs-3390	211	50	meurs	meurs	PROPN
iajs-3390	211	51	,	,	PUNCT
iajs-3390	211	52	j.b	j.b	PROPN
iajs-3390	211	53	.	.	PROPN
iajs-3390	211	54	serum	serum	PROPN
iajs-3390	211	55	c	c	PROPN
iajs-3390	211	56	reactive	reactive	ADJ
iajs-3390	211	57	protein	protein	NOUN
iajs-3390	211	58	levels	level	NOUN
iajs-3390	211	59	and	and	CCONJ
iajs-3390	211	60	genetic	genetic	ADJ
iajs-3390	211	61	variation	variation	NOUN
iajs-3390	211	62	in	in	ADP
iajs-3390	211	63	the	the	DET
iajs-3390	211	64	crp	crp	NOUN
iajs-3390	211	65	gene	gene	NOUN
iajs-3390	211	66	are	be	AUX
iajs-3390	211	67	not	not	PART
iajs-3390	211	68	associated	associate	VERB
iajs-3390	211	69	with	with	ADP
iajs-3390	211	70	the	the	DET
iajs-3390	211	71	prevalence	prevalence	NOUN
iajs-3390	211	72	,	,	PUNCT
iajs-3390	211	73	incidence	incidence	NOUN
iajs-3390	211	74	or	or	CCONJ
iajs-3390	211	75	progression	progression	NOUN
iajs-3390	211	76	of	of	ADP
iajs-3390	211	77	osteoarthritis	osteoarthritis	NOUN
iajs-3390	211	78	independent	independent	NOUN
iajs-3390	211	79	of	of	ADP
iajs-3390	211	80	body	body	NOUN
iajs-3390	211	81	mass	mass	PROPN
iajs-3390	211	82	index	index	NOUN
iajs-3390	211	83	.	.	PUNCT
iajs-3390	212	1	annals	annal	NOUN
iajs-3390	212	2	of	of	ADP
iajs-3390	212	3	the	the	DET
iajs-3390	212	4	rheumatic	rheumatic	ADJ
iajs-3390	212	5	diseases	disease	NOUN
iajs-3390	212	6	2010	2010	NUM
iajs-3390	212	7	,	,	PUNCT
iajs-3390	212	8	69(11	69(11	NOUN
iajs-3390	212	9	)	)	PUNCT
iajs-3390	212	10	,	,	PUNCT
iajs-3390	212	11	1976	1976	NUM
iajs-3390	212	12	-	-	SYM
iajs-3390	212	13	1982	1982	NUM
iajs-3390	212	14	.	.	PUNCT
iajs-3390	213	1	https://doi.org/10.1136/ard.2009.125260	https://doi.org/10.1136/ard.2009.125260	PROPN
iajs-3390	213	2	.	.	PROPN
iajs-3390	213	3	26	26	NUM
iajs-3390	213	4	.	.	PUNCT
iajs-3390	214	1	dainese	dainese	PROPN
iajs-3390	214	2	,	,	PUNCT
iajs-3390	214	3	p.	p.	PROPN
iajs-3390	214	4	;	;	PUNCT
iajs-3390	214	5	wyngaert	wyngaert	PROPN
iajs-3390	214	6	,	,	PUNCT
iajs-3390	214	7	k.v	k.v	PROPN
iajs-3390	214	8	.	.	PROPN
iajs-3390	214	9	;	;	PUNCT
iajs-3390	214	10	de	de	X
iajs-3390	214	11	mits	mit	NOUN
iajs-3390	214	12	,	,	PUNCT
iajs-3390	214	13	s.	s.	PROPN
iajs-3390	214	14	;	;	PUNCT
iajs-3390	214	15	wittoek	wittoek	PROPN
iajs-3390	214	16	,	,	PUNCT
iajs-3390	214	17	r.	r.	PROPN
iajs-3390	214	18	;	;	PUNCT
iajs-3390	214	19	van	van	PROPN
iajs-3390	214	20	ginckel	ginckel	NOUN
iajs-3390	214	21	,	,	PUNCT
iajs-3390	214	22	a.	a.	NOUN
iajs-3390	214	23	;	;	PUNCT
iajs-3390	214	24	calders	calder	NOUN
iajs-3390	214	25	,	,	PUNCT
iajs-3390	214	26	p.	p.	NOUN
iajs-3390	214	27	association	association	NOUN
iajs-3390	214	28	between	between	ADP
iajs-3390	214	29	knee	knee	NOUN
iajs-3390	214	30	inflammation	inflammation	NOUN
iajs-3390	214	31	and	and	CCONJ
iajs-3390	214	32	knee	knee	NOUN
iajs-3390	214	33	pain	pain	NOUN
iajs-3390	214	34	in	in	ADP
iajs-3390	214	35	patients	patient	NOUN
iajs-3390	214	36	with	with	ADP
iajs-3390	214	37	knee	knee	NOUN
iajs-3390	214	38	osteoarthritis	osteoarthritis	NOUN
iajs-3390	214	39	:	:	PUNCT
iajs-3390	214	40	a	a	DET
iajs-3390	214	41	systematic	systematic	ADJ
iajs-3390	214	42	review	review	NOUN
iajs-3390	214	43	.	.	PUNCT
iajs-3390	215	1	osteoarthritis	osteoarthritis	NOUN
iajs-3390	215	2	and	and	CCONJ
iajs-3390	215	3	cartilage	cartilage	NOUN
iajs-3390	215	4	2022	2022	NUM
iajs-3390	215	5	,	,	PUNCT
iajs-3390	215	6	30(4	30(4	NUM
iajs-3390	215	7	)	)	PUNCT
iajs-3390	215	8	,	,	PUNCT
iajs-3390	215	9	516	516	NUM
iajs-3390	215	10	-	-	SYM
iajs-3390	215	11	534	534	NUM
iajs-3390	215	12	.	.	PUNCT
iajs-3390	216	1	https://doi.org/10.1016/j.joca.2021.12.003	https://doi.org/10.1016/j.joca.2021.12.003	PROPN
iajs-3390	216	2	.	.	PROPN
iajs-3390	216	3	27	27	NUM
iajs-3390	216	4	.	.	PUNCT
iajs-3390	217	1	wolfe	wolfe	PROPN
iajs-3390	217	2	,	,	PUNCT
iajs-3390	217	3	f.	f.	PROPN
iajs-3390	218	1	the	the	DET
iajs-3390	218	2	c	c	NOUN
iajs-3390	218	3	-	-	PUNCT
iajs-3390	218	4	reactive	reactive	ADJ
iajs-3390	218	5	protein	protein	NOUN
iajs-3390	218	6	but	but	CCONJ
iajs-3390	218	7	not	not	PART
iajs-3390	218	8	erythrocyte	erythrocyte	NOUN
iajs-3390	218	9	sedimentation	sedimentation	NOUN
iajs-3390	218	10	rate	rate	NOUN
iajs-3390	218	11	is	be	AUX
iajs-3390	218	12	associated	associate	VERB
iajs-3390	218	13	with	with	ADP
iajs-3390	218	14	clinical	clinical	ADJ
iajs-3390	218	15	severity	severity	NOUN
iajs-3390	218	16	in	in	ADP
iajs-3390	218	17	patients	patient	NOUN
iajs-3390	218	18	with	with	ADP
iajs-3390	218	19	osteoarthritis	osteoarthritis	NOUN
iajs-3390	218	20	of	of	ADP
iajs-3390	218	21	the	the	DET
iajs-3390	218	22	knee	knee	NOUN
iajs-3390	218	23	or	or	CCONJ
iajs-3390	218	24	hip	hip	NOUN
iajs-3390	218	25	.	.	PROPN
iajs-3390	218	26	journal	journal	PROPN
iajs-3390	218	27	of	of	ADP
iajs-3390	218	28	rheumatology	rheumatology	NOUN
iajs-3390	218	29	1997	1997	NUM
iajs-3390	218	30	,	,	PUNCT
iajs-3390	218	31	24(8	24(8	NUM
iajs-3390	218	32	)	)	PUNCT
iajs-3390	218	33	,	,	PUNCT
iajs-3390	218	34	1486	1486	NUM
iajs-3390	218	35	-	-	SYM
iajs-3390	218	36	1488	1488	NUM
iajs-3390	218	37	.	.	PUNCT
iajs-3390	219	1	https://europepmc.org/article/med/9263139	https://europepmc.org/article/med/9263139	NOUN
iajs-3390	219	2	.	.	PUNCT
iajs-3390	220	1	28	28	NUM
iajs-3390	220	2	.	.	X
iajs-3390	220	3	styrkarsdottir	styrkarsdottir	PROPN
iajs-3390	220	4	,	,	PUNCT
iajs-3390	220	5	u.	u.	PROPN
iajs-3390	220	6	;	;	PUNCT
iajs-3390	220	7	lund	lund	PROPN
iajs-3390	220	8	,	,	PUNCT
iajs-3390	220	9	s.h	s.h	PROPN
iajs-3390	220	10	.	.	PROPN
iajs-3390	220	11	;	;	PUNCT
iajs-3390	220	12	saevarsdottir	saevarsdottir	PROPN
iajs-3390	220	13	,	,	PUNCT
iajs-3390	220	14	s.	s.	PROPN
iajs-3390	220	15	;	;	PUNCT
iajs-3390	220	16	magnusson	magnusson	PROPN
iajs-3390	220	17	,	,	PUNCT
iajs-3390	220	18	m.i	m.i	PROPN
iajs-3390	220	19	.	.	PROPN
iajs-3390	220	20	;	;	PUNCT
iajs-3390	220	21	gunnarsdottir	gunnarsdottir	PROPN
iajs-3390	220	22	,	,	PUNCT
iajs-3390	220	23	k.	k.	PROPN
iajs-3390	220	24	;	;	PUNCT
iajs-3390	220	25	norddahl	norddahl	PROPN
iajs-3390	220	26	,	,	PUNCT
iajs-3390	220	27	g.l	g.l	PROPN
iajs-3390	220	28	.	.	PROPN
iajs-3390	220	29	;	;	PUNCT
iajs-3390	220	30	frigge	frigge	PROPN
iajs-3390	220	31	,	,	PUNCT
iajs-3390	220	32	m.l	m.l	PROPN
iajs-3390	220	33	.	.	PROPN
iajs-3390	220	34	;	;	PUNCT
iajs-3390	220	35	ivarsdottir	ivarsdottir	PROPN
iajs-3390	220	36	,	,	PUNCT
iajs-3390	220	37	e.v	e.v	PROPN
iajs-3390	220	38	.	.	PUNCT
iajs-3390	220	39	;	;	PUNCT
iajs-3390	220	40	bjornsdottir	bjornsdottir	VERB
iajs-3390	220	41	,	,	PUNCT
iajs-3390	220	42	g.	g.	PROPN
iajs-3390	220	43	;	;	PUNCT
iajs-3390	220	44	holm	holm	PROPN
iajs-3390	220	45	,	,	PUNCT
iajs-3390	220	46	h.	h.	PROPN
iajs-3390	220	47	the	the	DET
iajs-3390	220	48	crtac1	crtac1	NOUN
iajs-3390	220	49	protein	protein	NOUN
iajs-3390	220	50	in	in	ADP
iajs-3390	220	51	plasma	plasma	NOUN
iajs-3390	220	52	is	be	AUX
iajs-3390	220	53	associated	associate	VERB
iajs-3390	220	54	with	with	ADP
iajs-3390	220	55	osteoarthritis	osteoarthritis	NOUN
iajs-3390	220	56	and	and	CCONJ
iajs-3390	220	57	predicts	predict	VERB
iajs-3390	220	58	progression	progression	NOUN
iajs-3390	220	59	to	to	ADP
iajs-3390	220	60	joint	joint	ADJ
iajs-3390	220	61	replacement	replacement	NOUN
iajs-3390	220	62	:	:	PUNCT
iajs-3390	220	63	a	a	DET
iajs-3390	220	64	large‐scale	large‐scale	NOUN
iajs-3390	220	65	proteomics	proteomic	NOUN
iajs-3390	220	66	scan	scan	NOUN
iajs-3390	220	67	in	in	ADP
iajs-3390	220	68	iceland	iceland	PROPN
iajs-3390	220	69	.	.	PUNCT
iajs-3390	221	1	arthritis	arthritis	PROPN
iajs-3390	221	2	&	&	CCONJ
iajs-3390	221	3	rheumatology	rheumatology	PROPN
iajs-3390	221	4	2021	2021	NUM
iajs-3390	221	5	,	,	PUNCT
iajs-3390	221	6	73(11	73(11	NUM
iajs-3390	221	7	)	)	PUNCT
iajs-3390	221	8	,	,	PUNCT
iajs-3390	221	9	2025	2025	NUM
iajs-3390	221	10	-	-	SYM
iajs-3390	221	11	2034	2034	NUM
iajs-3390	221	12	.	.	PUNCT
iajs-3390	222	1	https://doi.org/10.1002/art.41793	https://doi.org/10.1002/art.41793	ADJ
iajs-3390	222	2	.	.	PUNCT
iajs-3390	222	3	29	29	NUM
iajs-3390	222	4	.	.	PUNCT
iajs-3390	222	5	szilagyi	szilagyi	PROPN
iajs-3390	222	6	,	,	PUNCT
iajs-3390	222	7	i.a	i.a	PROPN
iajs-3390	222	8	.	.	PROPN
iajs-3390	222	9	;	;	PUNCT
iajs-3390	222	10	vallerga	vallerga	NOUN
iajs-3390	222	11	,	,	PUNCT
iajs-3390	222	12	c.l	c.l	PROPN
iajs-3390	222	13	.	.	PROPN
iajs-3390	222	14	;	;	PUNCT
iajs-3390	222	15	boer	boer	PROPN
iajs-3390	222	16	,	,	PUNCT
iajs-3390	222	17	c.g	c.g	PROPN
iajs-3390	222	18	.	.	PROPN
iajs-3390	222	19	;	;	PUNCT
iajs-3390	222	20	schiphof	schiphof	NOUN
iajs-3390	222	21	,	,	PUNCT
iajs-3390	222	22	d.	d.	PROPN
iajs-3390	222	23	;	;	PUNCT
iajs-3390	222	24	ikram	ikram	PROPN
iajs-3390	222	25	,	,	PUNCT
iajs-3390	222	26	m.a	m.a	PROPN
iajs-3390	222	27	.	.	PROPN
iajs-3390	222	28	;	;	PUNCT
iajs-3390	222	29	bierma	bierma	NOUN
iajs-3390	222	30	-	-	PUNCT
iajs-3390	222	31	zeinstra	zeinstra	PROPN
iajs-3390	222	32	,	,	PUNCT
iajs-3390	222	33	s.m.;van	s.m.;van	NOUN
iajs-3390	222	34	meurs	meur	NOUN
iajs-3390	222	35	,	,	PUNCT
iajs-3390	222	36	j.b	j.b	PROPN
iajs-3390	222	37	.	.	PUNCT
iajs-3390	222	38	plasma	plasma	NOUN
iajs-3390	222	39	proteomics	proteomic	NOUN
iajs-3390	222	40	identifies	identify	VERB
iajs-3390	222	41	crtac1	crtac1	NOUN
iajs-3390	222	42	as	as	ADP
iajs-3390	222	43	a	a	DET
iajs-3390	222	44	biomarker	biomarker	NOUN
iajs-3390	222	45	for	for	ADP
iajs-3390	222	46	osteoarthritis	osteoarthritis	NOUN
iajs-3390	222	47	severity	severity	NOUN
iajs-3390	222	48	and	and	CCONJ
iajs-3390	222	49	progression	progression	NOUN
iajs-3390	222	50	.	.	PUNCT
iajs-3390	223	1	rheumatology	rheumatology	NOUN
iajs-3390	223	2	2023	2023	NUM
iajs-3390	223	3	,	,	PUNCT
iajs-3390	223	4	62(3	62(3	NOUN
iajs-3390	223	5	)	)	PUNCT
iajs-3390	223	6	,	,	PUNCT
iajs-3390	223	7	1286	1286	NUM
iajs-3390	223	8	-	-	SYM
iajs-3390	223	9	1295	1295	NUM
iajs-3390	223	10	.	.	PUNCT
iajs-3390	224	1	https://doi.org/10.1093/rheumatology/keac415	https://doi.org/10.1093/rheumatology/keac415	NOUN
iajs-3390	224	2	.	.	PROPN
iajs-3390	225	1	30	30	NUM
iajs-3390	225	2	.	.	X
iajs-3390	226	1	mutar	mutar	PROPN
iajs-3390	226	2	,	,	PUNCT
iajs-3390	226	3	h.s	h.s	PROPN
iajs-3390	226	4	.	.	PROPN
iajs-3390	226	5	;	;	PUNCT
iajs-3390	227	1	hasan	hasan	PROPN
iajs-3390	227	2	,	,	PUNCT
iajs-3390	227	3	b.f	b.f	PROPN
iajs-3390	227	4	.	.	PROPN
iajs-3390	227	5	;	;	PUNCT
iajs-3390	227	6	muhi	muhi	PROPN
iajs-3390	227	7	,	,	PUNCT
iajs-3390	227	8	s.a	s.a	PROPN
iajs-3390	227	9	.	.	PROPN
iajs-3390	227	10	study	study	VERB
iajs-3390	227	11	the	the	DET
iajs-3390	227	12	level	level	NOUN
iajs-3390	227	13	of	of	ADP
iajs-3390	227	14	cartilage	cartilage	NOUN
iajs-3390	227	15	acidic	acidic	ADJ
iajs-3390	227	16	protein	protein	NOUN
iajs-3390	227	17	(	(	PUNCT
iajs-3390	227	18	crtac1	crtac1	NOUN
iajs-3390	227	19	)	)	PUNCT
iajs-3390	227	20	in	in	ADP
iajs-3390	227	21	serum	serum	NOUN
iajs-3390	227	22	of	of	ADP
iajs-3390	227	23	iraqi	iraqi	ADJ
iajs-3390	227	24	patients	patient	NOUN
iajs-3390	227	25	with	with	ADP
iajs-3390	227	26	osteoarthritis	osteoarthritis	NOUN
iajs-3390	227	27	.	.	PUNCT
iajs-3390	228	1	neuroquantology	neuroquantology	NOUN
iajs-3390	228	2	2022	2022	NUM
iajs-3390	228	3	,	,	PUNCT
iajs-3390	228	4	20(7	20(7	NUM
iajs-3390	228	5	)	)	PUNCT
iajs-3390	228	6	,	,	PUNCT
iajs-3390	228	7	153	153	NUM
iajs-3390	228	8	-	-	SYM
iajs-3390	228	9	158	158	NUM
iajs-3390	228	10	.	.	PUNCT
iajs-3390	229	1	https://doi.org/10.14704/nq.2022.20.7.nq33018	https://doi.org/10.14704/nq.2022.20.7.nq33018	PROPN
iajs-3390	229	2	.	.	PUNCT
iajs-3390	230	1	31	31	NUM
iajs-3390	230	2	.	.	PUNCT
iajs-3390	231	1	liu	liu	PROPN
iajs-3390	231	2	,	,	PUNCT
iajs-3390	231	3	y.	y.	PROPN
iajs-3390	231	4	;	;	PUNCT
iajs-3390	231	5	zhang	zhang	PROPN
iajs-3390	231	6	,	,	PUNCT
iajs-3390	231	7	m.	m.	NOUN
iajs-3390	231	8	;	;	PUNCT
iajs-3390	231	9	kong	kong	PROPN
iajs-3390	231	10	,	,	PUNCT
iajs-3390	231	11	d.	d.	PROPN
iajs-3390	231	12	;	;	PUNCT
iajs-3390	231	13	wang	wang	PROPN
iajs-3390	231	14	,	,	PUNCT
iajs-3390	231	15	y.	y.	PROPN
iajs-3390	231	16	;	;	PUNCT
iajs-3390	231	17	li	li	PROPN
iajs-3390	231	18	,	,	PUNCT
iajs-3390	231	19	j.	j.	PROPN
iajs-3390	231	20	;	;	PUNCT
iajs-3390	231	21	liu	liu	PROPN
iajs-3390	231	22	,	,	PUNCT
iajs-3390	231	23	w.	w.	PROPN
iajs-3390	231	24	;	;	PUNCT
iajs-3390	231	25	fu	fu	PROPN
iajs-3390	231	26	,	,	PUNCT
iajs-3390	231	27	y.	y.	PROPN
iajs-3390	231	28	;	;	PUNCT
iajs-3390	231	29	xu	xu	PROPN
iajs-3390	231	30	,	,	PUNCT
iajs-3390	231	31	j.	j.	PROPN
iajs-3390	231	32	high	high	ADJ
iajs-3390	231	33	follicle	follicle	NOUN
iajs-3390	231	34	-	-	PUNCT
iajs-3390	231	35	stimulating	stimulate	VERB
iajs-3390	231	36	hormone	hormone	NOUN
iajs-3390	231	37	levels	level	NOUN
iajs-3390	231	38	accelerate	accelerate	VERB
iajs-3390	231	39	cartilage	cartilage	NOUN
iajs-3390	231	40	damage	damage	NOUN
iajs-3390	231	41	of	of	ADP
iajs-3390	231	42	knee	knee	NOUN
iajs-3390	231	43	osteoarthritis	osteoarthritis	NOUN
iajs-3390	231	44	in	in	ADP
iajs-3390	231	45	postmenopausal	postmenopausal	ADJ
iajs-3390	231	46	women	woman	NOUN
iajs-3390	231	47	through	through	ADP
iajs-3390	231	48	the	the	DET
iajs-3390	231	49	pi3k	pi3k	PROPN
iajs-3390	231	50	/	/	SYM
iajs-3390	231	51	akt	akt	PROPN
iajs-3390	231	52	/	/	SYM
iajs-3390	231	53	nf	nf	PROPN
iajs-3390	231	54	-	-	PUNCT
iajs-3390	231	55	κb	κb	NOUN
iajs-3390	231	56	pathway	pathway	NOUN
iajs-3390	231	57	.	.	PUNCT
iajs-3390	232	1	febs	febs	VERB
iajs-3390	232	2	open	open	ADJ
iajs-3390	232	3	bio	bio	PROPN
iajs-3390	232	4	2020	2020	NUM
iajs-3390	232	5	,	,	PUNCT
iajs-3390	232	6	10(10	10(10	NUM
iajs-3390	232	7	)	)	PUNCT
iajs-3390	232	8	,	,	PUNCT
iajs-3390	232	9	2235	2235	NUM
iajs-3390	232	10	-	-	SYM
iajs-3390	232	11	2245	2245	NUM
iajs-3390	232	12	.	.	PUNCT
iajs-3390	233	1	https://doi.org/10.1002/2211-5463.12975	https://doi.org/10.1002/2211-5463.12975	PROPN
iajs-3390	233	2	.	.	PUNCT
iajs-3390	234	1	32	32	NUM
iajs-3390	234	2	.	.	PUNCT
iajs-3390	235	1	xu	xu	PROPN
iajs-3390	235	2	,	,	PUNCT
iajs-3390	235	3	j.	j.	PROPN
iajs-3390	235	4	;	;	PUNCT
iajs-3390	235	5	xiao	xiao	PROPN
iajs-3390	235	6	,	,	PUNCT
iajs-3390	235	7	j.	j.	PROPN
iajs-3390	235	8	;	;	PUNCT
iajs-3390	235	9	shi	shi	PROPN
iajs-3390	235	10	,	,	PUNCT
iajs-3390	235	11	z.j	z.j	PROPN
iajs-3390	235	12	.	.	PROPN
iajs-3390	235	13	correlation	correlation	NOUN
iajs-3390	235	14	between	between	ADP
iajs-3390	235	15	age	age	NOUN
iajs-3390	235	16	-	-	PUNCT
iajs-3390	235	17	related	relate	VERB
iajs-3390	235	18	serum	serum	NOUN
iajs-3390	235	19	follicle	follicle	NOUN
iajs-3390	235	20	stimulating	stimulate	VERB
iajs-3390	235	21	hormone	hormone	NOUN
iajs-3390	235	22	levels	level	NOUN
iajs-3390	235	23	and	and	CCONJ
iajs-3390	235	24	osteoarthritis	osteoarthritis	NOUN
iajs-3390	235	25	in	in	ADP
iajs-3390	235	26	postmenopausal	postmenopausal	ADJ
iajs-3390	235	27	women	woman	NOUN
iajs-3390	235	28	.	.	PUNCT
iajs-3390	236	1	biomedical	biomedical	ADJ
iajs-3390	236	2	research	research	NOUN
iajs-3390	236	3	2017	2017	NUM
iajs-3390	236	4	,	,	PUNCT
iajs-3390	236	5	28(13	28(13	NUM
iajs-3390	236	6	)	)	PUNCT
iajs-3390	236	7	,	,	PUNCT
iajs-3390	236	8	5772	5772	NUM
iajs-3390	236	9	-	-	SYM
iajs-3390	236	10	5775	5775	NUM
iajs-3390	236	11	.	.	PUNCT
iajs-3390	237	1	33	33	NUM
iajs-3390	237	2	.	.	PUNCT
iajs-3390	238	1	santos	santos	PROPN
iajs-3390	238	2	-	-	PUNCT
iajs-3390	238	3	baez	baez	PROPN
iajs-3390	238	4	,	,	PUNCT
iajs-3390	238	5	l.s	l.s	PROPN
iajs-3390	238	6	.	.	PROPN
iajs-3390	238	7	;	;	PUNCT
iajs-3390	238	8	ginsberg	ginsberg	PROPN
iajs-3390	238	9	,	,	PUNCT
iajs-3390	238	10	h.n	h.n	PROPN
iajs-3390	238	11	.	.	PROPN
iajs-3390	238	12	hypertriglyceridemia	hypertriglyceridemia	NOUN
iajs-3390	238	13	—	—	PUNCT
iajs-3390	238	14	causes	cause	NOUN
iajs-3390	238	15	,	,	PUNCT
iajs-3390	238	16	significance	significance	NOUN
iajs-3390	238	17	,	,	PUNCT
iajs-3390	238	18	and	and	CCONJ
iajs-3390	238	19	approaches	approach	NOUN
iajs-3390	238	20	to	to	ADP
iajs-3390	238	21	therapy	therapy	NOUN
iajs-3390	238	22	.	.	PUNCT
iajs-3390	239	1	frontiers	frontier	NOUN
iajs-3390	239	2	in	in	ADP
iajs-3390	239	3	endocrinology	endocrinology	NOUN
iajs-3390	239	4	2020	2020	NUM
iajs-3390	239	5	,	,	PUNCT
iajs-3390	239	6	11	11	NUM
iajs-3390	239	7	,	,	PUNCT
iajs-3390	239	8	616	616	NUM
iajs-3390	239	9	.	.	PUNCT
iajs-3390	240	1	https://doi.org/10.3389/fendo.2020.00616	https://doi.org/10.3389/fendo.2020.00616	PROPN
iajs-3390	240	2	.	.	PUNCT
iajs-3390	241	1	34	34	NUM
iajs-3390	241	2	.	.	PUNCT
iajs-3390	242	1	taay	taay	PROPN
iajs-3390	242	2	,	,	PUNCT
iajs-3390	242	3	y.	y.	PROPN
iajs-3390	242	4	;	;	PUNCT
iajs-3390	242	5	mohammed	mohammed	PROPN
iajs-3390	242	6	,	,	PUNCT
iajs-3390	242	7	m.	m.	NOUN
iajs-3390	242	8	;	;	PUNCT
iajs-3390	242	9	abbas	abbas	PROPN
iajs-3390	242	10	,	,	PUNCT
iajs-3390	242	11	r.	r.	PROPN
iajs-3390	242	12	;	;	PUNCT
iajs-3390	242	13	ayad	ayad	PROPN
iajs-3390	242	14	,	,	PUNCT
iajs-3390	242	15	a.	a.	PROPN
iajs-3390	242	16	;	;	PUNCT
iajs-3390	242	17	mahdi	mahdi	PROPN
iajs-3390	242	18	,	,	PUNCT
iajs-3390	242	19	m.	m.	NOUN
iajs-3390	242	20	determination	determination	NOUN
iajs-3390	242	21	of	of	ADP
iajs-3390	242	22	some	some	DET
iajs-3390	242	23	biochemical	biochemical	ADJ
iajs-3390	242	24	parameters	parameter	NOUN
iajs-3390	242	25	in	in	ADP
iajs-3390	242	26	sera	sera	NOUN
iajs-3390	242	27	of	of	ADP
iajs-3390	242	28	normotensive	normotensive	NOUN
iajs-3390	242	29	and	and	CCONJ
iajs-3390	242	30	hypertensive	hypertensive	ADJ
iajs-3390	242	31	obese	obese	ADJ
iajs-3390	242	32	female	female	NOUN
iajs-3390	242	33	in	in	ADP
iajs-3390	242	34	baghdad	baghdad	PROPN
iajs-3390	242	35	.	.	PUNCT
iajs-3390	243	1	journal	journal	PROPN
iajs-3390	243	2	of	of	ADP
iajs-3390	243	3	physics	physics	PROPN
iajs-3390	243	4	:	:	PUNCT
iajs-3390	243	5	conference	conference	NOUN
iajs-3390	243	6	series	series	NOUN
iajs-3390	243	7	.	.	PUNCT
iajs-3390	244	1	2021	2021	NUM
iajs-3390	244	2	.	.	PUNCT
iajs-3390	245	1	iop	iop	PROPN
iajs-3390	245	2	publishing	publishing	PROPN
iajs-3390	245	3	2021	2021	NUM
iajs-3390	245	4	,	,	PUNCT
iajs-3390	245	5	1853(1	1853(1	NUM
iajs-3390	245	6	)	)	PUNCT
iajs-3390	245	7	,	,	PUNCT
iajs-3390	245	8	01237	01237	NUM
iajs-3390	245	9	.	.	PUNCT
iajs-3390	246	1	https://doi.org/10.1088/17426596/1853/1/012037	https://doi.org/10.1088/17426596/1853/1/012037	ADJ
iajs-3390	246	2	.	.	NOUN
iajs-3390	246	3	35	35	NUM
iajs-3390	246	4	.	.	X
iajs-3390	246	5	paiva	paiva	PROPN
iajs-3390	246	6	,	,	PUNCT
iajs-3390	246	7	e.s	e.s	PROPN
iajs-3390	246	8	.	.	PROPN
iajs-3390	246	9	;	;	PUNCT
iajs-3390	246	10	andretta	andretta	PROPN
iajs-3390	246	11	,	,	PUNCT
iajs-3390	246	12	a.	a.	NOUN
iajs-3390	246	13	;	;	PUNCT
iajs-3390	246	14	batista	batista	PROPN
iajs-3390	246	15	,	,	PUNCT
iajs-3390	246	16	e.d	e.d	PROPN
iajs-3390	246	17	.	.	PROPN
iajs-3390	246	18	;	;	PUNCT
iajs-3390	247	1	lobo	lobo	PROPN
iajs-3390	247	2	,	,	PUNCT
iajs-3390	247	3	m.m.m.t	m.m.m.t	PROPN
iajs-3390	247	4	.	.	PROPN
iajs-3390	247	5	;	;	PUNCT
iajs-3390	247	6	miranda	miranda	PROPN
iajs-3390	247	7	,	,	PUNCT
iajs-3390	247	8	r.c.d	r.c.d	NOUN
iajs-3390	247	9	.	.	PUNCT
iajs-3390	247	10	;	;	PUNCT
iajs-3390	247	11	nisihara	nisihara	PROPN
iajs-3390	247	12	,	,	PUNCT
iajs-3390	247	13	r.	r.	PROPN
iajs-3390	247	14	;	;	PUNCT
iajs-3390	247	15	schieferdecker	schieferdecker	NOUN
iajs-3390	247	16	,	,	PUNCT
iajs-3390	247	17	m.e.m	m.e.m	NOUN
iajs-3390	247	18	.	.	PUNCT
iajs-3390	247	19	;	;	PUNCT
iajs-3390	248	1	boguszewski	boguszewski	PROPN
iajs-3390	248	2	,	,	PUNCT
iajs-3390	248	3	c.l	c.l	PROPN
iajs-3390	248	4	.	.	PROPN
iajs-3390	248	5	serum	serum	PROPN
iajs-3390	248	6	levels	level	NOUN
iajs-3390	248	7	of	of	ADP
iajs-3390	248	8	leptin	leptin	NOUN
iajs-3390	248	9	and	and	CCONJ
iajs-3390	248	10	adiponectin	adiponectin	NOUN
iajs-3390	248	11	and	and	CCONJ
iajs-3390	248	12	clinical	clinical	ADJ
iajs-3390	248	13	parameters	parameter	NOUN
iajs-3390	248	14	in	in	ADP
iajs-3390	248	15	women	woman	NOUN
iajs-3390	248	16	with	with	ADP
iajs-3390	248	17	fibromyalgia	fibromyalgia	NOUN
iajs-3390	248	18	and	and	CCONJ
iajs-3390	248	19	overweight	overweight	ADJ
iajs-3390	248	20	/	/	SYM
iajs-3390	248	21	obesity	obesity	NOUN
iajs-3390	248	22	.	.	PUNCT
iajs-3390	249	1	archives	archive	NOUN
iajs-3390	249	2	of	of	ADP
iajs-3390	249	3	endocrinology	endocrinology	NOUN
iajs-3390	249	4	and	and	CCONJ
iajs-3390	249	5	metabolism	metabolism	NOUN
iajs-3390	249	6	2017	2017	NUM
iajs-3390	249	7	,	,	PUNCT
iajs-3390	249	8	61	61	NUM
iajs-3390	249	9	,	,	PUNCT
iajs-3390	249	10	249	249	NUM
iajs-3390	249	11	-	-	SYM
iajs-3390	249	12	256	256	NUM
iajs-3390	249	13	.	.	PUNCT
iajs-3390	250	1	https://doi.org/10.1590/2359-3997000000248	https://doi.org/10.1590/2359-3997000000248	NOUN
iajs-3390	250	2	.	.	PUNCT
iajs-3390	251	1	https://doi.org/10.1016/j.biochi.2020.02.008	https://doi.org/10.1016/j.biochi.2020.02.008	NOUN
iajs-3390	251	2	https://doi.org/10.1136/annrheumdis-2013-204494	https://doi.org/10.1136/annrheumdis-2013-204494	NOUN
iajs-3390	251	3	https://doi.org/10.1177/1759720x12455959	https://doi.org/10.1177/1759720x12455959	PROPN
iajs-3390	251	4	https://doi.org/10.1136/ard.2009.125260	https://doi.org/10.1136/ard.2009.125260	NOUN
iajs-3390	251	5	https://doi.org/10.1016/j.joca.2021.12.003	https://doi.org/10.1016/j.joca.2021.12.003	PROPN
iajs-3390	251	6	https://europepmc.org/article/med/9263139	https://europepmc.org/article/med/9263139	PROPN
iajs-3390	251	7	https://doi.org/10.1002/art.41793	https://doi.org/10.1002/art.41793	PROPN
iajs-3390	251	8	https://doi.org/10.1093/rheumatology/keac415	https://doi.org/10.1093/rheumatology/keac415	PRON
iajs-3390	251	9	https://doi.org/10.14704/nq.2022.20.7.nq33018	https://doi.org/10.14704/nq.2022.20.7.nq33018	NOUN
iajs-3390	251	10	https://doi.org/10.1002/2211-5463.12975	https://doi.org/10.1002/2211-5463.12975	NOUN
iajs-3390	251	11	https://doi.org/10.3389/fendo.2020.00616	https://doi.org/10.3389/fendo.2020.00616	PROPN
iajs-3390	251	12	https://doi.org/10.1088/1742-6596/1853/1/012037	https://doi.org/10.1088/1742-6596/1853/1/012037	PROPN
iajs-3390	252	1	https://doi.org/10.1088/1742-6596/1853/1/012037	https://doi.org/10.1088/1742-6596/1853/1/012037	PROPN
iajs-3390	252	2	https://doi.org/10.1590/2359-3997000000248	https://doi.org/10.1590/2359-3997000000248	PROPN
iajs-3390	252	3	ihjpas	ihjpa	VERB
iajs-3390	252	4	.	.	PUNCT
iajs-3390	253	1	2024	2024	NUM
iajs-3390	253	2	,	,	PUNCT
iajs-3390	253	3	37(4	37(4	NOUN
iajs-3390	253	4	)	)	PUNCT
iajs-3390	253	5	272	272	NUM
iajs-3390	253	6	36	36	NUM
iajs-3390	253	7	.	.	PUNCT
iajs-3390	254	1	hamza	hamza	PROPN
iajs-3390	254	2	,	,	PUNCT
iajs-3390	254	3	m.a	m.a	PROPN
iajs-3390	254	4	.	.	PROPN
iajs-3390	254	5	;	;	PUNCT
iajs-3390	254	6	al	al	PROPN
iajs-3390	254	7	tamer	tamer	PROPN
iajs-3390	254	8	,	,	PUNCT
iajs-3390	254	9	y.y	y.y	PROPN
iajs-3390	254	10	.	.	PROPN
iajs-3390	254	11	;	;	PUNCT
iajs-3390	254	12	al	al	PROPN
iajs-3390	254	13	habib	habib	PROPN
iajs-3390	254	14	,	,	PUNCT
iajs-3390	254	15	o.a	o.a	PROPN
iajs-3390	254	16	.	.	PROPN
iajs-3390	254	17	modification	modification	NOUN
iajs-3390	254	18	of	of	ADP
iajs-3390	254	19	irisin	irisin	ADJ
iajs-3390	254	20	level	level	NOUN
iajs-3390	254	21	in	in	ADP
iajs-3390	254	22	overweight	overweight	ADJ
iajs-3390	254	23	/	/	SYM
iajs-3390	254	24	obese	obese	ADJ
iajs-3390	254	25	women	woman	NOUN
iajs-3390	254	26	during	during	ADP
iajs-3390	254	27	pregnancy	pregnancy	NOUN
iajs-3390	254	28	and	and	CCONJ
iajs-3390	254	29	its	its	PRON
iajs-3390	254	30	association	association	NOUN
iajs-3390	254	31	with	with	ADP
iajs-3390	254	32	some	some	DET
iajs-3390	254	33	metabolic	metabolic	ADJ
iajs-3390	254	34	risk	risk	NOUN
iajs-3390	254	35	factors	factor	NOUN
iajs-3390	254	36	.	.	PUNCT
iajs-3390	255	1	baghdad	baghdad	PROPN
iajs-3390	255	2	science	science	PROPN
iajs-3390	255	3	journal	journal	PROPN
iajs-3390	255	4	2020	2020	NUM
iajs-3390	255	5	,	,	PUNCT
iajs-3390	255	6	17(3	17(3	NUM
iajs-3390	255	7	)	)	PUNCT
iajs-3390	255	8	,	,	PUNCT
iajs-3390	255	9	1124	1124	NUM
iajs-3390	255	10	.	.	PUNCT
iajs-3390	256	1	http://dx.doi.org/10.21123/bsj.2020.17.3(suppl.).1124	http://dx.doi.org/10.21123/bsj.2020.17.3(suppl.).1124	PROPN
iajs-3390	256	2	.	.	PROPN
iajs-3390	257	1	37	37	NUM
iajs-3390	257	2	.	.	PUNCT
iajs-3390	258	1	peng	peng	PROPN
iajs-3390	258	2	,	,	PUNCT
iajs-3390	258	3	x.	x.	PROPN
iajs-3390	258	4	;	;	PUNCT
iajs-3390	258	5	wu	wu	PROPN
iajs-3390	258	6	,	,	PUNCT
iajs-3390	258	7	h.	h.	PROPN
iajs-3390	258	8	inflammatory	inflammatory	ADJ
iajs-3390	258	9	links	link	NOUN
iajs-3390	258	10	between	between	ADP
iajs-3390	258	11	hypertriglyceridemia	hypertriglyceridemia	NOUN
iajs-3390	258	12	and	and	CCONJ
iajs-3390	258	13	atherogenesis	atherogenesis	NOUN
iajs-3390	258	14	.	.	PUNCT
iajs-3390	259	1	current	current	ADJ
iajs-3390	259	2	atherosclerosis	atherosclerosis	NOUN
iajs-3390	259	3	reports	report	NOUN
iajs-3390	259	4	2022	2022	NUM
iajs-3390	259	5	,	,	PUNCT
iajs-3390	259	6	24(5	24(5	NUM
iajs-3390	259	7	)	)	PUNCT
iajs-3390	259	8	,	,	PUNCT
iajs-3390	259	9	297	297	NUM
iajs-3390	259	10	-	-	SYM
iajs-3390	259	11	306	306	NUM
iajs-3390	259	12	.	.	PUNCT
iajs-3390	260	1	https://doi.org/10.1007/s11883-022-01006-w	https://doi.org/10.1007/s11883-022-01006-w	NOUN
iajs-3390	260	2	.	.	PUNCT
iajs-3390	261	1	http://dx.doi.org/10.21123/bsj.2020.17.3(suppl.).1124	http://dx.doi.org/10.21123/bsj.2020.17.3(suppl.).1124	PROPN
iajs-3390	261	2	https://doi.org/10.1007/s11883-022-01006-w	https://doi.org/10.1007/s11883-022-01006-w	NOUN